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Abstract
In the various brachytherapy techniques the intent is to deliver as high a tumour dose 
as possible, limited only by surrounding normal tissue tolerance. The main feature of 
the techniques is very steep dose gradients, representing a potential limiting factor in 
accurate dose distribution measurements around sources. Dose distributions at 
distances less than 1 cm are therefore normally generated using either validated 
Monte Carlo (MC) simulations or standard dose calculation formalisms, for example 
that of AAPM TG 43, while dose measurements can only be performed at larger 
distances, normally greater than 1cm from the outer dimensions of the source 
encapsulation
Ge-doped silica fibres are a viable thermoluminescent dosimetry (TLD) 
system, providing good spatial resolution o f approximately 120 pm, sensitive 
response to ionizing radiations, large dynamic dose range, good reproducibility and 
reusability, dose rate independence, minimal fading, resistance to water and low cost. 
Dosimetric characterisation of commercial Ge-doped silica fibres have been obtained 
by subjecting them to kilovoltage therapeutic x-ray radiation beams, verifying their 
use for brachytherapy sources; dose response, reproducibility and fading at 90 kVp 
and 300 kVp have been investigated. Central-axis depth doses have been obtained at 
the two accelerating potentials using different field size applicators, measurements 
being made using the fibres in both water and a GAMMEX RMl 4571 solid water 
phantom. Comparison has been made with central-axis depth doses, measured using a
0.6 cm3 graphite-walled ionisation chamber data and British Journal o f Radiology 
Supplement 25 tabulated values (both in water). Ge-doped optical fibre dosimeters 
show good dosimetric response for low photon energies. These desirable 
characteristics support the use of these TL fibres as dosimeters for brachytherapy 
applications.
Ge-doped optical fibre TL dosimeters have been used to measure the dose distribution 
around two Low Dose Rate (LDR) *^ 1^ seeds; model 6711, the new thinner model 
9011 and a High Dose Rate (HDR) ^^ I^r (MicroSelectron V2) source at proximal
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distances down to 1 mm, measured in a Perspex medium. The anisotropy has also 
been measured in Perspex, for distances from 10 to 100 mm from a LDR ^^ 1^ seed 
model 6711 centre, in 10 mm increments and at angles 10° to 90° in 10° increments 
from the seed central axis. Measured doses have been compared with calculations 
and treatment planning system (TPS) predicted doses for the same locations. Monte 
Carlo simulations were obtained using the EGSnrc \ DOSRZnrc codes and TPS 
predicted doses were obtained using the system VariSeed V8.0.2. For ^^ 1^ seed model 
6711, the measurements agree with simulations to within 2.3 % ± 0.3 % along the 
transverse and perpendicular axes and within 3.0 % ± 0.5 % for measurements 
investigating anisotropy in angular dose distribution. Measured and Veriseed™ 
brachytherapy treatment planning system (TPS) values agreed to within 2.7 % ± 0.5 
%. For the new thinner ^^ 1^ model 9011, dose measurements were in good agreement 
with simulations to within 2.1 ±  0.2 %, while dose measurements and doses obtained 
through use o f the Variseed TPS agreed well, to within 2.2 ±  0.5 %. The above work 
has therefore demonstrated the applicability o f Ge-doped optical fibres for use in 
brachytherapy.
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Chapter 1
1. Introduction
Brachytherapy is a form of radiotherapy treatment in which sealed radioactive 
sources are used, the sources being placed inside or next to the area to be treated. 
Brachytherapy is commonly used to treat the cervix, prostate, breast and skin cancers 
(Podgorsak 2005). It has also been used to treat the brain, eye, head and neck region, 
the respiratory tract, the digestive tract, urinary tract and female reproduction tract 
(Podgorsak 2005). Among the artificial radionuclides that are currently commonly 
used as brachytherapy sources are ^^ I^r, ^°Co, ^^^Cs and with ^^ I^r and ^°Co being 
used in HDR temporary implant brachytherapy and and *^^Pd being used in LDR 
permanent implant brachytherapy (Baltas, Sakelliou et al. 2006).
A vital feature o f brachytherapy techniques is the extremely rapid fall off in 
dose rate around the source, delivering high dose to the tumour but much more limited 
dose to surrounding normal tissue. Using conventional dosimeters, high dose 
gradients represent a considerable challenge in obtaining accurate and high precision 
dose measurements at distances close to sources. As such, most efforts have been 
placed on making dose measurements at distances greater than ~ 1 cm, otherwise 
calculating dose through use of the AAPM TG algorithm (Nath, Anderson et al. 1995; 
Podgorsak 2005) and through validated Monte Carlo simulations. In addition, at 
close-up distances, sources cannot be assumed to be point emitters, use of the inverse 
square law leading to large variation in the calculated dose rate around brachytherapy 
sources. As such, interpolation of dose rate values is difficult without the availability 
of an extremely large table of measured data and benchmarked Monte Carlo 
simulations. It is only possible to extrapolate to small distances from dose rate profiles 
measured at distances of 5 and 10 mm by suppressing the inverse square law
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dependence, interpolating instead between thinly distributed measured values (Nath, 
Anderson et al. 1995). Such a restriction places limitations on verifying dose at 
distances near to brachytherapy sources, being particularly problematic when both 
rapid fall of in dose and small movement in sources occur, of even a few mm, 
implying inaccurate knowledge of dose to surrounding critical tissue (the bladder for 
instance in cervical cancer treatments). Specific consideration o f accuracy should be 
given to the 0.5 cm to 1.5 cm distance range; this range is the most critical for 
accurate calculation o f dose for prostate and other volume implants and for relating 
absolute dose rate to relative dose distribution (Rivard, Coursey et al. 2004). Accurate 
estimation o f dose at short distance (less then 5mm) is also critical in some other 
procedures, such as episcleral eye plaque therapy and for evaluation o f hotspots in all 
implants. In addition, the estimation o f dose distribution at large distances effects the 
accuracy of the overall dose distribution, and are significant for obtaining dose to 
organs at risk, thus, dose rate should be obtained at the smallest of distances (Rivard, 
Coursey et al. 2004). Dose rate measurements and calculations should also be 
available for intravascular brachytherapy at short distances (less than 5 mm) from the 
source (Podgorsak 2005). In this dissertation Ge-doped optical fibres, which provide 
for an effective form of thermoluminescence dosimeter, are studied to ascertain if  they 
can be successfully applied in obtaining dose measurements at such small distances 
from brachytherapy sources.
In regard to the above, Ge-doped optical fibres have particular characteristics that 
attract their use as thermoluminescence radiation dosimeters in therapeutic 
applications, including the fact that they provide sensitive response to ionizing 
radiations, are impervious to water, offer good spatial resolution (-120 pm), suffer 
limiting fading, are dose rate independent, respond over a high dynamic range, have 
low dose detection capability, show good reproducibility and represent a low cost 
dosimetry system. Ge-doped optical fibres have been chosen to be TL-dosimeters to 
be used herein to obtain dose measurements around both high dose rate (HDR) Ir-192 
(MicroSelectron V2) sources and two low dose rate (LDR) 1-125 brachytherapy 
sources (model 6711 and the new thinner model 9011) for distances very close to the 
sources (down to 1mm from the sources). Angular dose distribution is also measured
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around LDR 1-125 brachytherapy sources (model 6711). For validation purposes, the 
EGS/DOSRZnrc Monte Carlo simulation code has been used to obtained dose 
calculations at the same measurements points around the LDR sources. In addition, 
treatment planning system (TPS) predicted dose has also been obtained at the same 
measurements points around the LDR sources, use being made o f the VariSeed V8.0.2 
TPS
1.1. Motivation
This study aims to establish Ge-doped optical fibres as thermoluminescent 
dosimeters for brachytherapy applications and to investigate their ability to obtain 
dose measurements down to small distances, including 1 mm from sources. One such 
goal is to obtain dose measurements around some typical LDR sources and a HDR 
source using the Ge-doped silica (SiOi) optical fibre dosimeters at distances from 1 
mm up to 100 mm from the source centre. Also to be obtained are measures o f dose 
anisotropy, at distances of from 10 to 100 mm from a LDR *^ I^ seed model 6711 
centre, in 10 mm increments and at angles 10° to 90° in 10° increments from the 
central axis o f the seed, all measured in a PMMA medium. Measurements have then 
been compared with dose calculations obtained by Monte Carlo simulations, use 
being made o f the EGS/DOSRZnrc code, and also with predicted doses obtained 
using a VariSeed V8.0.2 TPS to verify dose measurement results. However, to 
achieve these aims, comprehensive dosimetry characterization of the Ge-doped 
optical fibre dosimeters are first required, to include dose response, fading, and 
reproducibility at low photon energies. All have been investigated within this 
dissertation to check the response of Ge-doped optical fibre dosimeters and to allow 
application o f correction factors when they are required, acknowledging that most 
modem brachytherapy sources emit photons at relatively low energies, in the 
approximate energy range 0.35 - 0.66 MeV. In addition, relative dose measurements 
are needed, to provide for comparison against published tabulated data, including 
percentage depth dose and solid water/water fluence correction factors. For the latter, 
investigation was typically performed using a therapy x-ray tube operated at
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accelerating potentials o f 90 kVp and 300 kVp (the energies available) for a range of 
field size applicators in water and also using a GAMMEX RMI 4571 solid water 
phantom. In addition, prior to using real brachytherapy sources, for radiation safety 
reasons and also to represent a challenge to the capability of the fibres, dose 
measurements were obtained around two lab sources; '^^Ba and ^°Co at distances 1 
mm to 20 mm from the sources encapsulation surface. The results o f these were 
compared with dose calculations obtained with the EGS/DOSRZnrc Monte Carlo 
code, the particular study aiming to establish the dose measurement methodology 
before application to clinical brachytherapy source dosimetry.
1.2. Structure of Thesis
Chapter 1: This chapter provides an introduction to the thesis, outlining the 
motivation and goals o f the work and then detailing the structure of the thesis.
Chapter 2: This chapter presents a review of the existing literature and underpinning 
theory, including interactions of radiations (photons and electrons) with matter, an 
overview o f brachytherapy and its dosimetry, including an explanation of the 
implementation techniques (surface, intracavitary, interstitial, intravascular, eye 
plaques), systems o f implant dosimetry (the Patterson-Parker system, the Quimby 
system, the Memorial System, the Paris system all being examples), brachytherapy 
radioactive sources (^^ I^ LDR and ^^ I^r HDR sources, all discussed in detail), source 
dosimetry (in particular a detailed discussion o f the AAPM TG-43 formula), radiation 
dosimeters (this section explaining TL dosimetry, properties of dosimeters including 
the available accuracy and precision, dose response, minimum detectable dose, dose 
rate dependence, energy dependence, directional dependence, fading and stability, 
storage and handling), optical fibres as TL-dosimeters in particular; the structure o f 
silica, defects, Ge-doped optical fibres and Ge-doped optical fibre dosimeters are all 
discussed, and finally; Monte Carlo simulation.
Chapter 3: In this chapter the selection procedures for Ge-doped optical fibre 
dosimeters are first discussed. This is then followed by characterisation o f Ge-doped
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optical fibre dosimeters, including dose response, reproducibility and fading, all 
investigated at relatively low photon energies, typically 90 kVp and 300 kVp. The Ge- 
doped optical fibre dosimeters are also used for a range of relative dose 
measurements; both percentage depth dose and solid water/water correction factors 
are measured and these are compared with associated reference tabulated data, at 90 
kVp and 300 kVp and for various field applicators, in water and a GAMMEX RMI 
4571 solid water phantom.
Chapter 4: This chapter concentrates on establishing the methodology of dose 
measurements using Ge-doped optical fibre dosimeters at distances down to 1 mm 
from the encapsulation surface, use being made o f two laboratory sources (of low 
activity and therefore relatively safe to use). This was carried out with the intent of 
preparing for use o f an appropriate, effective methodology before applying this to 
clinical brachytherapy source dosimetry. In-air dose measurements were performed 
using Ge-doped optical fibres around ^^^Ba and ^®Co sources at distances from 20 mm 
to 1 mm from the sources encapsulation surface, results being compared with 
EGS/DOSRZnrc Monte Carlo code calculations for photon-mediated dose only and 
for electron and photon-mediated dose. The comparison was performed to check 
whether beta dose has been filtered out by the source encapsulation or whether any 
beta dose contributions result from imperfections in the source encapsulation. Monte 
Carlo calculations are performed at the same distances to verify the measurement 
results.
Chapter 5: This chapter demonstrates high resolution LDR (Low Dose Rate) *^ I^ 
brachytherapy dosimetry, focusing on a 6711 model: Ge-doped optical fibres are used 
to measure dose in PMMA along the transverse and central axes, at distances from 1 
mm to 60 mm. Anisotropy doses are also obtained at polar angles o f 10° to 90° in 10° 
increments, and at distances o f 10 mm to 100 mm from the seed centre, in 10 mm 
increments. This chapter also illustrates dose calculations obtaining using 
EGS/DOSRZnrc Monte Carlo simulations in PMMA and, for the same set up, 
predicted doses obtained with a VariSeed™ 8.0.2 Treatment Planning System (TPS),
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the comparison between dose measurements and calculations being made to check 
and validate the Ge-doped optical fibres dosimeters.
Chapter 6: Following the American Association of Physicists in Medicine (AAPM) 
Task Group (TG-43) recommendation for study o f the dosimetric properties of a new 
LDR source (the THINSeed™, model 9011) prior to use in the clinical 
applications, chapter 6 investigates dose measurements along the central and 
transverse axes of the source, from 1 mm from the source centre to 60 mm using Ge- 
doped optical fibres dosimeters. For verification purposes, dose measurement results 
are compared with dose calculations obtained from Monte Carlo simulations and with 
predicted doses obtained from a VariSeed™ 8.0.2 TPS. There have been limited 
publications to date describing the dose distribution around this particular source 
(Rivard 2009; Kennedy, Davis et al. 2010).
Chapter 7: High resolution HDR ^^^ Ir brachytherapy source dosimetry is discussed in 
this chapter. Dose measurements around a ^^^ Ir HDR brachytherapy source along the 
central and transverse axes of the source are obtained, use being made of Ge-doped 
optical fibres, at distances from 100 mm down to 1 mm.
Chapter 8: Finally, in this chapter the conclusions of this research are presented, 
including suggestions for possible future work.
Published papers, published abstracts and a list of conference presentations arising 
from this work are attached in the appendix C
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Chapter 2
2. Literature Review and Underpinning Theory
2.1. Interactions of Radiation With Matter
In radiation therapy, tissue is typically irradiated with photons (x- or y-rays) or 
charged particles, most prevalently electrons and protons, to kill cancer cells or to 
avoid their spread. In the following, an explanation o f the interactions o f the 
radiations with matter (tissue) will be provided, focusing only on the photon and 
electrons, being the particular radiations of interest in this research.
2.1.1. Interactions of Photons With Matter
Photons interact with matter through a variety of interactions; only three of 
these interaction mechanisms can be considered to be of importance for the majority 
of radiation measurements made in medicine (see Figure. 2.1): the photoelectric effect 
which predominates for the low energy x- and gamma-rays (up to several hundred 
keV), pair production, which predominates for high energy photons (for tissues, above 
5-10 MeV), and Compton scattering, which is the most probable process over the 
range of energies between the previous two boundaries (Knoll 2000)
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Figure 2-1: The relative importance of the three major types of gamma-ray 
interaction (Knoll 2000)
2.1.1.x. Photoelectric Absorption
The photoelectric absorption process is an interaction of a photon with a 
tightly bound orbital electron of an absorber atom [in the K, L, M, N-shells etc] (Khan 
2003). The incident photon disappears as it is totally absorbed by the electron (known 
as the photoelectron), the electron being ejected from the atom with energy Ee, and 
given by the following equation:
Ee- = hv - Eh Eq. 2.1,
where: Eb is the binding energy of the photoelectron in its original shell and 
hv is the energy of the incident photon.
The following diagram (Figure. 2.2) demonstrates the photoelectric 
absorption interaction (Knoll 2000).
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Figure 2-2: Diagram illustrating the photoelectric absorption process (Khan 2003)
A vacancy is created in the electron shell as a result of the photoelectron 
emission. This vacancy is quickly filled by capturing a free electron from the medium 
(the absorber) and/or rearrangement o f electrons from other shells of the atom. 
Consequently, one or more characteristic x-rays might be created (Knoll 2000). Auger 
electrons also can be released, these being monoenergetic electrons produced through 
absorption of characteristic x-rays and subsequent outer-shell electron release from 
the atom (Khan 2003).
Photoelectric absorption predominates for low energy photon interactions 
and increases in high atomic number, Z, absorber materials. The probability o f the 
photoelectric interactions is expressed in the following relation (Khan 2003):
T Z Eq. 2.2,
p  h v
where — is the mass photoelectric attenuation coefficient and h v  is the energy o f the 
P
incident photon.
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2.1.1.2. Compton Scattering (Incoherent Scatting):
In the Compton scattering interaction, a photon interacts with a free electron 
of an absorber (Khan 2003). The incident photon transfers a part o f its energy to the 
electron and scatters at an angle 0 with respect to its original direction; the electron 
receiving a portion of the photon energy is referred to as the recoil electron and is 
emitted at an angle (p. The energy transferred to the electron can be any amount from 
zero up to a large fraction of the incident photon energy; the scattering angle of the 
outgoing photon can be at any angle (Knoll 2000). The Compton scattering process is 
demonstrated in the following diagram:
Recoil
electronIncident photon 
(energy ~ hv)
Scattered photon 
(energy = hv')
Figure 2-3: Diagram demonstrating the Compton scattering process. (Khan 2003)
By using the symbols in the diagram and applying the conservation of 
energy and momentum laws, the scattered photon energy is given by:
hv = --------— —----------- Eq. 2.3,
l + ^ ( l - C O S 0 )
where itiqC^  is the rest mass energy of the electron, 511 keV.
FATMA ISSA 2012 Page 10
Chapter 2: Literature Review and Underpinning Theory
Doped Optical Fibres Thermoluminescence Dosimetry fo r  Brachytherapy
Very little energy is transferred from the incident photon when the scattering 
angle 0 is very small while the electrons will receive the maximum possible energy 
from the incident photon if the scattering angle is 180°. The angular distribution of 
scattered photons can be calculated using the Klein-Nishina formula (Knoll 2000).
Compton scattering occurs if  the energy o f the photon is equal or exceeds 
the binding energy of the electron, thus as photon energy increases, photoelectric 
absorption decreases and Compton scattering increases. While the variation in 
Compton scattering is independent o f the atomic number Z, the Compton mass 
attenuation coefficient (o/p), does depend on the number of electrons per gram (Khan 
2003).
2.I.I.3. Pair Production
Photons can interact with matter through the pair production mechanism if the 
energy o f the incident photon is greater or equal to twice the electron rest-mass energy 
(511 keV). Figure 2.4 shows the pair production process. In the pair production 
process, the photon interacts with the electromagnetic field o f the atomic nucleus, the 
photon disappears and two electronic particles are created; namely the electron (e-) - 
positron pair (e+). Since, the rest mass energy o f the electron is 0.511 MeV, then 
1.022 MeV is the threshold energy for the pair production process to take place. For a 
photon energy that exceeds this threshold energy, the excess energy is shared between 
the two particles as kinetic energy (Khan 2003).
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Figure 2-4: Diagram demonstrating the pair production process (Khan 2003)
The positron quickly combines with an electron and two photons with energy 
511 keV each, emitted in opposite directions, will be produced in a process known as 
annihilation, as shown in figure 2.5 (Khan 2003).
^v=0.51MeV
Uv=. 0.51 MeV
Figure 2-5: Diagram demonstrating the production of annihilation radiation (Khan
2003)
The probability o f the pair production interaction depends strongly on the 
atomic number Z, increasing as the square o f Z, the pair production mechanism being 
an interaction with the electromagnetic field o f an atomic nucleus. Also, it increases 
as the photon energy increases above the threshold energy (Khan 2003).
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2.1.2. Interactions of Electrons With Matter
In energetic electrons passing through a medium, they interact with the 
medium through Coulomb interactions with orbital electrons and nuclei of medium 
atoms. However, during the collisions there are two possibilities; either the electrons 
may lose their kinetic energy (through collision and radiative losses) or by changing 
their direction of travel (i.e. scattering). Stopping power is used to define the energy 
losses of the former, while scattering power is used to define the scattering losses. 
Charged particles also interact with nuclei through reactions, typically creating 
radioactive nuclei (Khan 2003; Podgorsak 2005)
The stopping power (S) is defined as the rate of kinetic energy loss per unit 
path length of the particle, (dE/dx), whereas the mass stopping power is defined as S/p 
and is given in MeV cm^/g, with p the density of the medium (Podgorsak 2005).
Electrons that have been set into motion through radiation interactions go on 
to subsequently interact with orbital electrons or the nuclei of atoms, suffering elastic 
or inelastic collisions. In an elastic collision, the incident electron changes its 
direction and is deflected from its original path without loss o f energy (elastic 
scattering). Conversely, in an inelastic collision the electron is deflected from its 
original path and in so doing loses some of its energy, the latter being transferred to an 
orbital electron or is otherwise released as an x-ray in the form of a bremsstrahlung 
photon (Podgorsak 2005).
2.1.2.1. Electron-Orbital Electron Interaction
Coulomb interactions between the incident electron and orbital electrons o f a 
medium cause ionisations and excitation o f medium atoms (Podgorsak 2005). 
Ionisation occurs if  the energy transferred from electrons to the orbital electrons of 
medium atoms is sufficient to overcome the binding energy and thus liberate the 
electrons from their atoms. If the energy is insufficient to overcome the binding 
energy, then it results in excitation of atoms i.e. transfer an orbital electron o f the
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medium atom from an allowed shell to a higher shell, and subsequent de-excitation to 
a lower orbit (Khan 2003; Podgorsak 2005).
The liberated electrons resulting from the ionisation process are known as 
secondary electrons and these secondary electrons also move through the medium and 
interact with the medium atoms, resulting in ionisation or excitation, depositing their 
energy in the medium as dose until stopped (Khan 2003). Atomic excitations and 
ionizations also cause collisional energy losses, which can be defined by a collision 
(ionization) stopping power (Podgorsak 2005).
2.1.2.2. Electron-Nucleus Interactions
Due to the small mass of electrons compared to nuclei, they can also interact 
with the electromagnetic field of medium nuclei, resulting in sudden braking, the 
resultant energy loss being expressed as x-ray photons called bremsstrahlung. As the 
energy of electrons and the atomic number o f the medium increase, the rate o f energy 
loss as a consequence of bremsstrahlung increases. These types o f energy loss are 
characterized through use of the radiative stopping power (Khan 2003; Podgorsak 
2005).
2.2. Overview of Brachytherapy and Its Dosimetry
Brachytherapy, literally close-up therapy, is a form o f radiation treatment in 
which most typically encapsulated radioactive sources are located directly inside or 
close to the volume to be treated, hence the identification of short distance treatment, 
most prevalently o f cancer. Most brachytherapy sources are photon emitters, less 
frequently (3-emitters and much more rarely, neutron emitting sources, p or y 
radioactive source emitters are typically utilized in the form of for instance surface 
plaques but are also used in intraluminal, intraoperative and intravascular 
brachytherapy treatments (Podgorsak 2005).
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Brachytherapy is commonly used to treat the cervix, prostate, breast and skin 
cancers (Podgorsak 2005). It has also been used to treat the brain, eye, head and neck 
region (e.g. for the lip, floor of the mouth, tongue, nasopharynx and oropharynx), the 
respiratory tract (e.g. trachea and bronchi), the digestive tract (e.g. oesophagus, gall 
bladder and rectum), urinary tract (e.g. bladder, urethra and penis) and female 
reproduction tract (e.g. uterus and vagina). The main advantages o f brachytherapy 
treatments over external beam radiotherapy relate to the ability to deliver very 
accurate dose to the target volume, with the sources placed or inserted within the 
tissue to be treated, high dose being delivered to the tumour and very low dose to the 
surrounding normal tissue, largely avoiding surrounding normal tissue. Dose 
escalation is also possible, with inter/intrafraction movements and setup concerns 
being largely avoidable. Some of the disadvantages o f the brachytherapy techniques 
include that typically such techniques can only be applied if for instance a tumour is 
small and very well localized. In addition, use of the radioactive materials carries with 
it the reality of irradiation of staff and visitors, albeit under highly controlled 
arrangements, with special concern being paid regarding storing and preparing o f the 
radioactive materials Further, some brachytherapy applications necessitate surgical 
procedures, as in for instance in intraperitoneal colloidal ^^^Au therapy and ^^ I^ 
radiation synovectomy, with all of the radiation protection precautions that such 
procedures would imply (Podgorsak 2005).
Brachytherapy treatments can be categorized with respect to treatment 
duration, as in for instance: 1) temporary implants with radioactive sources removed 
after delivery of a prescribed dose, with a treatment o f duration of typically ~ hours to 
days; 2) permanent implants, with radioactive sources left in the patient at least for a 
duration of the effective lifetime o f the sources (i.e. over many half-lives). An 
example of the latter might be gold (^^^Au; ti/2 = 2.7 days) grain therapy. There are 
two methods of loading brachytherapy sources; hot loading and afterloading. In hot 
loading, radioactive sources are preloaded to an applicator so that the applicator 
contains the radioactive sources when inserted into the patient, while in the 
afterloading method, the empty applicator is inserted into the patient, and 
subsequently the radioactive sources are either loaded manually (manual afterloading)
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or automatically by way o f a machine (automatic remote afterloading) (Podgorsak 
2005). Brachytherapy treatments can also be classified with respect to dose rate, as 
follows: Low Dose Rate (LDR), with dose rates from 0.4-2 Gy/h; Medium Dose Rate 
(MDR), with dose rates from 2-12 Gy/h, and; High Dose Rate (HDR), with dose rates 
>12 Gy (Williams and Thwaites 2000; Gerbaulet, Potter et al. 2002).
2.2.1. Implementation Techniques: Clinical Use and Dosimetry Systems:
2.2.1.1. Surface (Mould):
In this technique, radioactive sources are positioned over the tissue to be 
treated, plastic moulds being pre-prepared to conform to the surface to be treated. As 
such, when in place, the sources are securely positioned on the outer surface o f the 
mould. The plastic moulds are prepared to conform in a well-defined way with the 
surface to be treated. The spacing between the skin surface and the sources plane is 
typically selected to provide a 0.5 to 1.0 cm treatment distance. The rules for source 
distribution and associated dosimetry in mould treatments are the same as those for 
interstitial sources (Podgorsak 2005).
2.2.1.2. Intracavitary
These always refer to temporary implants, the sources being inserted into 
existing body cavities (such as, uterus, around the cervix, uterine canal and vagina) 
close to the tumour volume. (Khan 2003; Podgorsak 2005). Sources are loaded into 
different applicators according to the target to be treated; for instance, a cervix 
applicator consists of a central tube (the so-called tandem) and lateral capsules 
(ovoids) (Khan 2003) (Podgorsak 2005). In regard to the Fletcher-Suit applicator 
(figure 2.6), the tandem and the ovoids (the latter sometimes also being referred to as 
the colpostats) are both made o f stainless steel and are secured to hollow handles to 
provide for afterloading of the sources. ICRU report No. 38 (ICRU 1985) includes
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the data recommended for gynaecological brachytherapy, including a description of 
the technique (source, applicator), the total reference air kerma rate, the time dose 
pattern, a description of the reference volume and dose reference points (bladder, 
rectum, lymphatic trapezoid, pelvic wall). The same report considers a 60 Gy 
absorbed dose as the reference dose for LDR treatments; consequently dimensions 
(width, height and thickness) of the 60 Gy pear shape of the isodose reference volume 
are defined. However, if the treatment also requires external beam radiotherapy 
together with the brachytherapy, then the dose to be delivered during the external 
beam treatment will need to be subtracted from the total 60 Gy dose (Podgorsak 
2005).
Figure 2-6: Shows a Fletcher-Suit applicator set (Fletcher 1973)
2.2.1.3. Interstitial
This can either be temporary or permanent. In interstitial treatments, 
radioactive sources are implanted surgically within the tumour volume. Both manual 
and remote afterloading procedures can be applied to insert temporary implants. In 
regard to the dosimetry systems, in the beginning years of the application of
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brachytherapy techniques, the total delivered dose as a function o f the volume or area 
treated were tabulated from calculations, ready to be looked up and used. 
Consequently, to obtain sufficient treatment times, the number of sources and the 
geometry of the source insertions within the target volume were referred to in using 
these tables. ICRU report No. 58 includes dosimetry information and 
recommendations for interstitial implant treatments, including clinical target volume 
description, explanation o f sources, technique and implant time, total reference air 
kerma, explanation of dose (including prescription point/surface, prescription dose, 
reference doses is exiting in the central plane, mean central dose and peripheral dose), 
an explanation o f regions o f high and low dose and dose uniformity regions, and 
Dose-Volume histograms (DYHs). It is important to record high dose regions o f > 
150 % of the mean central dose and low dose regions o f < 90 % of the peripheral dose 
in order to address any possibility for late damage effects or recurrence respectively 
(Podgorsak 2005).
2.2.1.4. Intravascular
Brachytherapy techniques are being utilized following angioplastic treatment, 
seeking to avoid re-stenosis through irradiation o f the lumen to create localized 
stiffening of the affected tissue (Podgorsak 2005). In this, a catheter containing 
radioactive sources or a radioactive stent is used to deliver dose to the affected 
(treated) coronary artery vessel wall, typically with a single radioactive source 
inserted into large or small arteries. The sources that have been used in this 
brachytherapy technique are ^^^ Ir and ^^Sr/^^Y; ^^^ Ir emits medium energy y rays 
(predominantly between 200- and 600 keV) and can be used both at LDR and HDR 
depending upon the activity chosen, while and ^^P are chosen because they are p 
emitting sources and so preferentially irradiate the affected tissue (Podgorsak 2005). 
Numerous factors should be considered when selection is made of suitable radioactive 
sources for this type of brachytherapy treatment, including to ensure sufficient dose is 
delivered to the target tissue, appropriate penetration depth is achieved and that there 
is appropriate limitation of radiation dose to staff. In this particular treatment, 14 Gy
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is typically the prescribed dose to be delivered at 2 mm from the source centre and the 
inner lumen surface should not receive a dose of higher than 30 Gy (Podgorsak 2005). 
It is important to mention that in such techniques, for clinical purposes calculation is 
required o f dose rates at highly limited distance, certainly < 5 mm (Podgorsak 2005).
2.2.I.5. Eye Plaques
Intraocular melanoma, the major common eye tumour, has been treated using 
*^ I^ seeds. These are loaded into an eye plaque and then placed externally to the sclera 
(outer) surface over the tumour base. The number of seeds chosen varies according to 
the plaque size, being typically between 7 - 2 4  for plaques o f diameters 12-20 mm, 
with activity of 0.5 - 5 mCi per seed to provide dose rates of 0.5-1.25 Gy/h, delivering 
a prescribed dose of 100 Gy in 5-12 consecutive days (Podgorsak 2005). If  the apical 
height is larger than 5 mm then the prescribed dose is taken at the tumour apex, while 
in the case of an apex of less than 5 mm high it is taken at 5 mm depth from the 
interior sclera. Tumour localization is defined using fundoscopy, fundus photography 
and ultrasound scans A and B, CT and magnetic resonance imaging (MRI). The 
ultrasound is utilized post-implant to verify plaque placement (Podgorsak 2005).
It is important to mention that in use of typically utilized p-emitting sources 
the penetration depth can be selected, such that for ^^Sr/^^Y (maximum electron 
energy o f 2.27 MeV) useful penetration is obtained to 12 mm into tissue, while for 
^^^Ru (maximum electron energy of 3.4 MeV) penetration is obtained to 20 mm into 
tissue, both nuclides being used for eye lesion treatment (Podgorsak 2005).
2.2.2. Systems of Implant Dosimetry
Several dosimetric systems have been used over the past 50 years, including 
the Patterson-Parker (Manchester) system and Quimby (Memorial) system, both o f 
which have been widely used for routine treatment planning using tables and defined
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source distributions, most particularly before the era of the common availability of 
computers. Other systems that have been extensively used under the same 
circumstances are the Paris and Stockholm systems. While, with the advent of 
computer treatment planning systems such highly defined source geometries have 
largely been superseded (Podgorsak 2005) (Khan 2003). Nevertheless in the interests 
of completeness and to underline the manifest relationship between dose delivered, 
source geometry and distance to the treatment target, sections 2.2.2.1 to 2.2.2.5 below 
contains brief review o f some of the more well-known defined geometry 
arrangements.
2.2.21. Patterson-Parker System (also Named Manchester System) (For 
Interstitial Therapy):
The Patterson-Parker system aims to provide delivery o f a uniform dose (±10  
% from the prescribed dose) to the plane or volume to be treated. Depending upon the 
size of the target volume, sources are uniformly distributed following particular rules, 
with greater source strength present in the periphery. The prescribed dose is usually 
10 % less than the minimum dose within the treated volume. Dose tables for this 
system provide the cumulative source strength necessary to deliver 900 cGy, by 
applying the appropriate factors and dose units as a function of area (planar implants) 
or volume (Podgorsak 2005) (Khan 2003) (Williams and Thwaites 2000). The sources 
can be arranged as follows:
• Sources in a single plane. Here, the tissue to be treated is considered to be a 
slab o f 1 cm thick, the prescribed dose being on a parallel plane and 0.5 cm 
away from the source plane (Podgorsak 2005) (Williams and Thwaites 2000).
• Sources in a double plane. Here, 2.5 cm thick tissue slabs are treated with 
sources that are inserted into two parallel planes, the total source strength 
being divided equally between the two planes, following the rules of single 
plane implants. However, if the separation between the two planes is greater
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than 1 cm correction factors are applied in order to attain a minimum dose no 
more than 10 % lower than the prescribed dose (i.e. the stated dose). The 
prescribed dose is at 0.5 cm from the source planes in each interior plane. For 
thick target volumes, the midplane dose in such that it is 20 % - 30 % lower 
than the prescribed dose (Podgorsak 2005); (Williams and Thwaites 2000). 
More details are provided in (Khan 2003). Figure 2.7 demonstrates three 
examples of planar implants; details are included in (Khan 2003),
A
Figure 2-7: Examples o f three planar implants. A: Both ends crossed. B One end 
uncrossed. C: Both ends uncrossed (Khan 2003).
Other Volumes. For some tumours it is better to implant sources in a 3D shape 
such as cylinders, spheres and cuboids (Khan 2003). As an instance, a cylinder 
consisting of eight needles in the belt, four in the core and four at one end; 
figure 2.8. Needles should be distributed uniformly and with spacing not more 
than 1 cm, and the needles should be at least eight needles in the belt and four 
in the core (Khan 2003). Distribution rules are applied from the rind to the 
core for different shapes of volumes such as a cylinder, sphere, rectangular 
solid, with 75 % of the source strength being inserted on the rind and 25 % in 
the core (Podgorsak 2005) (Williams and Thwaites 2000).
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f
Figure 2-8: Example of a cylindrical volume implant with one end uncrossed. The 
implant consists o f eight needles in the belt, four (not shown) in the core and four at 
one end. (Khan 2003)
2.2.2.2. The Quimby System
This system based on a uniform distribution o f source strength and a non- 
uniform delivered dose. Usually, dose in the centre of the volume to be treated is 
higher than dose near the periphery. The Quimby dose tables include the minimum 
dose within the implanted volume. In the case o f surface applicators, the prescribed 
dose is the maximum dose in the treatment plane. For planar implants, the Quimby 
table provides the activity-hours loading necessary to deliver 10 Gy in the centre o f 
the treatment planes and up to 3 cm distance from the implant plane, and therefore the 
stated dose is the maximum dose in the plane to be treated. In volume implants, the 
stated dose is the minimum dose within the volume of the implant (Khan 2003). 
Using this dosimetry system to deliver equal dose to similar planar or volume 
implants, the total source strength should be greater than that required by the 
Patterson-Parker system (Khan 2003; Podgorsak 2005).
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2.2.2.3. The Memorial System:
The Quimby system has been extended in this arrangement, with a lattice of 
point sources o f uniform strength, a spacing between them of 1 cm being used. Tables 
have been provided in activity-hours to deliver 10 Gy at a specified point. As an 
instance, for planar implants, “minimum peripheral” and “reference maximum dose” 
points are located 0.5 cm from the source plane. For volume implants, similar data 
points are selected within the volume o f implant and “central line peripheral dose” 
points. The tables utilize appropriate exposure rate constants and includes attenuation 
and oblique filtration effects (Khan 2003).
2.2 2.4. Paris System
The Paris system is applied for single and double plane implants only. The 
general rules for source selection and insertion for a desired dose distribution are 
(Podgorsak 2005) (Williams and Thwaites 2000):
o Sources have to be linear and inserted parallel.
• All source centres should be in the same plane (the central plane).
• The linear source strength must be uniform and identical for sources,
o Sources should have uniform and matching linear strength (activity).
« Source locations to be at equal distances from each other. However, in
case of use of long sources, the spaces between sources are kept wider.
The stated (reference) dose rate is equal 85% of the basal dose rate; the basal dose is
equal to the average o f minimum dose rates between sources situated inside the
implanted volume. Each minimum dose rate has to be within ± 10% of the average 
(basal dose rate), hence, this makes use of a limited number of sources (Khan 2003) 
(Podgorsak 2005).
FA TMA ISSA 2012 Page 23
Chapter 2: Literature Revietv and Underpinning Theory
Doped Optical Fibres Thermoluminescence Dosimetiy fo r Brachytherapy
Figure 2.9 provides an example calculation of the basal dose obtained using various 
implants patterns and applying the Paris system (Khan 2003).
(a)
(b)
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Figure 2-9: Basal dose (BD) in implants using Paris system. A: Line sources 
implanted in patterns of (a) single plane, (b) squares, and (c) triangles. B: Isodose 
curves in central plane o f a volume implant using the Paris system. The isodose values 
are normalized to the average basal dose, which is given by !4(BDi+BD2+BD3+BD4). 
( From (Dutreix, Marinello et al. 1988) In (Pierquin, Wilson et al. 1987) )
2.2.2.S. Manchester System ( for Intracavitary Therapy):
The Manchester system has generally been considered to be the dosimetry 
system of choice for intracavitary brachytherapy. The Manchester system, the oldest 
and most widely system used in the world, defines four dose points; point A, point B, 
a bladder point and a rectum point. The calculated dose rate at point A determines the
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duration of the implant for the given arrangement o f activities, while, dose at other 
points are also taken into account for assessment o f the treatment plan. After 
treatment planning became computerized, the majority of Manchester system users 
would test the isodose distributions in the frontal and sagittal planes, obtaining doses 
at the four defined points, with point A continuing to be the prescription dose point. 
Originally the definition of point A was the point at 2 cm superior to the lateral 
vaginal fornix and 2 cm lateral to the cervical canal, as shown in the figure 2.10. 
Later, it became defined as the point 2 cm superior to the external cervical os (or 
cervical end of the tandem), and 2 cm lateral to the cervical canal. Point B is defined 
as 3 cm lateral to the point A (Khan 2003). While it has been suggested that the ideal 
position for point A is located where the uterine vessels cross the ureter, tolerance of 
these structures is the major and restrictive factor in the irradiation of the uterine 
cervix (Khan 2003). The main limitation o f point A according to critics are as follows 
(Khan 2003): 1) point A relates to the sources not to a specific anatomic structure; 2) 
the dose to point A is very sensitive to the position of the ovoid sources relative to the 
tandem sources, which should not be the determining factor in deciding on implant 
duration, and; 3) the size of the cervix effects the position of point A, such that it is 
either inside or outside o f the tumour, as illustrated in figure 2.11. Consequently, dose 
prescription at point A can either run the risk of underdosage and hence residual 
viable cancer or of cancer genesis due to overdosage (Khan 2003) (Williams and 
Thwaites 2000).
■3cm->
B
2 cm
I
I
Figure 2-10: The Manchester system and definition of points A and B (Merredith 
1967)
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2cm'
2 cm
Figure 2-11: Discrepancies o f point A according to anatomy. A: point A inside large 
cervix, causing underdosage. B: Point A outside small cervix, causing overdosage. 
(Pierquin, Wilson et al. 1987)
2.2.3. B rachytherapy Radioactive Sources
Originally, LDR ^^^Ra (radium) sources were used for brachytherapy, not least 
because of the very long lifetime (ti/2 = 1620 years). Finally however, radiation safety 
considerations led to the cessation of the use o f this source for treatment of cancers; 
the high energies of ^^^Ra source gamma photons (some well in excess of 1 MeV), 
requiring considerable amounts o f shielding, both during storage and use, while the 
gaseous progeny ^^^Rn (radon) is an alpha emitter, there being an ensuring prospect of 
failure of encapsulation over the long term. Another undesirable practical aspect of 
the use of ^^^Ra sources concerned size and shape, the maximum practical specific 
activity of the active medium available at the time preventing manufacture of sources 
in the form of thin wires, leading to tubes and needles with a minimum length o f 2 
cm. Thus, the use of this source in the clinical application was limited and could not 
be applied for all cancers, excluding for instance the bronchus and bile duct. ^^^Ra and 
^^^Rn have now been replaced by anthropomorphic (fission reactor produced) 
radionuclides such as, '^^Ir, ^°Co, *^^Cs and with ^^^ Ir and ^^Co being used in 
HDR temporary implant brachytherapy and and ^^^Pd being used in LDR 
permanent implant brachytherapy (Baltas, Sakelliou et al. 2006).
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Baltas et al. (2006) have listed the following ideal properties of a brachytherapy 
source:
1. The perfect gamma-ray emission energy should be high enough to avoid 
increased energy deposition in bone by the photoelectric effect and also to 
minimize scatter. It should also be low enough to reduce protection 
requirements.
2. The half-life of sources should be such that there is negligible need for decay 
correction during the treatment time. In addition, sources of sufficiently long 
half-life could allow a permanent stock of sources to be retained and perhaps 
for radioactive decay within the lifetime of the source and its encapsulation to 
be ignored.
3. No charged-particle emission occurs or, if  there is, that this can easily be 
monitored.
4. No gaseous disintegration products.
5. The radionuclide should have high specific activity.
6. The materials should be presented in insoluble and nontoxic form. In addition, 
they should not be in the form o f powder, leading to possible dispersal in the 
case o f source damage.
7. The carrier of the radionuclide should be able to be fabricated in a variety 
shapes and sizes such as rigid tubes or needles, small spheres and wire; the 
wires should be able to be cut to required lengths with minimal risk, inlcuding 
contamination.
8. It should be impossible for the sources to be damaged as a result o f 
sterilization.
2.2.3.I. Iridium-192 Source:
^^^ Ir has been used as a brachytherapy source since 1958, first as seeds by 
Henschke (Baltas, Sakelliou et al. 2006) and then since 1960 as hair-pins and wires, 
being associated with the Paris System, developed by the Institute Gustave Roussy, by
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Bernard Pierquin, Daniel Chassagne, Andree Dutreix, and others (Baltas, Sakelliou et 
al. 2006). ^^ I^r has become perhaps the most popular radionuclide as an alternative for 
^^^Ra (Baltas, Sakelliou et al. 2006). The ^^^ Ir isotope is produced in a reactor by the 
n-y reaction (Godden 1988):
191
77
While Ir-194 is also produced as a result of the n-y reaction with Ir-193, this 
does not affect the use o f ^^^ Ir sources for treatment, the half-life of Ir-194 being only 
17 hours compared to that of 73.81 days for ^^ I^r. Generally, ^^ I^r sources are not 
delivered from a reactor to the clinical unit until eight days after production, the Ir- 
194 decaying by at least ten half-lives during this period (Godden 1988). The 
relatively short half-life of the ^^^ Ir makes it suited to use as a temporary implant, 
applying a decay corrections of about 1% per day. In addition, its high specific 
activity (maximum of 340.98 GBq mg'^) allows for very short treatment times (Baltas, 
Sakelliou et al. 2006). ^^^ Ir decays by beta minus emission (with a branching ratio of 
95.13%) followed by either gamma-ray de-excitation to the stable isotope Pt-192 or 
by electron capture (4.87%) followed by gamma-rays de-excitation to Os-192, as 
follows (Lindstrom and Marklund 1963):
192
77
While the predominant energies o f the beta-rays are 530 keV and 670 keV, the 
average energy of gamma rays of 370 keV implies the advantage o f a reduced 
requirement for thick shielding for personal protection purposes (Godden 1988).
^^^ Ir brachytherapy sources are usually fabricated in the form o f 0.3 mm 
diameter wires, with a 0.1 mm thick core consisting o f an alloy o f 30% Ir and 70% Pt 
(Khan 2003). The ^^^ Ir sources used in radiotherapy are high activity sealed sources 
(referred to as HASS sources) and dense. If  produced in the form o f a powder there 
would be implied possibilities of dispersal in the event of the failure o f encapsulation.
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Iridium-platinum alloy is a soft material, the proportions of which are chosen to 
accommodate the source mechanical requirements; the greater the proportion of 
platinum the better. Conversely, for HDR the demand is for a greater proportion of 
iridium, high specific activity production capabilities being desirable in relatively 
short irradiation times, longer irradiations being counterproductive (Baltas, Sakelliou 
et al. 2006). The wire is encased in a 0.1 mm platinum sheath to absorb the beta rays 
produced from ^^^ Ir decays, the wires are very resistant and strong and extremely 
malleable. The wires are placed into plastic tubes or hypodermic needles and the wire 
sources can be cut to suitable lengths to fît the tumour volume (Godden 1988). In the 
case o f HDR afterloading sources, thin stainless steel or titanium capsule is 
encapsulated the iridium sources to minimize the possibility of fracture/failure and 
permits smooth handling in HDR afterloading (Baltas, Sakelliou et al. 2006).
^^^ Ir in the form o f wires are not sealed sources; the ability to cut the wires 
leads to potential loss o f some of the radioactive material and consequent risk of 
contamination (Williams and Thwaites 2000). The ^^^ Ir wires are also supplied in 
form of coupled double pins (known as hair-pins) or single pins, both of 0.6 mm 
diameter (Williams and Thwaites 2000) (Godden 1988). A further disadvantage of 
using wire sources is that the cutting and loading o f these into plastic tubes requires 
special skills, during which time an operator might receive elevated dose to the 
fingers (Williams and Thwaites 2000). Manufacturers have therefore supplied the 
alternative o f ^^^ Ir seeds preloaded in nylon ribbons. The nylon ribbons contain 12 
seeds, with 1 cm intervals (Godden 1988) (Williams and Thwaites 2000); the seeds 
are encapsulated in stainless steel capsules, thus forming a real sealed source 
(Williams and Thwaites 2000). For HDR remote after loading systems, sources are in 
the form of very small cylinders (0.6 mm diameter, 3.5 mm long and 3 mm active 
length) (Williamson 2000), with activity o f 370 GBq (10 Ci) (Podgorsak 2005). 
Typically the applications for ^^^ Ir are for breast implants (wire), bladder and tongue 
implants (hairpins) and various HDR intracavitary and interstitial treatments 
(Williams and Thwaites 2000). However, some applications o f wires and hairpins 
need relatively LDR; the hairpins used in bladder treatments have been made
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available with an activity o f 0.1 Ci (3.7 GBq), placed on the wall o f the bladder, 
necessitating only 15 min o f irradiation (Baltas, Sakelliou et al. 2006).
Currently, ^^^ Ir represents the source of choice for temporary brachytherapy 
applications for almost all tumour treatments. The storage and use of the source do not 
form practical limitations, due to the low cost in source production and its short half- 
life (Baltas, Sakelliou et al. 2006).
The ^^^ Ir source form used in present study was the MicroSelectron HDR V2 
(manufactured by Mallinckrodt Medical B.V., Westerduinweg 3 on behalf o f 
Nucletron B.V., Veenendaal, and The Netherlands). The source design and structure 
are shown in figure 2.12
4.5mm
0.15mm
0.2mm0.15mm 0.3mm
3.6mm
R=0.4mm
0.65mm diam.
R=0.2mm
2.0mm O)
Figure 2-12: MicroSelectron HDR 192Ir source (Nucletron B.V., Veenendaal, The 
Netherlands) (Baltas, Sakelliou et al. 2006)
Details of the Decay:
Although mentioned in brief above, a more detailed account is provided herein
of ^^^ Ir decays, in accord with two decay schemes, as follows:
1^  ^decay scheme: ^^ I^r decays with predominant p’ emission (95%), to the 3^^^  
and excited states of ^^^Pt (figure B -la  and tables B-1, B-2 and B-3 are shown in
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the appendix B); in this, p' rays are emitted at six specific energy levels, with a 
maximum energy o f 0.675 MeV (table B-1 is shown in the appendix B), the mean 
energy of the six energies being 0.181 MeV; table B-1 includes all beta energies 
(appendix B). De-excitation then happens by emission of gamma -rays (94%) to the 
ground state of the most prevalent gamma ray emissions are 0.296, 0.309, 0.317, 
and 0.468 MeV, with absolute intensities o f approximately 29, 30, 83, and 48% 
respectively, with an average o f 2.2 photons emitted per P‘ decay (with average 
energy o f 0.367 MeV). The 6 % residual in de-excitation takes place by IC (Internal 
Conversion). As a consequence of IC, numerous electron energy emissions occur as 
CEs (Conversion Electrons) and as Auger electrons as a result of the emission of 
characteristic x-rays (table B-2 in appendix B). However, these electrons have very 
low emission intensity and their highest energies are 1.377 MeV (Baltas, Sakelliou et 
al. 2006).
2”^  decay scheme: As detailed in the table B-4 and table B-5 (as shown in the 
Appendix B), ^^^ Ir decays (5% of the time) via EC (electron capture) to the 4^*^  excited 
state o f *^^0s, then decays (60%) via gamma rays to the ground state o f ^^^Os, the 
gamma rays having energies in the range 0.110-0.704 MeV with the highest absolute 
emission intensity being 3.3 %. On average, 0.1 photons are emitted per decay with an 
average energy o f 0.252 MeV. In addition, characteristic x-rays, conversion electrons 
and Auger electrons are also emitted.
On average, 2.3 photons are emitted by both decay processes, with an average 
energy o f 0.355 MeV, with the average energy o f gamma-ray being 0.372 MeV 
(Baltas, Sakelliou et al. 2006).
2.2.3.2. Iodine-125 Source
1-125 is the daughter of xenon-125, which is produced in the reactor as a result 
of the n-y reaction with xenon-124, as follows (Godden 1988):-
124
54 Xe{n -  r)'llXe
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1-125, discovered by Allen Reid and Albert Keston in 1946, was first used in 
clinical application some 20 years later (Baltas, Sakelliou et al. 2006), seeds being 
used for permanent interstitial implants (Godden 1988). In production of sources, 
is absorbed as a very thin coating on the surface o f a silver rod 4.5 mm length and 0.8 
mm diameter. The silver rod is then encapsulated in a 0.5 cm thick welded titanium 
capsule.
with a half-life o f 59.4 days (Godden 1988), decays by electron capture to 
the excited state of tellurium-125 (^^^Te) (figure A-1 table A-1 and table A-2 are 
shown in the appendix A), which then spontaneously decays to the ground state by 
internal conversion (93%) and gamma photon emission (7%), the latter with an energy 
of 35.5 keV. The eleetron capture and internal conversion lead to charaeteristic x-ray 
production: Ka = 27.4 keV and Kp = 31.4 keV and Auger electrons. Due to the low 
energy of the electrons (maximum energy o f 0.035 MeV with intensity o f ~ 2% (see 
for instance table A-1 as shown in the appendix A), they are easily absorbed in the 
titanium capsule. (Baltas, Sakelliou et al. 2006; Williamson 2006). On average, 1.4 
photons are emitted per disintegration o f Due to the low energy of the emitted 
photons (average energy of 0.028 MeV; see for instanee the table A-2 shown in the 
appendix A), shielding is easily provided for (HYL of lead ~ 0.03 mm), making the 
handling o f the sources easy and safe (Baltas, Sakelliou et al. 2006). In addition, the 
moderate half- life of the enables the source to be used in both permanent and 
temporary implants and also suitable for storage (Baltas, Sakelliou et al. 2006). In 
addition, the ability to make high specific activity material allows production o f small 
sources with sufficient activity to use in permanent and temporary implants. As such, 
*^ I^ seed sourees have been used for temporary and permanent interstitial implant for 
brain tumours, permanent intestinal implants for lung, pancreas, breast, and prostate 
cancer, and temporary implants for pediatric tumours. A relatively recent 
brachytherapy application o f this source is permanent intestinal implants for prostate 
eancer (Baltas, Sakelliou et al. 2006). Dosimetry of the *^ I^ source is complicated 
compared to that for ^^^Cs and ^^Co due to its more complex spectrum (a mixture o f y- 
rays and x-rays) (Baltas, Sakelliou et al. 2006).
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Three seeds models are available for the clinical use; 6701, 6702 and 
6711. These seeds have been manufactured with similar size and encapsulation but 
vary in details o f the active source design (Khan 2003). A 6701 seed (now obsolete) 
is shown in figure (2.13); the seed contains three ion-exchange resin spheres, 
saturated with in the form of iodide ion and each with a radiographic gold marker 
at the centre. The three beads are encapsulated in 0.06 mm -thick titanium (sufficient 
to absorb Auger electrons and x-rays with energies of less than 5 keV). The titanium 
tube is welded at both ends (Godden 1988), usually, with sources welds o f 0.5 mm 
thickness, although some sources have very tiny welds o f 0.1 mm - 0.15 mm 
thickness; the latter sources show a more flat anisotropy function because o f the lower 
attenuation at the ends (Baltas, Sakelliou et al. 2006). A 6702 seed is shown in figure 
2.14; this is similar to the 6701 seed, but its diameter is 0.8 mm not 0.6 mm. A new 
design is the 6711 seed (figure 2.16), containing a silver wire with the active material 
(silver iodide (Agi)) absorbed on the surface; a layer of AgBr-AgCi 1 pm thick 
surrounds the Ag rod and the distributed to a depth o f 0.5 pm (Williamson 1991) 
as shown in figure 2.15). The silver wire is visible on the radiograph, allowing the 
seed position, dimension and orientation to be verified (Godden 1988). The 6711 
seeds emit two additional photons; characteristic x-rays of 22.1 keV and 25.2 keV 
energies, due to interaction o f photons with the silver wire (Khan 2003). In 
addition, most new seed designs are in a form minimizing the dosimetry anisotropy 
known as the butterfly effect (Baltas, Sakelliou et al. 2006).
1 - 1 2 5  a d s o r b e d 0.06
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Figure 2-13: Schematic diagram of model 6701 seed. Adapted from (Godde 1988).
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Figure 2-14: Schematic diagram of Amersham model 6702 seed. (Baltas, 
Sakelliou et al. 2006)
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Figure 2-15: Distribution o f the iodine in the model 6711 seed (Williamson 1991)
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Figure 2-16: Amersham model 6711 OncoSeed (Amersham Health, UK) (Baltas,
Sakelliou et al. 2006)
The latest o f these sources, the model 9011, is under development and has 
yet to be generally introduced into clinical use. The model 9011 and model 6711 
are both developed by Oncura, Inc. Both models are similar in regard to the materials 
used and the manufacturing processes. The major difference is in the source diameter, 
reduced from 0.8 mm (6711) to 0.51 mm (9011), the cross-section area being reduced 
by 59% (Kennedy, Davis et al. 2010).
The dimensions of the model 9011 source (to be used in the simulation later) 
have been obtained from (Kennedy, Davis et al. 2010). This group state that they have 
obtained the source material composition data and dimensions from mechanical 
drawings and also from personal contact with GE Healthcare. The consists o f a 
radio-opaque silver marker of 2.8 mm length and density p = 10.5 g cm'^, coated on 
the silver rod to a consistent 1.75 pm depth of AgBr and Agi with a molecule ratio of 
2.5:1 and with p = 6.20 g cm'^ (Kennedy, Davis et al. 2010) (Dolan, Li et al. 2006; 
Taylor and Rogers 2008). The silver rod was encapsulated within a titanium capsule 
(p = 4.54 g cm'^). Argon gas of p = 1.784 mg cm'^ filling the space between the 
titanium capsule and the silver rod (Kennedy, Davis et al. 2010); the argon gas is
FATMA ISSA 2012 Page 35
Chapter 2: Literature Revie^v and Underpinning Theory
Doped Optical Fibres Thermoluminescence Dosimetry fo r Brachytherapy
utilized as a covering gas to maximize weld strength (Rivard 2009). Table 2.1 
includes the dimensions of both of the models, 6711 ad 9011, as obtained from 
(Bâdrâgan and Sterian 2009) and (Kennedy, Davis et al. 2010) respectively.
Table 2-1: Source models; 6711 and 9011 materials dimensions (in mm)
(Kennedy, Davis et al. 2010)
P aram eter M odel 9011 Model 6711
Ag marker length 2.80 3.0
Ag rod bevel at 45° 0.05 0.05
Overall length 4.55 4.5
Inner length 4.00 3.70
Outer diameter 0.510 0.800
Inner diameter 0.396 0.70
Ag rod diameter 0.305 0.500
End cap thickness 0.260 0.400
In studies herein, both ^^ I^ source models; 6711 and 9011 have been used.
2.2.4. Source Dosimetry
Radionuclide source dosimetry methodology is generally applied in 
calculation o f dose rate at points o f interest around a source, the source being within a 
given medium (usually water). The accuracy of dosimetric data and parameters o f the 
source will strongly affect the accuracy of dose and dose rate calculations around such 
sources. Since it is typical that the solid sources used in modem brachytherapy are in 
the form of cylinders, therefore the assumption is made herein of a dose distribution
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which is cylindrically symmetric with respect to the source longitudinal axis. 
Anisotropy in the dose distribution around cylindrical sources is due to differential 
flux of radiation through the source and its encapsulation, the degree of anisotropy 
decreasing with distance from the source, resulting from increased scattering that 
partially compensates for the differential absorption in the primary radiation field. 
Methods of measurement or calculation formula that do not take into account the 
anisotropy will therefore be inaccurate (Baltas, Sakelliou et al. 2006).
In the following, explanation is provided o f the AAPM TG-43 formalism, 
which is the most complete formulistic approach available to calculate dose 
distribution around photon emitting sources. Modem Treatment Planning Systems 
(TPS) generally make use of this formula.
2.2.41. The AAPM TG 43 Formalism
In 1995, AAPM published the TG 43 protocol (Nath, Anderson et al. 1995), 
introducing the most complete dose calculation formalism to-date for prediction of 
dose distribution around brachytherapy sources. This formalism is based on the 
ICWG (Interstitial Collaborative Working Group) dose calculation model (ICWG, 
1990) (Interstitital Collaborative Working Group 1990; Baltas, Sakelliou et al. 2006). 
Details of the formula are explained in (Baltas, Sakelliou et al. 2006).
2.2.4.I.I. General 2D Formalism
The AAPM TG 43 protocol (Nath, Anderson et al. 1995), recommended the 
following general 2D formalism to use in calculating 2D dose distributions around a 
line brachytherapy source:
FA TMA ISSA 2012 Page 3 7
Chapter 2: Literature Review and Underpinning Theory
Doped Optical Fibres Thermoluminescence Dosimetry fo r Brachytherapy
h(r,e) = S^h-^P^2,(r)F(r,e)
G {r^ A )
Baltas, Sakelliou et al. 2006) (Rivard, Coursey et al. 2004)
Eq.2.4 (Nath, Anderson et al. 1995;
D (r,6) is the dose rate at a point P(r,0) (a point of interest) in water. The dose 
distribution is defined using the polar coordinate system (r,0), where r is the distance 
in cm from a suitable origin to the point of interest, P, and 0 is the angle between the 
radius r and the long axis of the source. The origin of the polar coordinate is usually 
the source centre and P(ro,0o) is a reference point which presents on the transverse 
bisector of the source, where ro = 1cm, Oq = 7i/2, as demonstrated in figure 2.17. This 
formalism is also found to be suitable for calculation o f the dose distribution for 
asymmetric sources (Rivard, Coursey et al. 2004).
ro = 1 cm
•" z
Figure 2-17: Geomatry used in the calculation o f dose distribution near a linear 
source (Rivard, Coursey et al. 2004).
Here:
• Sk is the air kerma strength of the source in U, lU = lpG y m^ h"^  = 1 cGy cm^ 
h"^  (Baltas, Sakelliou et al. 2006); 
o A is the dose rate constant in water, with A expressed in cGy h"^  U'^ (Baltas, 
Sakelliou et al. 2006);
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•  G(r,0) is the geometry function at radial distance and polar angle 0, G(r,0)
being a dimensionless quantity (Baltas, Sakelliou et al. 2006);
• G(ro,0o) is the geometry function at the reference point (ro,0o) with ro = 1.0 cm
and 00 = 90°;
• gL(r) is the radial dose function that accounts for the distance dependence of 
scatter and absorption of photons in the medium of water along the transverse 
axis (at 0 = 90°), with the radial function dimensionless;
• F(r,0) is the anisotropy function, which accounts for absorption and scatter of 
photons within the source active core and its encapsulation, the anisotropy 
function being dimensionless. (Baltas, Sakelliou et al. 2006), and;
• L refers to a linear source (Baltas, Sakelliou et al. 2006).
Sk is defined as the air kerma rate, {d ) , in vacuo (sometimes also referred 
to as the air-kerma strength), due to photons o f energy greater then ô (the cut-off
energy; see below), at distance d, multiplied by the square o f this distance, d^
Sk Kg(d) d^ Eq.2.5,
where d is the distance from the source centre to the point of Kg{d) specification (
usually but not necessarily associated with the point o f measurement) which should be 
on the transverse plane of the source. Sk is independent of distance; as such, d can be
any value. K^{d) is measured in free air, at a distance large compared to the detector
and source dimensions, typically ~ 1 m. ‘Tn vacuo” means the measurements should 
be corrected for photon attenuation and scattering in air and in any medium present 
between the source and detector, including the photon scattering from walls, floors 
and ceiling. The cut-off energy ô deducts all low energy photons or contamination 
photon such as characteristic x-rays produced from the outer source layers such as 
steel and titanium. Typically 6 = 5 keV for low energy photon emitting brachytherapy 
sources (Rivard, Coursey et al. 2004).
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The Dose rate constant (A )  is defined in water and represents the ratio 
between the dose rate constant at the reference position, P(ro,0o) and the air kerma 
strength, Sk • The dose rate constant unit, measured in cGyh’^U'  ^with U = pGy.m^.h'^ 
(Nath, Anderson et al. 1995; Rivard, Coursey et al. 2004), is given by:
A =
Eq.2.6,
This quantity varies with source design, depending on the source structure, source 
calibration geometry of measuring its Sk and the medium and the photon spectrum of 
the radioactive source (Williamson 1991).
The Geometry function (G(r,0)) ignores the absorption and scattering effects, 
describing the effect of the spatial distribution o f radioactivity inside the sources on 
the relative dose by including the effective inverse square law correction. The 
geometry functions for point and line source are shown below (Rivard, Coursey et al.
2004):
Gp (r, 6) = r~^  For point-source approximation
Eq.2.7a,
Zrsin 0 
1
if
For line source approximation
if  (9 = 0°
l / - T ' / 4
Eq.2.7b,
Where:
p is the angle in radians, subtended by the line source with respect to the calculation 
point P(r,0) and L is the active source length.
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The updated AAPM TG-43 protocol (Rivard, Coursey et al. 2004) recommends use of 
the line source geometry function to estimate the 2D dose distribution and use of 
either the point or line source geometry functions to estimate ID dose distributions 
(Rivard, Coursey et al. 2004).
The Radial dose function (gx(r)) accounts for dose drops on the transverse 
plane due to photon attenuation and scattering. The radial dose function is defined by 
the following equation:
 ^ D '( r „ A )  G A r A )  Eq.2.8
The subscript “x” indicates whether a point or line source geometry function is being 
applied. Therefore, it will be replaced by “P” if a point source geometry function is 
used or “L” in the case of use of the line source geometry function. The radial 
function is equal to unity at r = 1 cm. Values for the gp(r) and gk(r) tabulated data are 
available in the updated AAPM TG43 protocol (Rivard, Coursey et al. 2004). O f note 
is that commercial treatment planning systems use the fifth polynomial fit to calculate 
the tabulated gx(r) data:-
gx  W  = ^ 0  + <3/ + + a A  + a A  Eç{2.9
The parameters ao to as should be determined to fit the data to within ±2%.
The 2D anisotropy function (F(r,0)) is defined as:
F ( r ,^ )  = -•D{rA) G,{rA)
D { r A )  G A r,0 )  Eq.2.10
This function accounts for the discrepancy in dose with polar angle relative to the 
transverse plane. In other words, the anisotropy function accounts for scattering and 
absorption due to the medium and source structure for polar angles relative to the
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transverse plane (0 nil) The anisotropy function tabulated values are given in 
AAPM TG-43 (Rivard, Coursey et al. 2004). The anisotropy function is equal to unity 
on the transfer plane (0 = 90°); its value decreases as: (i) r decreases; (ii) as 0 reaches 
0° or 180°; (ill) as the thickness of the source encapsulation increases; (iv) as the 
photon energy decreases (Podgorsak 2005).
2.2.4.I.2. G eneral ID Form alism
The ID dose formalism for dose distribution is defined by one o f following 
equations (Rivard, Coursey et al. 2004):
f r  V
D {f) = Sf.A — gp{r)(^a„{r) For point source. Eq. 2.11a
i)(r) = Sf.A ;  Sl (r)^ an (^) For line source. Eq. 2.11b
Although, most treatment planning systems use Eq.2.11a, the AAPM TG-43 
(Rivard, Coursey et al. 2004) recommends using Eq.2.1 lb  because it is more accurate 
at small distances (< 1cm). Linear interpolation can be used to obtain missing g%(r) to 
match the ^^(r) points.
Most systems deal with seeds as point sources, dose around them therefore are 
spherically distributed not eylindrically distributed, and use the ID dose formalism. 
The point source assumption is reasonable if large numbers o f seeds are present in the 
implant and/or use is made of randomly orientated seeds. In these cases, the 
anisotropy function is replaced by the anisotropy factor; . Nevertheless, the 2D
dose caleulation should be used if small seed numbers and/or seeds orientation are 
well determined such as in temporary brain implants and ophthalmic plaque 
applications (Nath, Anderson et al. 1997).
The ID anisotropy function^^„(r), which is otherwise known as the anisotropy 
factor, is defined as the ratio of the solid angle-weighted dose rate, averaged over the
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whole An steradian space, to the dose rate at the same distance r on the transverse 
plane. It is given by the following equation:
with
<j>an = 2G{r 9 G (r,9) sin(6>) d9  (Weaver 1998)
An alternative definition o f the anisotropy faetor is the ratio of the 47i-averaged dose 
rate at a given radial distance and the dose rate at the same distance along the 
transverse axis:
[D (r,0 )dO .
Both Eq 2.1 la  and Eq 2.11b can be applied in the previous formula.
2.2.4.1.3. Sievert Integral Model
The Sievert integral model predicts dose distribution around single sources 
and is widely used with Csl37 tubes and needles. This model is based on integration 
of the dose distribution of point sources over the aetive length o f the source and 
includes photon scattering in the surrounding medium and source filtration (the source 
capsule); see details in (Nath, Anderson et al. 1997). The (Nath, Anderson et al. 1997) 
report recommends care in use of the Sievert integral model to calculate dose around 
low-energy sources such as ^^^ Ir wires and seeds. It is suggested that while the Sievert 
integral gives accurate dose distribution near the transverse axis o f *^ l^r, it can
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produce an error o f some 20 - 40% in dose calculation near the longitudinal axis. 
Using the Sievert integral, the AAPM Task Group 43 were thus not able to predict 
doses for tube source and needles (Nath, Anderson et al. 1997).
The standard dose calculation method fails to apply for intermediate energy 
sources such as ytterbium (^^^Yb) and americium (^ "^^Am) and with beta emitter 
sources developed to be used for intravascular brachytherapy. Therefore, a full 3D 
matrix of dose values has to determine for these sources (Nath, Anderson et al. 1997).
2.3. Radiation Dosimeters
A radiation dosimeter is a device or instrument that measures or assesses 
either directly or indirectly dosimetric quantities such as, exposure, kerma, absorbed 
dose, equivalent dose or dose rate. Dosimeters should exhibit a number o f desirable 
properties, including accuracy and precision of dose measurement, linearity of 
response (dose or dose rate dependence), a simple energy response, directional 
independence and good spatial resolution (Podgorsak 2005). Various types of 
dosimeters are available, including ionisation chambers, films (radiographic and 
radiochromic), luminescence (thermoluminescence and optically simulated 
luminescence), semiconductors (diodes), MOSFET, Gel (eg PRESAGE™), ete. The 
focus of the present thesis is on a particular form of thermoluminescence dosimeter, 
namely the Ge-doped SiOi system (see 2.3.1 below), this particular form o f dosimeter 
offering a number of highly desirable properties in response to irradiation.
2.3.1. Thermoluminescence (TL) Dosimetry
The TL dosimetry (TLD) system, comprising a TL medium and a TLD 
reader, is used for the measurement of integrated absorbed radiation dose. Upon 
irradiation, TL dosimeters store a fraction of the resultant absorbed energy in 
metastable energy levels, the latter being presented as electron traps formed from
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impurities/dopants deliberately introduced into the base medium in a highly controlled 
manner. The irradiation energy stimulates electrons to jump to these traps, the model 
system conventionally being described in terms o f a crystalline system formed o f a 
valence and conduction band and an intermediary forbidden band in which the 
trapping levels reside. The model is described in more detail below. For an amorphous 
system, as in the doped glass system used herein, it is found that the very same model 
can be conveniently used to interpret the functional TL response o f such non­
crystalline media. To de-trap a TL system, heat is applied, the de-trapped electrons 
losing their energy as light, the associated light yield being indicative of the absorbed 
dose.
2.3.1.1. Thermoluminescence Dosimeter
Luminescence is a phenomenon displayed in numerous materials, typically 
crystalline. Upon these materials being irradiated, they absorb radiation and retain a 
part of the absorbed energy inside the crystal lattice. Later on, with the application of 
appropriate stimulation, this energy is emitted as ultraviolet, visible or infrared light. 
The phenomenon o f releasing the stored energy in form o f light is denoted as 
luminescence. However, there are two types of luminescence, based on the time delay 
between the stimulation and the releasing o f the light and termed fluorescence or 
phosphorescence. The fluorescence takes place within the period of stimulation o f the 
luminescence material, release taking place within a time of between 10“ ®^ and 10"  ^
sec; the phosphorescence prevails over a time greater than 10“  ^sec and so can endure, 
albeit briefly, beyond the period of stimulation. If heat is used as the stimulating form 
of energy, then the phenomenon is known as the thermoluminescence and the material 
is called a thermoluminescent material (TL). If this material is used for dosimetry then 
it is referred to as a thermoluminescence dosimeter (TLD). If light is used as the 
stimulating form of energy then the phenomenon is ealled optically stimulated 
luminescence (OSL) (Khan 2003; Podgorsak 2005) (McKeever 1985).
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The thermoluminescence mechanism in a crystalline material is described by 
the band model, a phenomenological model for solids. In this model, electronic 
energy levels in the crystal lattice are classified into two energy band types; allowed 
energy bands and forbidden energy bands. The allowed energy bands are the valence 
band (ground state) and the conductive band. Electrons can occupy the allowed 
energy bands. The forbidden energy band is situated in the energy gap between the 
conductive and valence bands. Electrons cannot normally be present in the forbidden 
energy band (shown in figures 2.18 and 2.19) (Khan 2003). However, the traps (both 
the storage traps and recombination centres, explained below) are located in the 
forbidden energy band; the electron traps engage the states just below the conductive 
band and the hole traps engage the stated just above the valence band (Podgorsak
2005) (McKeever 1985).
Conduction
Electron Tr«o
Vnlence
a) Irradiation
Photon
b) Heating
Figure 2-18: A simple diagram showing the energy levels in a crystal lattice and the 
thermoluminescence process (Khan 2003).
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Figure 2-19: Energy bands diagram of a crystal containing defects (McKinlay 1981)
Before irradiation the trapping levels are blank (i.e. the hole traps and the 
electron traps are empty). When photons (x- or y-rays) pass through such a TL 
medium, they interact with it by one or more interactions, photoelectric absorption, 
Compton scattering, pair production and produce high energetic secondary charged 
particles, most usually electrons. Subsequently, the secondary charged particles ionise 
the medium atoms and liberate several free low energy electrons and holes (Khan 
2003). Some small fraction of the electrons in the valence band or those filing hole 
traps in the forbidden band will receive sufficient energy to jump to the conductive 
band and leave vacancies (if electrons come from the valence band) or leave empty 
hole traps (in this case of electrons filling hole traps in the forbidden band) 
(Podgorsak 2005). The electrons and holes move independently through their bands 
until they recombine or fall into a trap. Traps are represented in terms of intrinsic 
defects (vacancies) that exist in the crystal and extrinsic defects (impurities) that are 
added to the crystal (see section 2.3.S.2 for details). The traps are elassified as follows 
(Podgorsak 2005) and are represented in the diagram of Fig. 2.20:
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® Storage traps; these trap free charge carriers, then release them if heated (as 
in the thermoluminescence process) or if  excited by light (in the OSL process) 
(Podgorsak 2005).
• Recombination centres, also known as luminescence centres: charge carriers 
released from the storage traps recombine with the trapped charge carriers of 
opposite sign, energy is then released due to this recombination in the form of 
ultraviolet, visible or infrared light. By using photodiodes or photomultiplier 
tubes, the recombination energy can be measured (Podgorsak 2005).
As previously mentioned, if  the light release due to those transitions is 
immediate, then the phenomenon is called fluorescence. If sufficient energy is 
provided to liberate electrons from the traps, allowing them to fall to the valence 
band, the emission light in this case is known as phosphorescence (delayed 
fluorescence). If  heat is applied (~300C°) to speed up the phosphorescence, the 
phenomenon is referred to as thermolumineseence (Khan 2003). The energy traps can 
be deep, in which case the medium needs to be heated to make the electrons escape; if 
the energy traps are superficial then even under ambient light or room temperature 
conditions release can occur (a process referred to as fading).
Since dosimetry aims to measure integral dose with high preeision, therefore, 
the focus is on materials with a high phosphorescence yield. The yield may be 
improved by adding a controlled amount o f artificial impurities into the material, 
achieved by doping the base medium with other element called activators, such as 
LiF: Mg: Ti, the lithium fluoride being doped with magnesium and titanium (Chen 
and McKeever 1995).
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Figure 2-20: Schematic of energy levels in an insulator material
2.3.I.2. The Glow Curve
TL intensity emission is a function of the TLD temperature. If  the heating rate 
remains constant, the temperature will be proportional to the time during which 
heating is applied, and therefore the TL intensity can be plotted as a function o f the 
time. The resulting curve is known as the glow curve. In other words, the glow curve 
(also known as TL thermogram) is the curve that shows the intensity o f emitted light 
vs. the TL medium temperature.
In a TL-material the defects or artificial impurities give rise to electron traps at 
different trapping levels, each trapping level in a crystalline medium producing a 
related glow peak maximum that might/might not be determined during readout. The 
number of electron traps will control the area and peak height o f each glow peak; in 
turn the height and area of each glow peak depends on the number o f defects and 
impurities present in the lattice of the dosimeter and also upon the thermal history o f 
the dosimeter (MeKinlay 1981).
In addition, the peaks appeared in the glow curve are related to the depths of 
traps, which are responsible for thermolumineseence emission. As an example, the 
main dosimetric peak of the LiF:Mg,Ti glow curve is situated between 180° C and
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260° C as shown in figure 2.21. Such temperature range is chosen because peaks 
lower than this are affected by room temperature and hence prone to the fading effect 
previously mentioned; at elevated temperatures the light yield may be mixed with 
black body emission from the planchet that holds the heated TL medium in the TL- 
reader. The area under the dosimetric peak represents the TL-yield of the emission 
light, being directly associated with the absorbed dose given to a dosimeter 
(Podgorsak 2005). In a non-erystalline medium the trapping levels are non-localized 
and hence it is generally found that the glow-curve is o f a more broader, minimal 
feature character.
Figure 2.22 shows the glow curve of a Ge-doped optical fibre for temperatures 
between 10 C° and 450 C°, with just one broad peak with a maximum at 230C°.
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Figure 2-21: A typical glow curve of LiF: Mg: Ti obtained with a TLD reader at a 
low heating rate
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Figure 2-22: The glow curve of an irradiated Ge-doped optical fibre obtained using a 
Solaro TLD reader
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2.3.13. TLD R eader
TLD readers typically have the following significant components: 1) a 
phosphor heating system; 2) a light collection and detection system (Photomultiplier 
Tube (PMT)); 3) a signal-measuring system; 4) a display and recording system.
Electrometer
HV Thermolumineseence ~ charge
PMT
TLD
Heater
Figure 2-23: Schematic diagram illustrates a TLD reader (Podgorsak 2005)
Fig 2.23 shows the construction of a typical TLD reader. The TLD is placed in 
the planchet (heater cup) where it is heated by means of a reproducible heating cycle 
to speed up the yield of phosphorescence. The emitted light is detected and 
transformed to an electrical signal by the photomultiplier tube (PMT). The magnitude 
of the electrical signal is proportional to the relative light intensity. This electrical 
signal is then recorded as a charge or current via the electrometer (Khan 2003; 
Podgorsak 2005). A nitrogen atmosphere (N2) is connected to the TLD reader and 
made to flow at a steady well-controlled rate during the read out process, the N 2 being 
used to suppress false light signals due to oxidation during the heating process, where 
the O2 acting as trapping centres (Hashim 2009) (see the details in section 2.3.2.8 
storage and handling). TL response values and the TL glow curve can be obtained 
from the TLD reader monitor and saved in the TLD reader.
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2.3.1.31. Heating Cycle
The purposes of the heating cycle applied to the thermoluminescent material 
(TL) are to heat the phosphor until electrons are liberated from traps with the release 
of thermolumineseence, also to fade the low temperature traps and to remove 
electrons from deep traps. Figure 2.24 shows an example heating cycle, in this case 
used to readout a LiF : PTFE disc dosimeter. The heating cycle consists o f the 
following three stages (McKinlay 1981):
Preheat Phase
This is also known as the pre-read phase. In the preheat stage, the TL medium 
is heated at low temperatures to remove electrons from low temperature traps 
(superficial traps), thus removing low temperature unstable glow curve peaks. The 
preheat temperatures are lower than the read-phase temperatures (Hashim 2009) 
(McKinlay 1981).
Reading Phase
In this stage the TL medium is heated until light is released and the TL-yield is 
recorded. The readout phase starts directly after the preheat phase, the temperature 
being raised to a high level for a programmed period o f time. The light released 
throughout this period o f time is integrated, representing the TL-yield (Hashim 2009).
Annealing Phase
In the annealing phase, the TLD is heated at a further elevated temperature, 
higher than the temperatures used in the readout phase, thereby erasing any residual 
signal by erasure o f all electrons from deep traps (dosimetry traps), restoring the
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original background of the TLD. As such, the annealing stage restores the sensitivity 
of the detector to that obtained prior to previous use (Hashim 2009) (McKinlay 1981).
i.5
300 ®C
2U0 °C
120
Pre-heot Read Anneal
Time
Figure 2-24: Heating cycle and glow curve used in the reading out of LiF: PTFE disc 
dosimeters. The pre-heat temperature is used to remove the rapidly fading TL 
represented by the low-temperature peaks. The area of TL integration is denoted by 
the shaded portion of the curve (McKinlay 1981)
2.3.2. Properties of Dosimeters
The performance of dosimeters is evaluated through study of properties such 
as linearity, dose response, energy response, reproducibility, stability, effect of 
environment on dosimeter performance and others (McKinlay 1981).
2.3.2.1. Accuracy and Precision
The results of measurement always include a degree of inaccuracy, otherwise 
known as the uncertainty of the measurement and characterized by the accuracy and
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precision. The precision is determined by the reproducibility of the measurements 
under the same conditions and make assessments for the data obtained from the 
repeated measurements. However, in TL dosimetry at radiotherapy levels it is an 
expectation that should only be a small standard deviation of the distribution of the 
measurement results to reflect the high precision of the results (Podgorsak 2005). As 
will be seen in the main body of this thesis, such a situation is to obtain with the Ge- 
doped SiO] fibres.
The accuracy for any measures quantity is represented by the closeness 
between the true value and the expectation value for that quantity. The error o f any 
measurement quantity is given by the difference between the measured and the true 
value of that quantity. The error has both a numerical value and sign and should be 
corrected by introducing suitable correction factors (Podgorsak 2005).
2.3.2.2. Dose Response
It is desirable for dosimeters to show a linear relationship between 
thermolumineseence intensity and absorbed dose. Nevertheless, most conventional TL 
dosimeters exhibit a non-linear relationship, either supralinearity or sublinearity 
between TL intensity and absorbed dose within particular dose ranges, as 
demonstrated in figure 2.25. The supralinearity and sublinearity end in saturation. 
Supralinearity and sublinearity cause problems o f underestimation or overestimation, 
respectively. However, it is possible to continue using a detector that shows a non­
linear response provided that it is calibrated and corrected for the non-linearity 
(McKeever 1985).
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Figure 2-25: Schematic of a typical thermolumineseence growth curvem showing 
linear, supralinear and sublinear regions of a phosphor-based TLD (McKeever 1985).
Both supralinearity and saturation can be affected by previous thermal 
treatments and radiation, and consequently the last two influences can affect the 
reusability of a dosimeter. With this, a dosimeter may give a different response upon 
second and further subsequent use. Therefore, the annealing process is significant for 
many TL media, to re-obtain the original characteristic properties, in part solving the 
supralinearity and to keep a dosimeter re-useable (its sensitivity remaining the same 
during multi usages) (McKeever 1985).
2.3.2.3. M inim um  Detectable Dose
This is the lowest dose that can be detected by the detector. It corresponds to a 
TL intensity 2a above the TL yield of un-irradiated samples (i.e. the background 
level). The minimum detectable dose depends on the inherent sensitivity o f the 
detector material, the detector size, the sensitivity of readout machine and the thermal 
treatments and irradiation history (McKeever 1985).
Knowledge o f the minimum detectable dose (threshold dose) is important, 
especially when measurements are made for low doses (eg doses just above
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environmental radiation background) (Hashim 2009). The threshold dose is given by 
the following formula:
A  -  {Kean + 2ct)F  gq. 2.14,
where: F  = and and where: is the mean o f XL background, obtained by
taking the mean o f XL o f un-irradiated samples (i.e. freshly annealed samples), <J is 
the standard deviation o f the mean background, F  is the XL system calibration factor 
for each type o f dosimeter expressed in Gy nC"  ^ and m is the slope of the dose 
response graph (Hashim 2009).
2.3.2 4. Dose Rate Dependence
A further desirable property for dosimeters is to have independence of 
response for dose-rate. Xo-date, it has not been established for the dose rates 
applicable in brachytherapy that such dependency represents a problem for Ge-doped 
XLDs (as discussed later). If the dosimeter response depends on dose-rate, then 
appropriate corrections would need to be made.
2.3.2.S. Energy Dependence
Since the XL yield of a XL material is proportional to the energy originally 
absorbed by the XL material, it is important to evaluate the absorption coefficient o f a 
material with radiation energy. For photon irradiations (x- or y-rays), this evaluation is 
represented as the photon energy response S(E) o f the system, obtained by calculation
of the ratio o f mass energy absorption coefficient for the material to the
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mass energy absorption coefficient of the reference material; air or tissue
J  re f
where is the linear absorption coefficient and p  is the density (McKeever 1985): 
!p )„  j(Me„lp)r,f Eq. 2.15
The mass energy absorption coefficient is dependent on the mediating energy 
loss processes, including the photoelectric interaction, Compton scattering and pair 
production. Each depends on the energy of the radiation and the atomic number (Z) of 
the material irradiated (McKeever 1985).
It is desirable for a dosimeter to have a constant energy response over a large 
range of energy, thus low-Z dosimeter materials are preferable. In addition, the Z 
number o f a dosimeter is desirable to be close to that o f tissue (soft tissue, with 
effective atomic number, Zeff ~ 7.4), called a tissue equivalent dosimeter. Figure 2.26 
shows the difference in energy response for three different Zeff materials; it is clear 
that the lowest Zeff has the more desirable energy response. CaFi (Calcium Fluoride), 
CaS0 4  (Calcium Sulphate), LiF (Lithium Fluoride) have effective atomic numbers of 
16.9, 15.6 and 8.14, respectively.
a C aF j
g
LiF
I
10
P ho to n  energy  (M eV)
Figure 2-26: Energy response of TL materials of various effective atomic number 
materials. (McKeever 1985)
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A dosimeter should be calibrated over the range of radiation energy most 
likely to be used, the correction factor for the energy response then being applied as 
required (Podgorsak 2005).
2.3.2.6. Directional Dependence
The angular or directional dependence o f the dosimeter is defined by the 
variation in a dosimeter response with variation o f the angle o f the incident radiation. 
This will be affected by the constructional and physical size of dosimeters and the 
energy of the incident radiation. The directional dependence should be taken into 
account in certain applications, as for instance if  use o f made of dosimeters in in-vivo 
dosimetry (Podgorsak 2005).
2.3.2.T. Fading and Stability
Dose measured by TL media corresponds to the number of electrons trapped 
in different trapping levels. Fading is the inadvertent loss of TL signal before readout 
(McKinlay 1981), as discussed earlier. Therefore, it is important to assess the 
stability of a dosimeter within the environment in which a dosimeter will operate. The 
fading can be due to heat (thermal fading) or light (optical fading). Thermal fading: 
occurs during irradiation, between irradiation and during readout, particularly if  the 
trapping depth is very small so that room temperatures can stimulate to release of 
trapped electrons (McKeever 1985). Thermal fading is displayed on the glow curve as 
low temperature peaks (McKinlay 1981). To minimise such effects, it is desirable that 
the mean dosimetric peak o f the glow curve of a dosimeter be between 200-250°C, 
which is high enough to avoid the fading peak and low enough to avoid interference 
from the black-body signal (McKeever 1985). The magnitude of fading can be 
reduced by pre-irradiation annealing, as previously discussed. Similarly, optical 
fading is the emptying o f some proportion o f the traps due to optical stimulation. In 
other words, exposure of a dosimeter to sunlight, fluorescent lamps or any other type
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of artificial light source can cause release of trapped electrons (emptying o f traps) and 
consequent loss of a part of the TL signal (McKeever 1985).
2.3.2.8. Storage and Handling
Storage and handling o f dosimeters are among the characteristics that should 
be considered during dosimeter selection as it has been established that they can affect 
dosimeter TL sensitivity, stability, re-usability, precision and minimum detectable 
dose (McKinlay 1981). The effects produced by storage and handling o f dosimeters 
can be divided into: 1) environmental factors such as temperature, humidity, 
ultraviolet and visible radiation; 2) physical handling factors such as sieving, 
dispensing, picking up, cleaning, sterilising...etc
Environmental Factors: In storage and use, in order to avoid thermal fading, 
dosimeters should not be heated over normal ambient temperature. In addition, 
exposure to high humidity can reduce dosimeter sensitivity and enhance fading. 
However, humidity is not known to affect optical fibre response (the dosimeter o f 
interest in this research), while it is known to affect other dosimeters such as TLD-100 
and TLD-700, therefore, these effected dosimeter should be stored in conjunction with 
a desiccating agent when not in use and sealed in appropriate containers when in use 
(McKeever 1985). Exposure to ambient light and ultraviolet radiation has a twofold 
effect: it can produce a spurious TL signal in an unirradiated dosimeter, while for 
irradiated dosimeter, it can cause loss of trapped electrons (optical fading) and/or 
redistribution of trapped electrons due to phototransfer and consequently increase the 
TL-recorded signals (McKinlay 1981). Therefore, it is strongly recommended to keep 
dosimeters in light-tight envelopes while dosimeters are not in use. In addition, 
ambient light levels, especially fluorescent lights should be reduced when dosimeters 
are handled or not in their protected envelopes (McKinlay 1981).
Physical handling Factors: Scratching or abrading should be avoided when 
handling dosimeters as this can lead to reduction o f the TL sensitivity and produce
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spuriousthermoluminescence, created through tribothermoluminescence. 
Tribothermoluminescence is a phenomenon exhibited in many phosphors, defined by 
the trapping of charge in the thermoluminescence traps as a result o f mechanical 
effects that can include friction, grinding, sieving or pounding of a specimen 
(McKeever 1985). It has been found that such tribothermoluminescence signal can be 
removed or suppressed by carrying out the readout in the presence of an oxygen-free 
atmosphere, the presence of oxygen being important for this phenomenon to be 
produced. Therefore, thermoluminescence readout should always be carried out in a 
nitrogen or argon atmosphere, also eliminating the chemiluminescence spurious 
signals probably produced by oxidation o f the surface (McKeever 1985). It is further 
recommended to use vacuum forceps to eliminate handling problems, including 
surface contamination (McKinlay 1981).
2.3.3. Optical Fibres as Thermoluminescence Dosimeters
It is desirable that the dosimeter o f choice should be able to measure dose in 
very small volumes, dose being a point quantity (Podgorsak 2005). As such, the 
availability o f a high spatial resolution dosimeter is of importance in in-vivo 
dosimetry. Conventional thermoluminescence dosimeters (TLDs) such as Lithium 
fluoride ( LiF: mg: Ti and LiF, Cu, P ) and Calcium sulphate are crystalline material, 
their main advantages being that they are tissue equivalent ( Zeff o f LiF is 8.14 
compared with Zeff for tissue o f ~ 7.4), and they have moderately good spatial 
resolution, within ~ mm, but are hygroscopic (Hashim, Al-Ahbabi et al. 2009). The 
existence of a new TL material is represented by optical fibres, overcoming the 
hygroscopic problem due to their glassy constituency which also make fibres resistant 
to water and protect them from corrosion, thus increasing their lifespan. Optical fibre 
TL dosimeters also have some other key advantages over conventional TLDs. These 
include low cost and higher spatial resolution since optical fibres can be manufactured 
in small diameter (~ several tens of pm). The optical fibre dosimeter is seen to 
represent a promising and powerful dosimeter that can be used as in-vivo dosimeter, 
by placing them directly on/in tissue due to their resistance to water, and can be
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Utilized for particular dose measurements such as in the intra-contrary artery 
brachytherapy (Yusoff, Hugtenburg et al. 2005). In regard to direct readout OSL (not 
investigated herein), optical fibres have the potential to be placed many meters from 
the control electronics to remotely monitor radiation; also they can monitor a number 
of sensors so can used as multiplexed (O'Keeffe, Fitzpatrick et al. 2008). The optical 
fibre dosimeter has been chosen for this research to perform dosimetry measurements 
around HDR ^^^ Ir and LDR brachytherapy sources.
Optical fibre is made of silica (SiO]), consisting of three components (figure 
2.27); the core, being of similar dimension to that o f a strand o f hair (carrying the 
light pulses in optical communications), the cladding, which contains the core within 
it (the function of the latter being to inhibit loss o f light signals by ensuring total 
internal refieetion of the light pulses into the core (the core having a higher reflective 
index than the cladding) (Zanger and Zanger 1991), as shown in figure 2.28, and the 
buffer coating that includes both the core and cladding, to protect the core and 
cladding from the environment, moisture and damage (Hashim, Al-Ahbabi et al. 
2009); Ong et al., 2009).
Total internai reflection is ensured by the addition of a dopant, germanium 
(Ge) in the present case, to ensure that the refractive index of the core is higher than 
that for the cladding (Zanger and Zanger 1991).
Buffer
Cladding
Core
Figure 2-27: Basic structure of optical fibres
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L osses
L osses
Cladding
Core
Figure 2-28; Demonstration of the significance o f the cladding and its lower reflective 
index compared with the core (Zanger and Zanger 1991).
In optical fibers, dose information is transmitted using optical signals as 
opposed to an electrical signal. Therefore, optical fibres are immune to electrical and 
electromagnetic interferences, which can cause problems to other electronic 
dosimeters (O'Keeffe, Fitzpatrick et al. 2008).
2.3.31. S tructure of Silica (Amorphous SiOz)
Silica is an amorphous material. The most common structures of SiOi at low 
pressure are a-quartz, (3-quartz, and tridymite. The quartz consists o f a continuous 
framework o f SiÜ4 tetrahedral molecular arrangements (Si is presents as a central 
atom, bounded to four oxygen atoms (figure 2.29)), each oxygen atom is bound to 
two silicon atoms (each oxygen atom being shared between two tetrahedral) to 
produce the SiOi (McKinlay 1981).
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Figure 2-29: Tetrahedral structural unit for silica (SiOi) (Hashim 2009)
However, there are dislocations and intrinsic point defects in the silica 
structure, and displace lattice atoms also exists and likely to be near impurities. Due to 
the difference in the electronegativity between silicon and oxygen, a 40% ionic and a 
60% covalent bond is produced. The covalent nature gives quartz the quite rigid 
structure, avoiding microscopic diffusion of lattice atoms. Presenting o f mixed ionic 
and covalent natural bonds in silica cause the appearance o f two mechanisms for 
radiation damage; breaking o f covalent band and vacancy and interstitial creation. The 
majority of the defects caused by ionisation radiation occur at impurities. Thus, 
electrons and holes released by radiation might be trapped and give rise to optical 
absorption and luminescence (McKeever 1985).
2.S.3.2. Defects
Defects in silica are similar to defects in any crystalline material. In contrast, 
silica as an amorphous material does not possess long range order, having only short 
range order (see figure 2.30). Defects are generally two types; intrinsic and extrinsic. 
Numerous intrinsic defects are present in pure silica structures, such as vacancies and 
interstitial centres and broken S i-0 bands. The defects related with oxygen vacancies, 
known as E ’-centres, are the most significant in the description o f physical and optical
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properties; figure 2.31 shows one o f the E-centres. The most common defect in silica 
is the broken or dangling oxygen bond, this makes atoms with dangling orbitals that 
are occupied by unpaired electrons. The dangling oxygen bonds are potential hole 
traps, and empty Si orbitals can trap electrons. However, irradiation can produce 
broken bonds. Extrinsic defects have been created by adding impurities such as A1 
and Ge into silica. Impurities are the key to the thermolumincesnce process as they 
cause localized energy levels within the forbidden energy gap. The presence o f the 
extrinsic defects (impurities), lead to large increase in the sensitivity of 
thermoluminescence (McKeever 1985).
Figure 2-30: The amorphous structure of glassy silica (Si02) in two-dimensions. No 
long-range order is present.
Figure 2-31: Model o f the E’-centre, consisting of an oxygen vacancy (dotted circle) 
with an unpaired electron located at the Si (I) site (McKeever 1985).
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2.3.3.3. Germanium Doped Optical Fibres
Optical fibres that are used for the radiation dosimetry purposes are usually 
doped by adding impurities to increase their sensitivity for radiation (Youssef, Amin 
et al. 2001), as pure optical fibres have been shown to have low sensitivity for 
radiation (Huston, Justus et al. 2001). Ge-doped optical fibres provide superior TL 
yield to that a number of other well-indicated dopants in silica, including O2 and A1 
(Hashim 2009). Thus, Ge-doped optical fibres will be the dosimeter of interest for this 
research.
Germanium doped optical fibres are produced by adding germanium impurity 
to silica (SiOi), the Ge atom replacing a Si atom and trapping electrons to form Ge^^ 
as shown in figure 2.32 (Hayes and Jenkin 1987). The Ge dopant is known to be a 
deep electron trap in SiO? (Hashim 2009).
Figure 2-32: A possible schematic model for relaxed excitons in a-quartz involving 
an O-vacancy-O-intestinal Frenkel pair. For Ge-doped silica; the shaded Si atom is 
replaced by Ge (Hayes and Jenkin 1987).
2 3.3.4. Germanium Doped Silica Optical Fibre Dosimeters
The TL dosimeter used in this study is commercial telecommunication fibres 
of Ge-doped silica glass. Most often optical fibre is fabricated from very pure silica 
(SiOi), which has a refractive index of n = 1.458 at Lo = 850 nm. Selective doping at
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the centre (core) of the fibre give raise to material of higher refractive index than the 
surrounding region (cladding), thus forming a waveguide. Ge-doped fibres 
(INOCORP, Canada) comprises a 9.0 pm core (in the present work) in cladding 
(diameter 124.7 ±1 .0  pm) and an outer polymer coat (leading to fibre outer diameter 
of 250 ± 1 0  pm). The Ge-doped fibre used herein has been supplied at a length o f 22 
m.
Prior to first use, the outer coating cladding buffer is carefully removed using 
a fibre stripper (Miller, USA), avoiding scratching or nicking of the fibre core that can 
produce triboluminescence. The remaining fibre is then cleaned with cotton 
containing some methyl alcohol to remove any residual buffer. It is then cut into 
lengths o f approximately 5.0 ±0 .1  mm using a CT 30 cleaver (Fujikura, Japan) to 
ensure a standard situation for each sample. An electronic balance (B303-S METTER 
TOLEDO, Switzerland) has been used in present wortk to measure the optical fibres 
weights; the mass of the fibre samples thus prepared have been found to have a mean 
and standard deviation o f 0.20 ± 0.01 mg (see later). In use, the TL yield o f the 
optical fibres are normalized to individual fibre weights.
The optical fibres are handled herein using a vacuum tweezer (Dymax 30, 
Charles Austen Pump LTD, England) to avoid surface scratches. To decrease 
exposure to high ambient light levels the optical fibres have been retained in a 
darkened environment when not being irradiated or read out (McKeever 1985; 
Hashim, Al-Ahbabi et al. 2009). The optical fibres are retained in gelatine capsules 
during irradiations and retained in a darkened environment when not in use in order to 
reduce the handling and environmental effects.
Readout of Ge-doped optical fibres is performed some 12 hours post any 
irradiation in order to maintain control of thermal fading, with use being made of a 
Toledo TLD reader (manufacture by D. A. Pitman Ltd., Weybridge, Surrey, England) 
for the former. The readout is carried out in the presence of a nitrogen gas flow to 
suppress the effect of triboluminescence and oxidation, as previously explained. The 
following parameters were used during the readout: preheat temperature o f 160 °C for 
10 second; readout temperature o f 300 °C for 25 second with a ramp rate of
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25 °C /sec. Then, the annealing temperature o f 300 °C for 10 second was used to 
eliminate any remaining signal.
Thermal annealing is performed prior to irradiations; samples are placed in an 
alumina container, covered by an aluminum foil and placed inside an oven (Carbolite, 
UK). The samples are then annealed at a temperature of 400 °C for 1 hr and then 
allowed to cool to room temperature by leaving the samples in the oven following 
switch off, thus avoiding thermal stress (Hashim 2009). In the thermal annealing 
cycle, any remaining TL signal induced by electrons trapped in deep traps is removed. 
The annealing resets the original characteristics of optical fibres, therefore 
maintaining their sensitivity and reproducibility, makes optical fibres reusable (see 
chapter 2 for the details).
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Customer & part number 
Product S/N / Order number 
Fiber Type 
Fiber Model
y
RoHS
Optical properties
Corf lcNve
Specialty Optical Fiber 
Manufacturer
www.coractive.com
Attenuation @ 1060nm 
LPti cut-off wavelengtfi:
Core Numerical aperture 
Cfiromatic dispersion simulation
Physical characteristics 
Length
Typical core diameter 
Cladding diameter 
Coating diameter;
Screen proof tested
University of Surrey 
601-24271 / BF 6237 
SM Low N.A, Ge doped Silica/Silica fib| 
SM-GE-1060-VLNA
Guaranteed Data Unitsspecifications
£ 1 0.7 dB/ km
850 - 950 878 nm
0.10 ±0.02 0.08
-33.0 ps/nm-K
22 22 m 1
9.0 pm I
124.7 ±1.0 124.7 ±0.6 pm J
250 ± 10.0 252.0 ±1.0 K p #
>100 110
(a)
A lum ina
O ptical fibres inside gelatin capsules 
\  \  ^
(b) (c)
Figure 2-33: (a) Infomiation sheet for commercial Ge-doped S102 optical fibres used in this 
study, (b) Ge-doped optical fibre prior to preparation, (e) Ge-doped optieal fibres after the 
preparation, inside the gelatine capsules, also the alumina that accommodates the fibres 
during the annealing process is shown in the picture.
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Figure 2-34: Equipment used for sample preparation of TL dosimetric system studied; (a) 
Fibre stripper, (b) fibre eleaver, (c) vacuum tweezer, (d) methanol, and (d) balance
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2.4. Monte Carlo Simulation
Absolute and relative dosimetry experimental results should ideally be verified 
by comparing with established Monte Carlo methods, as has for instance been 
diseussed for well characterized or Pd-103 studies elsewhere (Rivard, Coursey et 
al. 2004). In the present work, dose measurement results obtained through use of Ge- 
doped optical fibre TLDs will be compared with EGSnrc/DOSRZnrc Monte Carlo 
methodology. The EGSnrc/DOSRZnre Monte Carlo code (Rogers, Kawrakow et al. 
2010) was used in this study to model ’^^ I and '^^Ir experiments and calculate dose 
around these sources.
NRC RZ-codes are for cylindrical RZ geometries; the souree and target 
medium were modelled as cylinders with different radii along the transverse axis of 
the source (R-axis), and with the central axis of the source (Z-axis). These cylinders 
have been divided into sets of planar slabs along the Z-axis (the central axis of seeds). 
Figure 2.35 and figure 2.36 show the longitudinal (Z-axis) and transverse axes (R- 
axis) of the source, and the eylindrical and slabs models of the source.
Figure 2-35: 3D diagram of source geometry modeling. Adapted from 
(Camgoz, Yegin et al. 2010)
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Figure 2-36: The defined and axes
For the Z-direction, dose ealculated points are located in the middle of the 
slabs, while in the R-direction dose ealculated points are located in-between the 
cylinders. Since the modelling geometry is based on cylindrical and planes shapes, the 
intersections of planes and cylinder shells produce rings, and slabs together with rings 
create voxels (volumetrie pixel or volumetric phantom elements); these voxels are 
small volumes. Dose is caleulated at points located for each voxel situated around the 
seed (in the Perspex phantom) using polar coordinates. (Camgoz, Yegin et al. 2010). 
Dose distribution around the seed on the polar system is defined by (R, 0), where R = 
r and Z =  zq + r x  cos(O); the z q  is the midpoint of the seed and r is radius of the 
geometry cylinder (or the distance from the seed centre to the point of interest), as 
demonstrated in Figure 2.37. Symmetry applies in the case of the seed 6711 and is 
assumed in the simulation processes. Therefore, the angular dose distribution for the 
region 0°-90° is assumed to be the same as that for the region 90° -180°; as such, the 
simulation was only performed for the region 0°-90°.
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Figure 2-37: Polar coordinate system (R,Z) for the PMMA phantom around the seed, 
P is the dose calculation point: P(r,0) = P'(r,8), assuming source symmetry (Camgoz, 
Yegin et al. 2010)
The number of histories used in our simulation was 10,000 million. The global 
photon cutoff energy (PCUT) and the global electron cutoff energy (ECUT) were 0 
.001 MeV and 0.521 MeV, respeetively.
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Chapter 3
3. Thermoluminescence Response of Ge-Doped 
S1O2 Fibre Dosimeters to kV X-Ray Radiation
3.1 Introduction
The TL response o f commercially available Ge-doped fibres to ionizing 
radiations has been the subject o f investigations for in excess of a decade. Before 
discussing the application o f these fibres to the dosimetry o f x-rays generated using 
kV potentials, and noting that to-date the TL-response of Ge-doped fibres to low 
energy x-ray irradiations has not been studied in detail, discussion will first be had o f 
some of the previous studies of Ge-doped fibres as TL dosimeters.
(Ramli, Bradley et al. 2009) investigated the Ge-doped fibre response to alpha- 
particles emitted from an source (1.77 MBq) and compared the TL
characterisation with that of TLD-100 rods; in terms of dose response , the TL- yield 
of TLD-100 was reported to be approximately 10 times that of Ge-doped fibres and 
approximately 30 times that o f Al-doped fibres, each o f 5 mm length. Use was made 
of SEM (Scanning Electron Microscope) and EDXRS (Energy Dispersive X-Ray 
Speetroscopy) analysis to evaluate the dopant concentration, these were found to be 
0.35-0.88 mol % and 0.15-0.19 mol % for Al-doped and Ge-doped respectively. 
(Hashim, Al-Ahbabi et al. 2009) studied the response of Ge-doped silica optical fibres 
to high energy photons and electrons; 6 MV photon energy and 6, 9, 12 MV electron 
energies, for a range of doses. The TL measurements illustrated a linear dose response
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(1-4 Gy) for photon and electron enrgies, the fading being negligible over 5 days, 
while the minimum detectable dose was found to be 4, 30 and 900 pGy for TL-100 
and Ge- and Al-doped optical fibres respectively for 6 MV photons, and 3-5, 30-50, 
800-1400 pGy for TL-100, Ge- and Al-doped optical fibres respectively, for 6-, 9-, 
and 12-MeV electron beams. (Ong, Kandaiya et al. 2009) also investigated Ge-doped 
optical fibres’ dosimetric response, specifically for 6 and 10 MV photon energies and 
5 and 14 MeV electron energies and for an Ir-192 HDR source. The Ge-doped optical 
fibres showed linear response up to 12 Gy for these energies, good reproducibility 
within 4-6% (at l a  SD), fading to within 6% over 1 month, it being reported that the 
fibres were re-useable, and with dose rate and angular independence. In addition, 
central axis percentage depth dose (FDD) at different depths from the surface to 20 
cm was measured using optieal fibres, at the solid water phantom. The fibres were 
irradiated to 5 Gy at dmax for 10 MV photon and 2 MeV electron beams, results being 
compared with PDDs measured in the soild water phantom using a Wellhofer Farmer 
type ionization chamber FC65-G and a PTW Markus parallel plate chamber irradiated 
for 10 MV photon and 2 MeV electron beams, respectively, and compared with PDDs 
measurements in water using silicon diode data provided by Radiotherapy unit o f Mt 
Miriam Hospital in Penang, for both energies. For 10 MV photon energy, PDDs 
measured using optical fibres and by ionisation chambers were in agreement to within 
4 % after 0.5 cm depth in the solid water phantom, and to maximum deviation o f 4.1 
% to PDDs measured in water. However, large deviation was recorded to the surface 
to 10.9% in solid water phantom using the optical fibres and to 35.9 % in water using 
silicon diode, the reason for this large deviation being due to the fact that the effective 
points o f measurements differed between the two dosimeters. For the 12 MeV 
electron beam the agreement was observed to be within 4 % between the optical 
fibres, the Markus ionisation chamber and the silicon diode, although a deviation of 
9.7 % was recorded between fibre measurements and the silicon diode measurements 
at the depth o f 6.5 cm due bremsstrulung production. (Yusoff, Hugtenburg et al. 2005) 
found that the highest TL-yield for Al- and Ge-doped SiOi was 4 mole % and 2.5 
mole % respectively. From such studies it has been observed that Ge-doped optical 
fibres offer superior TL yield to that of a number o f other well-indicated dopants in 
silica, including O2 and Al (Hashim 2009).
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(Youssef, Amin et al. 2001) studied the response o f sueh fibres subjected to 
^^Co photon irradiation at different doses, the Ge-doped optical fibres being observed 
to have good characteristics for medical radiation dosimetry at therapy levels: the 
dose being reproducible to within 3%, reusability being confirmed, linearity o f dose 
vs. TL-yield over the range from 1 Gy -  120 Gy and low fading of 7 % during the 
first 30 days after irradiation. (Abdul Rahman, Bradley et al. 2010) evaluated the TL- 
response of Ge-doped optical fibres for synchrotron microbeam radiation therapy (the 
beam having 107 keV mean x-ray energy and an energy spectrum in the range 50-350 
keV). This particular radiation therapy facility employs a very high dose gradient, 
with dose changing by hundreds o f Gy within ~ 10 pm. The TL-yield was found to 
increase linearly from 1 Gy to 2 kGy, being adequate for the intended synchrotron 
microbeam radiotherapy dosimetry requirements, saturating beyond this due to the 
filling of all defects centres (dopant). Within the linear range, the TL yield was found 
to be 2.5 times greater than that obtained in a previous study (Hashim, Al-Ahbabi et 
al. 2009) for the same kind of Ge-doped optical fibres, irradiated with 6 MV photons, 
this being due to dose-rate non-reciprocity. The TL-yield reproducibility was found to 
be better than 4% (1 SD).
Commercial optical fibres’ dosimetric properties have also been studied by 
Espinosa et al. (Espinosa, Golzarri et al. 2006) for ^^Co beams for doses in the ranges 
0.01 Gy -  3 Gy and 4 Gy - 5x10^ Gy. They found the TL response of optical fibres to 
depend linearly on the fibre mass, to have linear dose response up to 3 Gy, increasing 
beyond that up to 5 x 10  ^ Gy, also offering high reprodueibility, being re-useable 
numerous times, and with minimal fading (not given a value by the authors) o f over a 
15 month period.
The potential o f Ge-doped optical fibre TL dosimeters for measurement o f the 
photoelectron dose enhaneement produced in irradiation of a high-Z target, stable 
iodine (Z = 53), was studied by Abdul Rahman et al. (Abdul Rahman, Hugtenburg et 
al. 2012) with low energy photons (90 kVp X-ray). The application o f this in a 
radiation synovectomy technique has been one driver for such study, it being found 
that a TL-yield enhancement of 60 % and 61 % was produced respectively eompared
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with the TL-yield in the absence o f the L contrast medium, use being made of 
Polyurethane and Perspex phantom materials; the MCNPX Monte Carlo simulation 
values employed to verify the experimental measurements were 64 % and 60 % 
respectively. 90 kVp was chosen, because with this the maximum photon yield is ~ 30 
keV, close to the K-edge o f iodine at 33.2 keV. The results o f this work appear to be 
highly promising for treatment o f the synovium, the iodine being introduced into the 
synovial joints space, 100 Gy being required to be delivered to the synovial 
membrane according to the estimation of 1 Gy per 1 g of synovectomy membrane 
(Johnson, Yanch et al. 1995)
(Abdul Rahman, Nisbet et al. 2011) also investigated for photon and electron 
beams whether the response o f Ge-doped optical fibres is dose rate dependent. Ge- 
doped optical fibres were irradiated with 6-15 MV photon beam delivered at rates in 
the range 100-600 cGy min'^ while for 9-20 MeV electron beams the dose rates were 
in the range 100 and 1000 cGy min"\ The dose rate dependency was found to be very 
weak, with reduction in the TL-yield response at the highest dose rate of 3.5%, 3.9 % 
and 3.8 % for electron beams of energies 9, 16 and 20 MeV respectively, eompared 
with the lowest dose rates, and 2.6 % , 2.8 % and 2.5 % respectively for the 6, 10 and 
15 MV photon beams. At fixed dose rate, the dosimeters showed a flat response of 
better than 4% and 3 % for electron and photon beams and good reproducibility to ± 
1.5 %.
Noor et al (Noor, Hussein et al. 2010) investigated the potential o f dosimeters 
in obtaining dose in- and out-of-field (by which is meant outside o f the planned target 
volume, PTV) in use of high energy IMRT. Samples of Ge-doped optical fibres and 
TLD-100 were placed within an anthropomorphic phantom (RANDO) and irradiated 
with 6 and 15 MV photon energies to obtain in- and out-of-field dose measurements, 
using IMRT five-field plans for treatment o f prostate cancer; the measurements were 
performed along the z-axis. The IMRT plans delivered were taken from data for two 
patients with pathological diagnosed prostate cancers of different prostate volume. No 
significant variation was recorded between TLD-100 and Ge-doped optical fibres 
measurements for IMRT doses for 6 MV photon energy for both in- and out-of-field.
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while for the 15 MV photon energy out-of-field measurements, a large discrepancy 
was noted between TLD-100 (corrected and uncorrected for neutron production) and 
Ge-doped optical fibres. For 6MV irradiations the agreement is expected since the 
energies involved are below the photoneutron production threshold (~ 10 MeV). For 
the 15 MV out-of-field measurements (wherein photon dose no longer masks the very 
much smaller neutron dose), the large difference is understood to be due to the faet 
that TLD-100 contains ^Li, which has a large thermal neutron absorption cross-section 
(~ a few thousand bam) and corrections need to be applied (e.g. using the results of 
Kry et al (KRY, PRICE et al. 2007)) to compensate for the effects of neutron dose, 
while for Ge-doped optical fibres, the thermal neutron absorption cross-section for 
germanium and silica are small ~ 10 and ~ 1 bam, respectively, and therefore 
negligible.
Ge-doped optical fibres dosimeters were utilized in an IMRT dosimetry study 
by Noor et al (Noor, Eiussein et al. 2011), the work seeking to verify IMRT 3D dose 
distributions. Using Ge-doped optical fibres placed into a Rando phantom, two 
prostate caneer patient treatment plans were delivered to the phantom, the irradiations 
being performed for two nominal photon energies, 6 MV and 15 MV. Comparison 
was made using the well established dosimeters LiF TLD-100 and TLD-700 to obtain 
dose using the same setups. The Ge-doped optical fibres provided excellent 
verification of the IMRT TPS results for both low and high dose regions for both 
nominal photon energies and good agreement with TLD-100 and TLD-700 values 
were also shown. In addition, TL-yield/ dose calibration curves were obtained for the 
optical fibres for 6 MV and 15 MV nominal energies for the dose range 10-300 cGy, 
the relationship between TL-yield and dose being linear; the TL-yield response o f the 
fibres for 15MV was lower than that for 6 MV, in line with expectation.
This dissertation builds on previous experience, as above, and investigates the 
use of Ge-doped optical fibres in the dosimetry o f kilovoltage therapeutic x-ray 
beams. This is because the majority of photon energies emitted from brachytherapy 
sources are between 0.35 - 0.66 MeV (although there are low energy exceptions to 
this). In this chapter the response of Ge-doped optical fibres at low energy x-ray
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photons using a superficial kVp x-ray set are studied. Fibre characteristics including 
dose response, reproducibility and fading are determined. The identified 
characteristies are important features and through use of an x-ray set, the exploratory 
investigation could be carried out relatively quickly (a situation not possible using the 
brachytherapy sources that are discussed later in this thesis), allowing the radiation 
controlled clinical environment to be released back for clinical applications without 
any implied disruption to clinical schedules.
In addition, for kilovotage x-ray beam dosimetry, only limited data is 
available in the literature for the use o f solid water phantoms (Hill, Holloway et al. 
2005). An addendum to the FPEM dosimetry Code of Practice (Aukett, Burns et al. 
2005) mentions difficulties in dealing with small applicators for relative dosimetry 
measurements (percentage depth dose (PDD) and applicator factor measurements) at 
low energy kilovoltage energies, in partieular in aligning the dosimeter and irradiation 
field centre. In this dissertation optical fibres are also used for relative dosimetry 
measurements, thus investigating their ability to tackle the problems mentioned in the 
IPEM dosimetry code of practice, and also to obtain appropriate solid water phantom 
correction factors for dosimetry in kilovoltage x-ray beams.
3.2 Selection of Dosimeters
The TL-dosimeter medium used throughout the duration o f the present 
research is a commercial communication fibres system o f Ge-doped SiOi optical fibre 
model SM-GE-1060-VLNA, produced and supplied by CorActive High Teehnology, 
Canada, the construction of which was explained in section 2.S.3.4.
As mentioned previously, dopants are added to the core of optical fibres to 
make fibres that are appropriate for communication purposes, generating the 
conditions required for total internal reflection through change of the refractive index 
at the core-cladding interface. It is apparent that the dopants and defect centres are 
inhomogeneously distributed within the core, affecting the TL yield (Abdul Rahman,
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Bradley et al. 2010). Due to the non-uniformity in the concentration of the Ge dopant 
along the length of the fibres, a selection (i.e. screening) procedure should be 
performed prior to any dosimetric investigation.
ICRP recommendations are that dosimetry should be accurate within to ± 3% 
for dose measurements for external radiation beams and within 2 to 5 % for depth 
dose, tray factor and wedge factor measurements (ICRP 1984). In pursuit o f such 
accuracies, an appropriate screening study was first carried out, aimed at discarding 
outlying high and low response fibres, retaining Ge-doped optical fibres with a TL 
yield within 3% of the mean value.
The selection process is performed by irradiation of a large group of fibres at 
fixed penetrating photon energy and fixed dose. In present work, 1935 Ge-doped 
optical fibres were prepared as also explained in section 2.3.3.4. The samples were 
then placed in three gelatine capsules, the capsule containing 767 fibres, the 2"^d 
695 fibres and the 3"^  ^containing 473, samples. Each capsule was placed on the top of 
a 5 cm thick solid water phantom to produce full backscatter. Irradiation was 
performed using a DXT300 X-ray unit (Pantak Inc., Branford USA), with an 8 cm 
diameter applicator, and FSD (Focus Skin Distance) of 30 cm, to deliver 3 Gy at 90 
kVp (details are summarised in table 3.1). 12 hours post irradiation, readout of 
samples was performed to obtain the TL-yield o f the samples.
3.3 Dosimetric Properties of Ge-doped Optical Fibres
Key dosimetric parameters were investigated for the two accelerating 
potentials and irradiation field set-up parameters shown in Table 3.1. The parameters 
include dose response, reproducibility and fading. Relative dose measurements were 
performed, obtaining central axis percentage depth dose (PDD) values, use being 
made of doped fibres irradiated in water and solid water phantoms.
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3.3.1. Solid W ater Phantom
RMI 4571 (GAMMEX RMI, Madison, WI) solid water phantom material was 
used in this study, in the form o f slabs with dimensions of 300 mm x 300 mm, and 
with thickness varying from 1 mm to 50 mm. To provide backscatter, a total thickness 
of 50 mm of this solid water was positioned beneath the dosimeters for all 
experiments (except the PDD measurements in water).
3.3.2. Irrad ia tions Setup
During irradiation, optical fibres were retained in gelatine capsules (15 fibres 
in each to allow statistical analysis o f reproducibility), although there is exception for 
PDD measurements as the samples were placed in a custom built jig  (shown in the 
figure 3.1). Irradiations were carried out at the Royal Surrey County Hospital 
(RSCH), Guildford, using a DXT300 X-ray unit (Pantak Inc., Branford USA). The 
unit has a 5 mm beryllium window and is capable o f operation at accelerating 
potentials of between 90 and 300 kVp. Table 3.1 summarises the x-ray unit 
parameters related to this study.
Table 3-1: x-ray beam parameters
Tube
Potential
(kVp)
Added
Filtration
HVL FSD
Field size applicators
Applicator
dimension
Applicator
specification
90 1.65 mm Al
2.5 mm 
Al
30
cm
4, 6 and 8** cm 
diameter
Open-ended
applicators
300
0.3 mm Sn+0.5 
mm Cu +1.5 
mm Al
2.8 mm 
Cu
50
cm
10 X 10 cm^  ** 
and 6 and 4 cm 
diameter *
Closed ended 
cones:
HVL: H alf Value Layer. FSD: Focus Skin Distance. * Note: 6 cm fields at 300 kVp were obtained by 
inserting lead cut-outs. A ll fields are circular fields except that o f  the 10 x 10 cm^ squared field at 
SOOkVp. ** Note: 8cm diameter and 1 0 x 1 0  cm^ applicators are used with the standard set-up.
FATMA ISSA 2012 Page 81
Chapter 3: Thermoluminescence Response o f  Ge-Doped Si02 Fibre Dosimeters to kVX-Ray Radiation
Doped Optical Fibres Thermoluminescence Dosimetry fo r Brachytherapy
The standard set-up was applied for all experiments except for the FDD 
measurements. The following measurements were performed:
3.3.2.1. Dose Response:
Dose response for Ge-doped optical fibres was investigated by irradiating the 
optical fibres over the dose range 0.1- 45 Gy for 90 kVp and 300 kVp accelerating 
potentials.
3.3.2.2. Reproducibility:
The reproducibility was estimated by repeating the last experiment three 
times, inclusive o f annealing cycles., exclusively for the dose range 1- 6 Gy.
3.3.2.3. Fading:
The quantity of TL-signal lost by optical fibres following irradiation was 
evaluated through the use of seven groups of 15 fibres; following irradiation at 90 
kVp and 3 Gy, readout was carried out for different delay periods, up to a maximum 
of 7 days.
3.3.2.4. Central Axis Percentage Depth Dose
Relative dosimetry measurements represented by percentage depth dose 
(FDD) measurements were determined. FDD is defined as the quotient (expressed as a 
percentage) o f the absorbed dose at any depth at an irradiated medium to the absorbed 
depth at a fixed reference depth, along the central axis of the beam (Khan 2003). In 
contrast with megavoltage beams, kilovoltage x-ray beams have a maximum absorbed
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dose at the skin surface or very close to the surface, dose subsequently dropping off 
quickly with increasing depth avoiding over dose below the skin surface. As such, low 
x-ray energy beams can be used for treatment of skin cancer. However, FDD at depths 
beyond the depth of maximum dose increase with beam energy, due to the increasing 
beam penetration. (Khan 2003)
Central axis percentage depth doses (FDD) were obtained at 90 kVp and 300 
kVp, for a range o f applicator sizes (see table 3.1 for the details), for both the solid 
water phantom and a water phantom, normalized to a depth o f 2 cm to avoid surface 
uncertainties (Hill, Holloway et al. 2005). Measured results were compared with 
British Journal of Radiology (BJR) supplement 25 tabulated data (BJR 1996) and 
measurements taken with a 0.6 cc graphite-walled ionisation chamber (with positional 
uncertainty of ±1 mm) in a water phantom. The setup of the FDD experiments in 
water is illustrated in figure 3.1
3.3.2.5. RMI-457 Solid Water Phantom Correction Factor
For routine use it is much easier to use a solid water phantom instead o f water. 
However, a correction factor between water and solid water material should be 
determined (Hill, Holloway et al. 2005). As mentioned previously, limited data is 
available for the values of the RMI-457 solid water phantom/ water correction factor 
for low energy x-rays beams. The use o f Ge-doped optical fibres to obtain the 
correction factors for 90 kVp and 300 kVp for the field sizes shown in table 3.1 has 
therefore been investigated. All measurements were taken at 2 cm from the phantom 
surface (PSD + 2 cm). The setup to obtain the RMI correction factors is shown in the 
figures 3.1 and 3.3.
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- PMMA jig containing the samples
Figure 3-1: The set-up used to obtain the FDD and RMI / water correction factor 
measurements in water at 90 kVp
Figure 3-2: The 6 cm and 4 cm diameter lead-cut out used with 10 
applicator to obtain circular field
0 cm
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The position of lead cut-out in case of use it 
b
Figure 3-3: The set-up of the RMI/ water correction factor measurements in the solid 
water at 2 cm thickness for (a) 90 kVp and (b) 300 kVp
Figure 3-4: The set-up used for dose response, fading and reproducibility 
experiments: (a) for 90 kVp and (b) for 300kVp
/XSX 20/2 Page 85
Chapter 3: Thermohiminescence Response o f  Ge-Doped Si02 Fibre Dosimeters to kVX-Ray Radiation
Doped Optica! Fibres Thermoluminescence Dosimetiy fo r Brachytherapy
3.4 Results and Discussion
3.4.1. Selection of Dosimeter
Figures 3.5 and 3.6 demonstrate the selection process of a group of 676 fibres. 
The wide variation resulting from dopant non-uniformity produces a coefficient of 
variation (CV) of 18 %, the CV expressing the spread o f data from the mean (figure 
3.5). Post selection, the variation has been reduced by discarding outliers to retain 
only those with a TL-yield within 3% of the mean; 4 subgroups of selected fibres 
were produced. Figure 3.6 shows the TL-yield of the selected groups, providing 
individual responses within 3% of the mean, as recommended in (ICRP 1984).
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Figure 3-5: Response for 676 randomly selected Ge-doped fibres, irradiated at 90kVp 
to a fixed dose of 3Gy
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Figure 3-6: TL-yield post selection for the optical fibres irradiated at 90kVp, 3Gy, of 
(a) Group 1 (b) Group 2 (c) Group 3 and (d) Group 4 of good selected fibres. The 
error bars represented the standard error of the mean
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3.4.2. Dose Response
Linearity of response is obtained within the dose range of clinical interest of 
10 cGy to 45 Gy, at both 90 kVp and 300 kVp (Figure 3.7 and 3.8) and for the range 
of doselO cGy to 6 Gy (Figure 3.9 and 3.10), repeated three times. The inset to the 
figures illustrates the dose response in the small dose range (10 cGy to 100 cGy). 
Least square fits to the data have been obtained while the error bars represent the 
standard deviation of the mean. The values of correlation coefficient (r^) confirm 
linearity.
The relative sensitivity at 90 kVp was about four times higher than that at 300 
kVp, in accord with the associated energy absorption coefficients, dominated by the 
photoelectric effect at lower photon energies. The observation of linearity o f response 
with dose is in agreement with (Hashim, Ramli et al. 2007), their results showing 
linearity of response of Ge-doped optical fibres up to at least 10 Gy, when irradiated 
at an accelerating potential o f 48.9 kVp.
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Figure 3-7: Dose response of optical fibres over the dose range 0.1 - 45 Gy, irrad iated  at 
90kVp.
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Figure 3-8: Dose response of optical fibres over the dose range 0.1 - 45 Gy, irradiated at 
300 kVp.
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Figure 3-9: Dose response of optical fibres over the dose range 0 . 1 - 6  Gy, irradiated 
at 90kVp. To evaluate reproducibility, the experiment was repeated twice.
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Figure 3-10: Dose response of Ge-doped optical fibres for dose range 0.1-6 Gy, 
irradiated at 300kVp. To evaluate reproducibility, the experiment was repeated twice.
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3.4.3. Reproducibility
Reproducibility was obtained to within 2%, improving upon that reported by 
(Abdul Rahman, Bradley et al. 2010), (Ong, Kandaiya et al. 2009) and (Youssef, 
Amin et al. 2001); the first group reporting reproducibility to within ± 4% for a 
synchrotron microbeam (energy spectrum range, 50-350 keV, with mean energy of 
107 keV) and the second group reporting reproducibility to within 4 -  6 % for 6 and 
10 MV photon energies and 5 and 14 MeV electron energies, while the third group 
reported reproducibility to within 3% for Co-60 photon energies irradiations. This is 
almost certainly due to a more stringent selectivity being practiced herein.
3.4.4. Fading
While it is generally acknowledged for phosphor TLDs that there is a need to 
correct for fading (McKeever 1985), for Ge-doped optical fibres fading has been 
found to be very small (Fig. 3.11). It has been found herein to lose (1.4 ± 0.06) % of 
the TL-yield recorded 12 hours after irradiation. The observation o f minimal fading is 
in line with that found by (Hashim, Al-Ahbabi et al. 2009), (Ong, Kandaiya et al. 
2009) and (Abdul Rahman, Nisbet et al. 2011), being due to the deep trapping levels 
involved.
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Figure 3-11: Fading of Ge-doped fibres signals observed up to one week post 
irradiation (for a 90 kVp beam and a dose of 3Gy). The error bars represent the 
uncertainty in term of SEM (standard error of the mean).
3.4.5. C entral Axis Percentage Depth Dose (FDD)
3.4.5.I. FDD at 90 kVp
Central axis pereentage depth dose (FDD) data has been obtained for 
applicators of 8, 6 and 4 cm diameter field size (Figures 3.12 3.13 and 3.14 
respectively). The figures also show comparison with 2.3 mm A1 (HVL), 2 mm A1 
(external filter), 80kVp BJR supplement 25 tabulated data (BJR 1996) and data 
measured by ionisation chamber, for the same parameters listed in table 3.1 The 
curves are least square fits while the error bars represent 2 % uncertainty in optieal 
fibre dose measurements.
Measured doses were normalized at depth 2 cm, as recommended by IAEA 
TRS-398 protocol (IAEA 2000), avoiding surface problems, including electron 
disequilibrium. (Hill, Holloway et al. 2005). FDD measurements made with optical 
fibres in water were in good agreement with the same measurements made in RMI
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457, also with PDD tabulated data and with PDDs from ion chamber measurements 
made at the RSCH. The maximum discrepancy observed between PDD measurements 
using optical fibres in water and in RMI 457 was 3.1% for the 6 cm diameter 
applicator. The maximum difference between PDD measurements obtained through 
use of the optical fibres in water and PDD measurements obtained from the tabulated 
data was 2.3% (being that for the 8cm circular applicator). The maximum difference 
between PDD measurements obtained through use of the optical fibres in water and 
that supplied by the RSCH through ion chamber measurements was 2.1% (for the 6 
cm diameter applicator). These results are in line with that o f (Hill, Holloway et al. 
2005), the maximum deviation between doses measured in RMI 457 solid water 
phantom and phantom observed by this group being 2.4% for 75 kVp, 2.2mmAL 
(HVL), 1.65 mmAl (filter) with an 8cm diameter applicator .
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Figure 3-12: PDD measured using Ge-doped fibres in water and a solid water 
phantom for 90 kVp, 2.5 mm A1 (HVL) using 8 cm diameter open-ended applicator. 
PDD tabulated data for 2.3 mm A1 (HVL), 80 kVp and 0.6cc graphite-walled 
ionization chamber PDD data are included for comparison
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Figure 3-13: PDD measured through use of Ge-doped fibres in water and solid water 
phantom for 90 kVp, 2.5 mm A1 (HVL) using 6 cm diameter open-ended applicator. 
PDD tabulated data for 2.3 mm A1 (HVL), 80 kVp and 0.6cc graphite walled 
ionization chamber PDD data are included for comparison
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Figure 3-14: PDD measured by Ge-doped fibres in water and solid water phantom for 
90 kVp, 2.5 mm A1 (HVL) using 4 cm diameter open-ended applicator. PDD 
tabulated data for 2.3 mm A1 (HVL), 80 kVp and 0.6cc graphite walled ionization 
chamber PDD data are included for comparison
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3.4.S.2. PDD a t3 0 0 k V p
Figures. 3.15, 3.16 and 3.17 show analogue 300 kVp central axis FDD data to 
that obtained at 90 kVp, restricted this time to a 10 x 10 cm^ square field size and 6, 4 
cm diameter field size applicator, respectively. The circular fields were obtained by 
making use of 6 and 4 cm lead cut-outs (figure 3.2), respectively with the 10 x 10 cm 
applicator (refer to Table 3.1 for details). For comparison purposes, also included are 
300 kVp, 4.0 mm Cu (HVL), BJR supplement 25 PDD tabulated data (BJR 1996) and 
ionisation chamber PDD data, obtained using the same parameters as shown in Table
3.1. As before, doses were normalised to the dose at a depth o f 2 cm to obtain the 
PDDs. The curves are least square fits, the error bars representing an uncertainty of 2 
% in dose measurement.
Good agreement was obtained between PDD measurements in water; PDDs 
measured by optical fibres were within 1.5% and 1.1% with ionization chamber 
measurements and BJR tabulated data respectively. The agreement between optical 
fibre measurements for PDD in the RMI 457 solid water phantom and water was 
within 2.5% for the 10 x 10 cm^ field size applicator. The maximum deviation 
between the optical fibre measurements for PDD in water and in RMI 457 was 3.7% 
for the square applicator with a 6 cm diameter lead insert, while this deviation was 
2.5% for the square applicator with a 4 cm diameter lead insert. This was better then 
(Ong, Kandaiya et al. 2009) results, as this group stated that the agreement between 
the optical fibre and ionisation chamber measurements for PDDs for 12MeV electron 
energy was within 4% beyond 0.5 cm depth and 10.9% at the surface. For the 6 and 
4 cm circular field size, PDD values obtained from optical fibre measurements in the 
solid water phantom are not significantly different from measurements made in water. 
One notes here that the use of a lead cut-out with the square applicator might be 
expected to lead to scatter production for small field sizes and consequent affects on 
depth doses, as also mentioned by (Lee and Chan 2000). Nevertheless, for all PDD 
measurements, doses measured in the solid water phantom agreed with those 
measured in water, within measurement uncertainties. The small size and sensitivity 
of the optical fibre dosimeters offer considerable potential in providing PDDs for
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small field size applicators, overcoming the alignment problems mentioned in the 
addendum to the IPEMB code (Aukett, Bums et al. 2005).
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Figure 3-15: PDD measured by Ge-doped fibres in water and solid water phantom for 
300 kVp, 2.8 mm Cu (HVL), 1 0 x 1 0  cm^ applicator. Also shown for comparison are 
PDDs (obtained using the same irradiation parameters) measured though use of an 
0.6ce graphite-walled ionization chamber (data supplied by RSCH) and BJR 
tabulations PDD measurements for 300 kVp, 4.0 mm Cu (HVL) are also shown for 
comparison
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Figure 3-16: PDD measured by Ge-doped fibres in water and a solid water phantom for 300 
kVp, 2.8 mm Cu (HVL), 6 cm diameter field size. Also included for comparison are PDDs 
(obtained using the same irradiation parameters) from 0.6cc graphite-walled ionization 
chamber measurements supplied by the RSCH and BJR tabulations PDD measurements for 
300 kVp, 4.0 mm Cu (HVL) are also shown for comparison purposes.
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Figure 3-17: PDD measured by Ge-doped fibres in water and a solid water phantom for 300 
kVp, 2.8 mm Cu (HVL), 4 cm diameter field size. Also included for comparison are PDDs 
(obtained using the same irradiation parameters) from 0.6cc graphite-walled ionization 
chamber measurements supplied by the RSCH and BJR tabulations PDD measurements for 
300 kVp, 4.0 mm Cu (HVL) are also shown for comparison purposes
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3.4.6. RMI-457 Correction Factor
There are relatively few studies concerning dose discrepancies between water 
and epoxy resin phantom materials (Allahverdi, Nisbet et al. 1998) (Buckley, 
Thomadsen et al. 2001) (Thomadsen, Constantinou et al. 1995) (Tello, Tailor et al. 
1995) (Thwaites 1985) (Thwaites D I 2003) . These show deviations between water 
and epoxy resin phantom materials for megavoltage photon energies, with a 
correction factor for the RMI 457 phantom of 0.996 for Co-60. In this study, the RMI 
457 phantom correction factor for 300 kVp at depth 2 cm was found to be 0.955 ± 
0.102, 0.955 ±0.140 and 0.955 ±0.137 for 10 x 10 cm^ and 6 cm and 4 cm diameter 
applicators, respectively, where the latter two were obtained by making use o f 6 cm 
and 4 cm lead cut out with the 10 x 10 cm^ applicator. As such, the mean RMI 457 
phantom correction factor at 300 kVp at depth 2 cm is 0.955 ± 0.221.
The RMI 457 phantom correction factor was found to be 1.154 ± 0.134, 1.154 
± 0.033 and 1.157 ± 0.063 for the 8 cm, 6 cm and 4 cm circular applicators 
respectively at depth 2 cm. As such, the mean RMI 457 phantom correction factor at 
90 kVp at depth 2 cm is 1.155 ± 0.152.
3.5 Conclusion
Dosimetric parameters for the optical fibres such as dose response, 
reproducibility and fading were investigated for x-rays generated at 90 kVp and 300 
kVp. The parameters include dose response, reproducibility and fading. Relative dose 
measurements were performed, obtaining central axis percentage depth dose (PDD) 
values, use being made o f doped fibres irradiated in water and solid water phantoms. 
TL yields were compared with published data and ionization chamber measurements.
At 90 kVp and 300 kVp, Ge-doped optical fibres provide good reproducibility 
to within ± 2 % and linear dose response over a useful range o f therapeutic doses (0.1 
to 45 Gy). TL fading was found to be minimal, at < 1.5% over a seven days period. 
The RMI-457 solid water phantom correction factor at 2 cm depth was found to be
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1.155 ± 0.152 and 0.955 ± 0.221 at 90 kVp and 300 kVp respectively. PDD 
evaluations made with Ge-doped optical fibres irradiated at 90 kVp in a water 
phantom, agree to within 3.1% with measurements made in a RMI 4571 solid water 
phantom and to within 2.3% with BJR tabulated data. PDD measured values for 300 
kVp, beams obtained using Ge-doped optical fibres in water, were in good agreement 
with BJR tabulated data and ionization chamber measurements to within 1.1% and 1.5 
% respectively. This study indicates that for all PDD measurements, doses measured 
in the solid water phantom agreed with those measured in water, within measurement 
uncertainties. The small size and sensitivity o f the optical fibre dosimeters offer 
considerable potential in providing PDDs for small field size applicators, overcoming 
the alignment problems mentioned in the addendum to the IPEMB code.
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Chapter 4
4. Establishment of Ge-Doped SiOi Fibre TLDs 
for Brachytherapy Using Two Lab Sources
4.1. Introduction
As explained in the previous chapter, investigations of Ge-doped optical fibre 
dosimeters at 90 kVp and 300 kVp have shown them to provide very favourable 
dosimeteric characteristics, providing high dynamic range (linear response up to 45 
Gy), good reproducibility to within 2 % and very low fading (Issa, Latip et al. 2011). 
In addition, Ge-doped silica fibres offer good spatial resolution (-120 pm), are o f low 
cost and are impervious to water. These advantages all point to Ge-doped optical 
fibres being an excellent candidate dosimeter for brachytherapy applications. Not 
least, they offer the capability to map dose variations over small distances ( «  1cm) 
from the sources.
The essential aim of this research is to establish Ge-doped optical fibres as 
thermoluminescence (TL) dosimeters for brachytherapy dosimetry. In this particular 
part o f the study, the aim is to establish the methodology o f dose measurements using 
Ge-doped optical fibre dosimeters at distances down to 1 mm from the encapsulation 
surface, using two laboratory (low activity) sources, before applying such 
methodology to clinical brachytherapy dosimetry. This requires investigation to 
accommodate sensitivity o f detection, both for the possibility o f short range dose 
deposition from beta components as well as gamma/x-mediated dose. In-air 
measurements are made at distances close to radionuclide sources, evaluating the fall
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off in dose along the transverse axis of ^^^Ba and ^®Co radioactive sources, at 
distances from 2 mm up to 20 mm from their midpoints. Measurements have been 
compared with Monte Carlo code DOSRZnrc simulations for photon-mediated dose 
only and electron and photon-mediated dose, comparison been performed to check 
whether beta dose has been filtered out by source encapsulation or beta dose 
contributions result from any imperfections in the source encapsulation. Monte Carlo 
calculations are also performed at the same distances to verify the measurement 
results.
The ^^^Ba and ^^Co laboratory sources were deliberately chosen as critical tests 
of sensitivity, being o f much lower activity (< 0.5 MBq) than that of brachytherapy 
radionuclides (allowing source manipulation under low radiological exposure 
conditions, as befits a pilot study) and also offering some potential for investigating 
beta dose close to the encapsulation surface.
4.2. Radioactive Sources
The low and high energy photon emitter radioactive sources (laboratory 
sources), ^^^Ba and ^®Co were chosen in this study, in part due to the energy range 
offered, 0.32 up to 1.33 MeV, respectively and in part because of the associated beta 
emissions, a fraction o f which may not be stopped by the encapsulation in the 
standard lab sources that have been made available to us. As a consequence, the beta 
dose may be capable o f being detected close to the source. Currently ^^^Ba and ^°Co 
are not typically used as brachytherapy sources, although it should be noted that ^°Co 
has been used in the past, as the basis of high dose-rate source afterloading devices 
(Khan, 2003), notably the Cathetron (Liversage, Martin-Smith et al. 1967) and the 
Ralstron (Wakabayashi, Osawa et al. 1971). ^®Co is now infrequently used, due to its 
short half life and to its greater expense and shielding requirements compared to ^^^Cs 
for instance.
The present study seeks to establish the measurement methods before 
translating such methodology to real brachytherapy applications. The low activity
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sources available to us further represent a sensitivity challenge. Full descriptions of 
the sources are given below.
At the time of use, the '^^Ba source had an activity of 0.41 MBq. '^^Ba has a 
half-life of 10.74 years, decaying by electron capture. The maximum beta energy is 
0.32 MeV (1.5%), while the predominant photon emission energies of photon 
emissions are provided in Table 4.1.
The Ba-133 radioactive source construction is shown in figure 4.1 (all 
dimensions are in mm). The active material is absorbed onto a 1 mm diameter ion 
exchange resin bead, sealed between clear polystyrene windows; the polystyrene 
windows with the active material are surrounded by a plastic wafer.
25.4
23.5
2 .0 - 2.1
linin diam. active bead 
(between 0.5 mm polystyrene windows)
Figure 4-1: *^^Ba construction, dimensions in mm (Amersham International PLC 
1981)
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Table 4-1: Predominant Photon Emissions.
Photon energy (keV) Energy kind Photons per disintegration (%)
302.6 Gamma 18.3
356.0 Gamma 62.1
383.9 Gamma 8.9
81.0 x-ray 34
4.2.2/°Co
At the time of use, the ^°Co source had an activity of 0.434 MBq. ^°Co has a 
half-life of 5.27 years, beta decaying and emitting gamma rays. The predominant 
emission energies are provided in table 4.2 while figure 4.2 shows the construction of 
the radioactive source. The active part is of a cylindrical shape and of dimensions 2 
mm X 2 mm, surrounded by stainless steel (type 316) produced in the form of a 
capsule of 2.2 mm thickness and designed to be sufficient to filter p-particles (0.1-0.2 
mm platinum equivalent being sufficient to filter the (3-particles provided the source is 
centrally displaced in the encapsulation).
TAG
6.4
Figure 4-2: ^^Co construction, dimensions in mm (Amersham 1979)
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Table 4-2: Shows the % o  Energy Spectra
Emission energy 
(keV) Energy kind Photon/particle per disintegration (%)
317.9 Beta 99.9
1173.283 Gamma 99.9
1332.501 Gamma 100
4.3. Phantom  Device
A 6 cm X 6 cm X 2 cm Perspex (PMMA) phantom was designed for this 
study (figure 4.3). It contains appropriate locating notches, the largest notch being 
centrally displaced to accommodate the source while more superficial notches located 
on both sides of the source along the transverse axis of the source were provided to 
accommodate fibres at distances of 2, 3, 4, 5, 10, 15, 20 mm from the central position 
of the source. The samples were irradiated as depicted in figure 4.4.
Figure 4-3: Perspex phantom: (a) without source and samples, (b) Perspex 
phantom with % o  source and samples.
4.4. Irrad iation
Irradiations were carried out at the University of Surrey Radiation Laboratory. 
Figure 4.4 illustrates the anangement applied for both source situations.
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In the case of irradiations, the source was placed in its locating notch 
(half inside and half out in air). The Ge-doped SiOi fibres had previously been placed 
in their locating positions on the phantom and, with the source in position, were 
irradiated as shown in Figure 4.4b. A wall o f 50 mm thick lead bricks surrounded the 
phantom, including Pb bricks placed on the top of the arrangement, in order to 
provide for protection of staff (figure 4.5). A three-week period of irradiation was 
performed, giving rise to doses to distal fibres of -  0.02 Gy and proximal fibres o f -  
10 Gy, including accounting for the stainless steel shielding. This is a dose range that 
is measurable by Ge-doped optical fibres (Yaakob, Wagiran et al. 2011).
In the case of ^°Co irradiations, due to its size and shape, the source was 
placed on the top of the locating notch, as shown in Figure 4.4a. All other 
arrangements were as for the ^^^Ba situation. Irradiation was performed for 3 days. 
The distal dose for this period of time is -  0.02 Gy and the proximal dose is -  8.0 Gy 
taking into account the stain steel shielding. Only fibres offering a TL-yield response 
within 3% from the mean values provided by the group of fibres were used in the 
irradiations (as detailed earlier, regarding the selection process).
Plan view
Source position Samples positions
60Co Side view
2mm 5mm
H
20 mm
5mm\  2mm
0  H
a a aaaa^  ^aaaa a a a
1mm20 mm
Phantom 2mm ^^ ^Ba/
a)'°Co
1 / > ^ 5mm
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* m a
T
H
. 20 mm 1mm
Figure 4-4: Setup of: (a) '^^Ba experiment; (b) ^°Co experiment
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phahtom’^ i
Ba source
Lead Castle (50 mm)
a) b)
Figure 4-5: (a) The experimental setup; (b) Lead sheet placed on the top of the lead castle 
during irradiations
4.5. M onte Carlo simulation
For verification purposes, the EGSnrc/ DOSRZnrc Monte Carlo code (Rogers, 
Kawrakow et al. 2010) was used to calculate dose around the ^^^Ba and ^^Co sources 
along the transverses axis of the sources (R-axis), the locations corresponding to the 
same positions used for the fibres in measurements, as illustrated in figure 4.4.
The number of histories used in the simulations was 10  ^ for ^^^Ba and 10  ^for 
^°Co respectively. This leads to a 3 hour computation time and consequently 0.2 % 
and 1.6% estimated errors for '^^Ba and ^°Co respectively. The global photon cut-off 
energy (PCUT) and the global electron cut-off energy (ECUT) were 0.001 MeV and 
0.521 MeV, respectively. The photon spectrum detailed in table 4.1 was used in 
simulation of the ’^^Ba experiment. In regard to the ^°Co source, simulation was 
preformed twice; here the spectrum detailed in table 4.2 was utilized, first excluding 
any beta component, presuming that the stainless steel capsule was sufficient to 
absorb all p-particles, the radioactive source being centrally located within the 
encapsulation. The second simulation was performed using the entire details of table
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4.2 to check for detection o f p-particles escaping the encapsulation. Both simulation 
results were compared with measurement results.
4.5.1. Source Modelling
The ^^^Ba source was modelled as polystyrene, divided into 8 slabs 
along the vertical axis; 4 in air and 4 in Perspex along the central axis of the source 
(Z-axis), and into 2 cylinders along the horizontal axis (R-axis) with the same central 
axis (the central axis o f the source). The active part was modelled as a 1 mm x 1 mm 
cylinder, made of polystyrene material. The *^^Ba energy spectra shown in Table 4.1 
were used in the simulation.
^®Co: The cobalt source was modelled as 3 cylinders made of stainless steel 
with different radii along the R-axis, and accommodating the 2 mm x 2 mm cobalt 
cylinder which represents the active part o f the source. The three cylinders were then 
divided into 10 slabs along the Z-axis, and the active part into 4 slabs. The % o  
energy spectrum shown in table 4.2 was used in the simulation.
4.5.2. Phantom Modelling
The set up of both the ^^Co and ^^^Ba experiments shown in figures 4.4a and 
4.4b were modelled. As the measured dose points were in air, the phantom was 
assumed to be 6 cm x 6 cm x 2 cm air and 6 cm x 6 cm x 6 cm Perspex. The 
phantom was modelled as a cylindrical geometry.
In the case of the ^^^Ba experiment, the phantom was modelled by dividing it 
into 9 slabs with various thicknesses along the Z-axis and into 15 cylinders with 
different radii along the R-axis. Conversely, in the case o f ^^Co, the phantom was 
modelled by dividing it into 17 slabs with various thicknesses along the Z-axis and 
into 16 cylinders with different radii along the R-axis
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4.6. Investigating Radionuclide Source Shielding Performance Using 
Ge-Doped Optical Fibres Dosimeters
Herein, investigation was made o f the sensitivity o f Ge-doped optical fibre 
TL dosimeters to detect beta-and gamma radiation for distances ranging from 2- to 
20 mm from a ^^Co source. Ge-doped optical fibres measurements along the 
transverse axis of the ^^Co source at distances from 20 mm down to 2 mm from the 
source centre were compared with dose obtained by DOSEZnrc Monte Carlo 
simulation, where MC simulations performed at the same distances and (3-particles 
energies was included in the simulation spectra to investigate whether beta dose 
contributions result from any imperfections in the source encapsulation and to 
double check the ability of the stain steel encapsulation to filter all beta- particles.
4.7. Results and Discussions
4.7.1. Dose Along Transverse Axis of ^^ B^a
Figures 4.6 and 4.7 show comparison between Ge-doped optical fibre 
measurements and dose calculations using DOSRZnrc along the transverse axis o f the 
^^^Ba source (R-axis) from 2 mm to 20 mm, as depicted in figure 4.4, for a 3 week 
irradiation period. The error bars represent the uncertainty in dose calculation in terms 
of standard error o f the mean. The Monte Carlo and measured doses were normalized 
at 2 mm. The absolute difference between dose measurements and calculation was on 
average 2.6 %. The power curve fitting (Allomeotric 1) was used to fit the 
measurement points. The plots o f figure 4.6 and 4.7 are caste in the form o f a linear/ 
linear and Log/ linear scale respectively, the latter o f which helps to better illustrate 
the lower dose points. In the latter case, it is apparent that simulated doses shows 
systematically larger values than measurements, albeit within the estimated errors. 
This is often the case with simulations since the simulations indicate a more ideal 
case, failing to take account o f all possible losses.
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Figure 4-6: R elative  d ose  resu lting from  ’^^Ba irradiation over a period  o f  three w eek s sh ow n  
on linear sca le , m easured u sin g  G e-dop ed  optical fibre dosim eters and com pared w ith  
D O SR Z nrc M on te Carlo sim u lations for photon-m ed iated  d ose  a lon g  the transverse ax is . T he  
error bars represents the uncertainty in d ose  m easurem ents in  ten n s o f  the standard error o f  
the m ean. T he error bars o f  d o se  ca lcu lation  are w ith in  the s ize  o f  the markers.
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Figure 4-7: R elative d ose  resu lting from  '^^Ba irradiation over  a  period o f  three w eek s sh ow n  
on the lo g  sca le , m easured using  G e-doped  optical fibre d osim eters and com pared w ith  
D O SR Z nrc M onte Carlo sim ulations for p hoton-m ediated  d o se  a lon g  the transverse ax is . T he  
error bars represents the uncertainty in d ose  m easurem ents in term s o f  the standard error o f  
the m ean. T he error bars o f  d ose  calcu lation  are w ith in  the s ize  o f  the markers.
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4.7.2. Dose Along Transverse Axis ^®Co (From Photons Only)
Figures 4.8 and 4.9 show dose measured along the transverse axis of the 
source (for a three-day irradiation period), compared against simulations obtained 
using DOSRZnrc, made again along the transverse axis of the ^^Co source (R-axis), 
the (3-component being excluded from the simulated spectra. The error bars represents 
the uncertainty in dose calculation in terms of standard error of the mean. Doses were 
normalized to dose at 2 mm from the source centre. The shape of the curve obtained 
through measurements is re-obtained in simulation, measurement and calculated 
relative dose being in good agreement; an absolute difference between dose 
measurements and calculations was on average 1.6 %. Exponential curve fitting 
(ExpDecl) was applied to fit the measurement points. The plot of figure 4.8 is on 
linear/linear scale, while the plot of figure 4.9 is on linear/log scale, again as adopted 
for Figures 4.6 and 4.7
1.2 
% 1-0 
■o 0.8
0)
a
R
O
0.6
0.4
0.21
0.0
■ G e-doped optical fibres m easurem ents 
#  D O SRZnrc calculations
 G e-doped optical fibres m easurem ents
 DOSRZnrc calculations
1— '— I— '— I— '— I— '— r
0 2 4 6 8 10 12 1416 182022 
Distance (mm)
Figure 4-8: Relative dose measurements and photon-mediated dose simulations 
obtained using the DOSRZnrc Monte Carlo code, obtained along the transverse axis 
of the ^Co source. The error bars represents the uncertainty in dose measurements in 
terms of the standard error of the mean. The error bars of dose calculation are within 
the size of the markers. Plot is on linear scale
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Figure 4-9: Relative dose measurements and photon-mediated dose simulations 
obtained using the DOSRZnrc Monte Carlo code, obtained along the transverse axis 
of the ^C o source. The error bars represents the uncertainty in dose measurements in 
terms of the standard error of the mean. The error bars of dose calculation are within 
the size of the markers. Plot is on log scale
4.7.3. Dose Along Transverse Axis ^^Co (From Photon and Beta Contribution)
Figure 4.10 compares the Ge-doped fibre measurements obtained in a 3 day 
irradiation period and dose calculations using DOSRZnrc, along the transverse axis of 
the ^°Co source (R-axis), from 2 to 20 mm. Herein the entire ^^Co spectra was 
simulated including beta and photon irradiations. The error bars represent the 
uncertainty in dose calculation in ternis of standard error of the mean. Doses were 
normalized to that at 2 mm. Good agreement is obtained between dose measurements 
and DOSRZnrc simulations that include both beta-particle and gamma-ray energies, 
where the averag of absolute difference between both measurements and calculations 
of dose was 1.6%. Current results are in line with previous findings excluding 
consideration of beta emissions, confirming that within measurement uncertainties
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beta particle dose contributions are absent, the encapsulation acting in accordance 
with design.
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Figure 4-10: Measured and simulated relative dose along transverse axis of ^^Co 
source, the simulation included beta particles as well as photons. Error bars are 
standard error of the mean. The smooth fits to the measured data provide a guide to 
the eye. The lower plot is on a log/linear scale
FATMA ISSA 2012 Page 114
Chapter 4: Establishment o f  Ge-Doped Si02 Fibre TLDs fo r  Brachytherapy Using Two Lab Sources
Doped Optical Fibres Thermoluminescence Dosimetry fo r Brachytherapy
4.8. Conclusion
Ge-doped optical fibres dosimeters have been employed in obtaining doses at 
distances very close to the source (currently down to separations o f 2 mm). Dose fall 
off measured for separations from 2 mm up to 20 mm, were found to be in good 
agreement with simulations of photon-mediated dose obtained using the DOSRZnrc 
Monte Carlo code. Agreement was within 2.6 % and 1.6 % for the ^^^Ba and ^°Co 
sources, respectively. The dose measurements and calculation results were re-obtained 
and the same agreement was obtained when comparing dose measurements with 
simulations of photon and electron-mediated dose obtained using the DOSRZnrc 
Monte Carlo code. Absence of disagreement points to source encapsulation being 
effective in filtering out beta dose and the source is set in the medial o f its 
encapsulation. These encouraging results support the use of Ge-doped fibre 
dosimeters for dose distribution measurements, applicable at distances that range from 
very close to brachytherapy sources though to more distal evaluations, offering 
considerable advantages over more conventional dosimeters. The methodology is to 
be applied in obtaining doses around an LDR (Low Dose Rate) source and ^^^ Ir 
HDR (High Dose Rate), as will be seen in the next chapters.
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Chapter 5
5 High Resolution LDR 1-125 
Brachytherapy Source Dosimetry: 
Seed (Model 6711)
5.1 Introduction
Preliminary work described in an earlier chapter has investigated Ge-doped 
optical fibre TL dosimeters for x-rays generated at potentials o f ~ 90 kVp and 300 
kVp, demonstrating linearity o f dose over a wide dynamic range (from < 1 Gy up to 
45 Gy), good reproducibility to within 2%, minimal fading and the ability to measure 
percentage depth dose in agreement with tabulated data and ionization chamber 
measurements, to within 1.1% and 2.1% respectively (Issa, Latip et al. 2011). The 
results pointed to a potential use in brachytherapy dosimetry, modem brachytherapy 
sources typically emitting photons of energy between 0.35- 0.66 MeV. Subsequently, 
Ge-doped optical fibre dosimeters were investigated, obtaining in-air dose 
measurements around two laboratory radionuclide sources (^^Co and ^^^Ba) of 
relatively low activity (434 kBq and 408 kBq respectively at the time o f use). At 
distances from the sources of 2 mm, agreement with DOSRZnrc Monte Carlo dose 
simulations was obtained to within 3 % (Issa, Abdul Rahman et al. 2012). Having all 
of the above mentioned dosimetric characteristics, in the present work I seek to 
establish commercially available Ge-doped optical fibres as TL dosimeters for 
brachytherapy dosimetry, offering high spatial resolution - 1 0 0  pm, low cost and a 
non-hygroscopic character.
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In brachytherapy, encapsulated radioactive sources are either placed directly 
into or immediately adjacent to the tissue to be treated. The main advantage of the 
technique is the high dose delivered to the tumour and the rapid fall off in dose to 
surrounding normal tissues. The fall off o f dose with separation d  from the source is 
non-analytic, between - I j d  and \ j d ^ , the high dose gradient close to the source 
presenting a significant challenge to the accuracy o f dosimetry measurements 
(Meigooni, Meli et al. 1988). Using conventional dosimeters the high dose gradients 
make it impractical to obtain measurements at separations «  1 cm from the source. 
As such, most efforts have been placed on performing dose measurements at distances 
> 1 cm and performing Monte Carlo simulation or calculation through the use of the 
AAPM TG-43 algorithm (Nath, Anderson et al. 1995; Podgorsak 2005). The degree 
to which dose is uncertain can create problems, not only in regard to small (~ mm) 
source movements and tumour dose but also in regard to dose to surrounding critical 
tissue. Inaccuracy in dose estimation at separations o f < 5 mm can also be critical in 
procedures such as episcleral eye plaque therapy and in the possible creation of 
hotspots in implants. Thus, dose measurements should be obtained at the smallest 
possible distance (Rivard, Coursey et al. 2004)
Through the use of lithium fluoride (LiF) thermoluminescence dosimeters 
(TLDs) in an epoxy resin solid water equivalent phantom (model 4571, Radiation 
Measurement Inc., Middleton, WI), Nath et al. (Nath, Meigooni et al. 1993) obtained 
dose rate measurements around two types of ^^ I^ brachytherapy source (models 6702 
and 6711, 3M Medical Products Division, St. Paul, MN) and ^^^ Ir brachytherapy 
sources (Best Industries, Springfield, VA). 2D dose-rate distributions were obtained 
for separations from the source-centre to points o f measurement of not less than 0.5 
cm, Nath et al calling for further work to extend measurements to < 0.5 cm, not least 
for ^^ I^, ^^^ Ir and ^®^ Pd. Rivard et al. (2004) have also indicated a need in 
brachytherapy dosimetry requiring dosimeters o f active volumes sufficiently small to 
allow measurement of dose in high-gradient dose regions, ideally offering adequate 
precision and reproducibility for la  statistical uncertainty (type A) < 5 % and l a  
systematic uncertainty < 7 %. It was suggested at the time that LiF was the only 
dosimeter satisfying all the above requirements.
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The present study obtains dose measurements using Ge-doped optical fibres, 
both along the central and transverse axes and at various well-distributed angles 
around low dose rate (LDR) sources, at distances from the source down to 1 mm. 
Dose measurements have been compared with simulations of dose, obtained using of 
the EGSRZnrcVDOSRZnrc Monte Carlo code, and from the Variseed™ Treatment 
Planning System (hereafter abbreviated to TPS).
5.2 I Source
OncoSeed™ sources, model 6711 (Oncura, Plymouth Meeting, PA), were 
used in the present study. The seed geometry, dimensions, structures and composition 
and decay scheme are explained in detail in chapter 2 (section 2.2.3.2)
Three experiments were performed in this study, on each occasion using one 
of three seeds; at the time of initiation of irradiation two of the seeds had the same 
activity o f 14.76 MBq (air kerma strength 0.507 pGym^/h) and these were used in the 
and 3"^  ^ experiment, while for the 2"^ experiment the seed had an activity o f 14.8 
MBq (air kerma rate 0.508 pGym^/h).
5.3 Phantom s
Use was made of the phantom media polymethylmethacrylate (PMMA) (also 
known as Lucite, Plexiglas or Perspex), density 1180 kg m'^. Three individual forms 
of irradiation geometry were used investigating the following: (i): possible source 
asymmetry; (ii) dose distribution along the transverse and longitudinal axes o f the 
source seed, the so-called R- and Z-axes respectively, and; (iii) angular dose 
distribution, to demonstrate an ability to measure dose anisotropy. The three different 
phantom designs had a central hole to accommodate the source seed (hole size 5.0 
mm length x 1.0 mm diameter). Sets of holes were machined to accommodate the 
fibres. The first o f the phantoms was equipped with optical fibres that were 
symmetrically displaced along the ± directions of the seed R-axis at 1 mm to 100 mm
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from the source centre and at 5 mm to 100 mm from the source centre along the Z- 
axis. The second phantom was equipped with optical fibres at locations covering the 
same range along the ± R-axis and ± Z-axis separations, but restrictively at 
alternating locations along the ± axes . For the third phantom, provision was made for 
optical fibre separations of 10 mm to 100 mm from the source centre, the fibres being 
distributed at angles o f 10° to 90° with respect to the Z-axis, in 10° increments. In 
addition, provision was made for fibre separations o f 1 mm to 5 mm from the source 
centre at the angles 20°, 40°, 80° from the Z-axis.
To provide full scatter conditions, the ^^ I^ source was surrounded by a 
sufficient amount of phantom material (Meigooni, Meli et al. 1988; Nath, Meigooni et 
al. 1993). Thus, during irradiation, each PMMA sheet containing the *^ I^ source and 
optical fibres was sandwiched between two slices of PMMA, each of dimensions 200 
mm X 200 mm x 50 mm (figure 5.1). A 50 mm thick phantom is considered to offer 
adequate backscatter for low energy brachytherapy sources (Perez-Calatayud, Granero 
et al. 2004; Kennedy, Davis et al. 2010). In each irradiation, the fibre centres were 
made to be in alignment with the source centre.
5.4 Irradiations
Irradiations were performed at the St Lukes Oncology Centre, Royal Surrey 
County Hospital (RSCH), Guildford. The first of these irradiations was aimed at 
examining whether the source was symmetrically displaced within the encapsulation. 
In this particular investigation the duration o f irradiation was some 7 days, ensuring a 
measurable dose for the distal fibres. The second investigation sought to obtain doses 
along the R and Z axes, with seven optical fibres placed in each location o f interest 
(from 1mm to 50 mm) along the R and Z axes o f the source. Regarding angular dose 
mapping, six optical fibres were placed at separations from 1 mm to 10 mm and at the 
angles 20°, 40° and 80°; a further seven fibres were placed at the angles 10° to 90° in 
10° increments, and at distances of 10 mm to 50 mm from the seed centre, in 10 mm 
increments. The duration of irradiations for the 2"^ and 3*^  ^ experiments were 18 days 
each, to obtain a dose to distal fibres o f ~ 0.1 Gy (at a separation of 55 mm) and -  20
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Gy to proximal fibres (at a separation of 1 mm) along the R-axis (Yaakob, Wagiran et 
al. 2011).
5.5 Radiation Protection Issues, Health and Safety
Based on the inverse square law, to provide the enough distance between an 
operator and seeds, seeds were handled using forceps (figure 5.2.d) and behind the 1 
cm lead screen fixed on the preparation laboratory bench (figure 5.2.a). Unused seeds 
were stored in the seed safe (not shown in the pictures), seeds were carried in a 
lead storage container or lead capsules (figure 5.2 b, c, e, f), and returned to them after 
finishing an implanted process or irradiation of the dosimeters.
Phantom  a: for central and transverse  
axes d ose  ineasureinnts
Phantom  b: for polar d ose  
m easurem ents
5 cm  th ick n ess o f  PM M A
Figure 5-1: Setup of dose measurements
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e) f)
Figure 5-2: (a) Lead shielded protective barrier, (b) and (c) lead storage 
container, (d) Forceps, (e) and (f) lead capsule
5.6 M onte Carlo Simulation
Results of dose measurements are compared against simulations for 
verification purposes, use being made of the EGSnrc/DOSRZnrc Monte Carlo code 
(Rogers, Kawrakow et al. 2010). Section 2.4 explains EGSnrc/DOSRZnrc Monte 
Carlo code in details.
The number of histories used in the simulation was 10^, leading to a run time 
of 62.3 hr and an estimated error of 0.14 %. The global photon cutoff energy (PCUT)
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and the global electron cutoff energy (ECUT) were 0.001 MeV and 0.521 MeV, 
respectively.
5.6.1 Source and Phantom M odelling
The m odel-6711 seed shown in figure 2.16 and table 2.1 was modelled by 
dividing the source into nine slabs (of various thickness) along the Z-axis, and as four 
cylinders (of different radii) along the R-axis, with one central axis (source axis). The 
source and phantom were modeled as concentric cylinders o f differing materials, 
oriented along the R-axis. These cylinders were divided into slabs with different 
thickness and materials along the Z-axis, the origin o f the Z-axis is at the centre o f the 
seed (central o f  the middle o f  the Ag slab): the seed was divided into 9 slabs; 0.04 cm 
Titanium slab, two slabs o f 0.005 cm and 0.3 cm (mixed o f air and Titanium), then 
three slabs o f 0.1 cm thickness (mixed o f Ag (core), air and Titanium), then two slabs 
o f  0.005 cm and 0.3 cm (mixed o f  air and Titanium), then a 0.04 cm Titanium slab. 
However, the source was modeled to be in the centre o f  the PM MA phantom. The 
modeling construction is shown in figure 5.3.
The end welds o f the silver rod was modeled as flat for both models (model 
6711 used in the current study and model 9011 which is also used in this thesis and 
will be described in chapter 6), this assumption was in line with (Dolan, Li et al. 
2006), where Doran et al studied the model 6711 and noted that in radiographs o f  the 
sources, the shape o f  the end weld was flat, convex and concave with equal frequency 
(Kennedy, Davis et al. 2010). Also, Davis et al agreed with Doran et al basing on their 
radiography studies. (Kennedy, Davis et al. 2010)
Table 5.1 shows the 1-125 spectra used in the simulation, as recommended in 
report TG-43U1 (Rivard, Coursey et al. 2004). In turn, the phantom was divided into 
33 cylinders o f  different radii along the R-axis. The phantom with seed was divided 
into 61 slabs o f various thickness along the Z-axis.
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Table 5-1: I spectra used for the Monte Carlo simulation
Photon energy (keV) Photon per disintegration (% )
27.202 40.5
27.472 75.6
30.98 20.1
31.877 4.38
35.492 6.60
5.7 VariSeed™  T reatm ent Planning
A VariSeed™ 8.0.2 Treatment Planning System (TPS) was used to obtain 
doses along the R- and Z-axes of the seed. Doses were normalised to the dose 
obtained at a distance of 10 mm from the source centre.
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Figure 5-3: sketch demonstrating modelling design of the seed and phantom used in Monte Carlo simulation. 
All dimensions are in cm (a) Illustrated are the cylinder dimensions along the R-axis. (b ) The cylinder and slab 
divisions, and slabs dimensions, and the modelling materials
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5.8 Results and Discussion
5.8.1 ^^ 1^ Seed (Model 6711) Symmetry:
Figure 5.4 shows dose measured using Ge-doped optical fibres at distances 
from 1 mm up to 50 mm along the ± R-axis of a seed of 14.76 MBq and dose 
simulation using the DOSRZnrc Monte Carlo code. The dose measured along the + 
R-axis is highly symmetric with that on the - R-axis, confirming the assumption made 
in the simulation that the source in the seed is symmetric within the encapsulation. 
EGSnrc/DOSRZnrc results were within ± 3 % of doses measured with the Ge-doped 
optical fibres. Dose measurements and calculations were normalized at the dose point 
at 20 mm. Log scale was used, error bars represent uncertainty in terms o f standard 
error of the mean, error bars for dose calculations with Monte Carlo simulation are 
within the size of markers.
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Figure 5-4: Measured and simulated doses in PMMA along seed transverse axis 
as a function of distance for a 14.76 MBq source (certified air kerma strength 0.507 
gGym2/h) following 7 days of irradiation. The error bars represent the standard error 
of the mean. Dose measurements indicate a high degree of source symmetry.
5.8.2 Dose Along Transverse Axis of The Seed:
Figure 5.5 illustrates dose measurements in PMMA using Ge-doped optical 
fibres obtained along the transverse axis of another seed (14.8 MBq), from 1 mm 
-  50 mm from the seed centre vs. dose simulations and TPS values. Agreement 
between measurements and TPS values and between measurements and DOSRZnrc 
Monte Caro simulations were found to be within 2.7 ± 0.6 % and 1.9 ±  0.4 % 
respectively. The largest absolute difference between the measured percentage dose 
and that obtained through use of the TPS along the R-axis was 16.9 % at 1 mm, the 
discrepancy reducing to 2.4 % by 2 mm. To obtain relative dose the dose points were 
normalized to the dose at a distance of 10 mm in PMMA. The uncertainty in relative
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dose measurements was within ± 2%, being in line with investigations of (Nath, 
Meigooni et al. 1993), who perfonned dose measurements around the source for 
distances (note that it is not clear whether these were measured from the source 
centre or source edge) in the range 5 mm up to 100 mm in a solid water phantom, 
using small LiF TLDs ( 1 x 1 x 1  mm) up to a distance of 20 mm and then with use of 
larger sized LiF TLDs (3.1 x x 0.89 mm) for distances > 20 mm . Log scale is 
used in the figure 5.5, the insert demonstrates departure from the relation between 
dose and inverse square distances 1/ r .^ Error bars represent the uncertainty in terms of 
standard error of the mean and the size of error bars of Monte Carlo dose calculations 
are in the same size of markers
—■ — G e-doped  optical fibres ineasiueinents
— D O SR Znrc calculations
•••ic”  Treatment P lanning calculations
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Figure 5-5: Measured and calculated dose in PMMA along the transverse axis of a 
different seed model 6711 (14.8 MBq and air kerma strength 0.508 pGym^/h) for 
an 18 day duration irradiation. The error bars represent the standard error of the mean.
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5.8.3 Dose Along Central Axis of The I Seed:
Dose measurements using Ge-doped optical fibres in a Perspex phantom and 
dose calculations using DOSRZnrc and VariSeed 8.0.2 Treatment Planning System 
(TPS) along the central axis (Z-axis) of the 1-125 seed were compared, results are 
shown in the figure 5.6 on log scale, exponential (Exp3P2) curve fitting was applied 
to fit all points. The average difference between dose measurements and Monte Carlo 
simulation results is 2.7 ± 0.6 %, while the average difference between dose 
measurements and values provided by the TPS was 9 ± 4 %. Error bars represent the 
uncertainty in terms of standard error of the mean, error bars size for Monte Carlo 
dose calculation are in the same size of markers.
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■  Ge-doped Optical fibres Measurements 
#  DOSRZnrc calculation 
A Treatment Planning System Calculation
 Ge-doped Optical fibres Measurements
 DOSRZnrc Calculation
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Figure 5-6: Measured and calculated dose in PMMA, along the central axis o f the 
source as a function of distance, using a 14.8 MBq (certified air kerma strength 0.508 
pGym2/h) for an 18 day irradiation. The error bars represent the standard error o f the 
mean.
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5.8.4 Angular dose Distribution Around The Seed:
Figure 5.7 shows measured polar dose distribution and the associated 
simulation results obtained in PMMA for a 14.76 MBq source at separations from 
10 mm to 100 mm, normalized to the dose at 50 mm. Angular dose distribution 
simulation results, to be compared with measured values, were in some cases difficult 
to obtain at particular integer values o f angle due to practical restriction on accurate 
definition of r,z values, as implicit in the general formula provided in section 2.4. The 
discrepancy between measured and simulated angular distribution of dose ranged 
between 1.9 ± 1.3 % and 3.4 ± 1.0 %, corresponding to distances of 60 mm and 90 
mm from the seed centre. Error bars represent the uncertainty in terms o f standard 
error o f the mean, error bars size for Monte Carlo dose calculation are in the same size 
of markers.
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125 ,Figure 5-7: Angular dose distribution in a PMMA phantom, measured around a I seed 
(14.76 MBq and air kerma strength 0.507 pGym^/h). An irradiation o f  18 days was used, 
doses being measured using Ge-doped optical fibers and calculated using o f  DOSRZnrc 
Monte Carlo, at 10-90 mm from the source centre. The error bars represent standard error ot 
the mean.
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5.9 Conclusion
Ge-doped optical fibre dosimeters have been demonstrated to be of 
considerable utility in obtaining high spatial resolution dose measurements along the 
central and transverse axes of LDR 1-125 seed model 6711, measured within PMMA 
to within an uncertainty of ± 2 %. Dose measurements were in good agreement with 
simulations to within 2.3 ±  0.3 %, while dose measurements and values obtained 
through use of the Variseed TPS agreed well, to within 2.7 ±  0.6 %. The measured 
polar (angular) distribution of dose was in agreement with simulations using the 
DOSRZnrc Monte Carlo code, with an average o f 3.0 ±  0.5 %.
The response of SiOz is likely to be different in water and PMMA. The current 
results suggest this is not a big problem but change in the photon spectrum with 
distance would give an appreciation o f the changing response, i.e. utilising a large 
detector (kerma) approximation. Therefore, it will be worth to investigate that by 
using EGSnrc/FLURZnrc code to run Monte Carlo simulation to calculate the 
spectrum as a function o f depth and fold the photon spectrum with the relative mass- 
absorption coefficients o f SiOi to water. Alternatively the attenuation of each photon 
component (and their respective contributions to the mass-absorption coefficient) 
could be considered as a function of distance, this would not take scattering into 
account but this process is fairly limited for Also, investigating the differences 
between PMMA and water at these at low energies would also be useful using Monte 
Carlo simulation. In addition in future work it is intended that this study will be 
repeated to obtain dose distributions for this LDR source in an epoxy resin solid water 
equivalent phantom in a full scatter situation.
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Chapter
6 High Resolution LDR 1-125 
Brachytherapy Source Dosimetry: 
Seed (Model 9011)THINseed™ 
Brachytherapy Source
6.1 Introduction
Interstial brachytherapy by implanted permanent sealed sources into or around 
the prostate gland is one of the common modalities for treatment in the early stages of 
prostate cancer (Bottomley, Ash et al. 2007; Kennedy, Davis et al. 2010). In regard to 
the implant process, the seeds are loaded into the prostate using needles, guided by 
ultrasound imaging. While it is common to use 20 gauge needles, this can lead to a 
number o f complications, including oedema, bleeding, bruising, and urinary 
complications (Bottomley, Ash et al. 2007) (Kennedy, Davis et al. 2010); (Yue, Chen 
et al. 2002). It is apparent that use of thin seeds, allowing use of thinner needles, 
would reduce the occurrence of such complications. Thus Oncura Inc have developed 
a new seed (THINSeed™, model 9011), manufactured by GB Healthcare 
(Alington Heights, XL). The diameter of this source is reduced to 0.51 mm compared 
with 0.8 mm for model 6711, producing a 59 % reduction in the cross-sectional area 
(Kennedy, Davis et al. 2010).
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The American Association o f Physicists in Medicine (AAPM) Task Group 
(TG-43) recommended investigation of the dosimetric properties of model 9011 
prior to its use in clinical applications (Nath, Anderson et al. 1995); (Rivard, Coursey 
et al. 2004); (Kennedy, Davis et al. 2010). To-date only two studies regarding this 
new seed are known by this author to have been carried out; Rivard (Rivard 2009) and 
Kennedy et al. ((Kennedy, Davis et al. 2010). These studies will be discussed in 
detail, below.
Rivard determined the brachytherapy dosimetry parameters for the model 
9011 seed and performed a dosimetric comparison between the seed models 9011 and 
6711, using Monte Carlo simulation to obtain the dose-rate constant, radial dose 
function and anisotropy functions for both models. He concluded that Monte Carlo 
simulations of dose rate distributions for both models show similar trends and dose 
fall off features but with dose rate distributions for the two source models sufficiently 
different (> 2%) to necessitate separate treatment planning data entry.
Using LiF:Mg,Ti thermoluminescent dosimeter (TLD-100) microcubes (1 x 1 
X 1 mm^), Kennedy et al. obtained the required AAPM TG-43 brachytherapy 
dosimetry parameters for the new thin source (THINSeedTM, model 9011) and 
also for model 6711, including dose-rate constant, radial dose function and anisotropy 
functions. They also conducted Monte Carlo simulations. Dose measurements were 
corrected for energy dependence using the Monte Carlo simulations as were the 
experimentally obtained correction factors ((Nunn, Davis et al. 2008) (D. Davis, K. 
Ross et al. 2003); (Kennedy, Davis et al. 2010). Subsequently, they compared their 
results with published data, including that o f (Rivard 2009) and TG-43U1 (Rivard, 
Coursey et al. 2004)) and with consensus model 6711 values. Generally, but discussed 
in specific terms below, good agreement was obtained between measurements and 
calculations, and also with published values. It was also found that the 2D anisotropy 
function for 9011 is similar to that of model 6711. The experimental values for both 
models are in agreement with MC calculation values, as well as with published data 
and TG-43U1 parameters. Kennedy et al stated that both ^^ I^ models look 
dosimetrically similar, but they still display separate specific characteristics; as such
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this group agreed with Rivard in that separate dosimetric data should be entered into 
the treatment planning system.
In the Kennedy study measurements were performed in a PMMA phantom 
(density p = 1.18 d= I.Ol gcm'^) o f composition C = 59.50%, H = 8.11%, O = 32.34%, 
and N  = 0.05%, not least because o f the available purity o f the material and absence 
of high-Z elements (compared for instance with Solid Water™’ which contains 
calcium). Two PMMA phantoms were designed for the study; the radial phantom and 
anisotropy phantom (details are to be found in the paper of Kennedy et al (Kennedy, 
Davis et al. 2010)) were drilled to accommodate the seed and TLDs. Each PMMA 
phantom was 30 x 30 x 1 cm^, providing at least 5 cm o f material between farthest 
hole and the edge o f the phantom in the xy-plane; during irradiation, two PMMA 
plates of 30 X 30 X 5 cm^ were placed above and underneath the phantom 
accommodating the seed and TLDs to provide adequate backscatter (Kennedy, Davis 
e tal. 2010).
MC simulation was utilized for two reasons: 1) to obtain predicted TG-43 
parameters for ^^ I^ models 9011 and 6711, independently from the TLD measurement 
results, and: 2) to obtain phantom correction factors c(r,6) for TLD measurements, 
being the correction between water and PMMA.
The results of this group were:
1) for dose-rate constant: the TLD and MC values for model 9011 were within 
2.8% and 1.1%, respectively from Rivard values (Rivard 2009), while the TLD and 
MC values for model 6711 were within 1.8% of the Rivard results. Perez-Calatayud et 
al. (2010) claimed that the difference between Kennedy et al (Kennedy, Davis et al. 
2010) results and Rivard was due to the difference in the methodology o f the Monte 
Carlo simulation, noting that in Rivard’s model, the silver was not included in the 
active layer composition. This same group obtained a dose-rate constant value for 
model 6711 that was in agreement with TG-43U1;
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2) Radial dose function: the experimental and Monte Carlo radial dose 
function values for model 9011 were in good agreement, the difference between MC 
and TLD measurements at distances r > 8 cm was ~ 13 %, not too different from that 
found by (Dolan, Li et al. 2006), who reported ~ 10% discrepancy between TLD and 
MC values for the radial dose function for model 6711. For model 9011, the reason 
for the difference was suggested to relate to the large uncertainty in MC calculation 
between PMMA and water at large radial distance. The radial dose values for model 
6711 obtained with this group are in good agreement with the TG-43U1 values. 
Generally, the radial dose function values for both 6711 and 9011 are comparable for 
all distances.
3) The anisotropy function: good agreement was obtained between anisotropy 
values from MC calculation and TLD measurements. The greatest differences 
between MC predicated values and TLD measurements were found at the angles 0° 
and 180°, due to the discrepancy between the physical source geometry and the ideal 
model assumed in the Monte Carlo calculations. It was also noted that there is ~ 0.5 
mm space on either end of the silver rod within the encapsulation, such that during 
irradiation the silver wire could move toward either end o f the source.
In the work carried out within this dissertation on the THINSeed™, model 
9011 ^^ I^ source, the aim has been to investigate dose measurements along the central 
and transverse axes of the source, from 1 mm from the source centre to 50 mm using 
Ge-doped optical fibres dosimeters. This work therefore provides dose measurements 
significantly closer to the source than previous measurements described above by 
Kennedy et al (closest dose point measurement was 5 mm) and Rivard (obtained 
doses from Monte Carlo calculations only). For verification purposes, dose 
measurement results were compared with dose calculations obtained from Monte 
Carlo simulation and with predicted doses obtained from the TPS.
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6.2 Source:
Use has been o f the seed (THINSeed™, model 9011). The seed geometry, 
dimensions, structures and composition and decay scheme are explained in detail in 
section 2.2.3.2 (chapter 2). At the time o f irradiation, the ^^ I^ seed had an activity of 
15.69 MBq and air kerma strength 0.538 pGym^/h.
6.3 Phantom s
Use was made of the phantom media polymethylmethacrylate (PMMA) (also 
known as Lucite, Plexiglas or Perspex), density 1180 kg m" .^ The phantom was 
machined to enable the investigation o f the dose distribution along the transverse and 
longitudinal axes o f the source seed, the so-called R- and Z-axes respectively. The 
phantom design had a central hole to accommodate the source seed (hole size 5.0 mm 
length X 6.0 mm diameter). Sets o f holes were machined to accommodate the fibres, 
at locations covering the same range along the ± R-axis and ± Z-axis separations, 
but restrictively at alternating locations along the ±  axes, the fibres being placed at 
distances from 1 mm to 100 mm along R-axis and from 5 mm to 100 mm along Z- 
axis. Otherwise, the phantom in similar to the phantom used to obtain dose 
measurements along R- and Z- axes o f ^^ I^ model 6711 explained in chapter 5.
To provide full scatter conditions, the ^^ I^ source was surrounded by a 
sufficient amount of phantom material (Meigooni, Meli et al. 1988; Nath, Meigooni et 
al. 1993). Thus, during irradiation, the PMMA phantom containing the ^^ I^ source and 
optical fibres was sandwiched between two slices o f PMMA, each of dimensions 200 
mm X 200 mm x 50 mm (figure 5.1). A 50 mm thick phantom is considered to offer 
adequate backscatter for low energy brachytherapy sources (Perez-Calatayud, Granero 
et al. 2004; Kennedy, Davis et al. 2010). In each irradiation, the fibre centres were 
made to be in alignment with the source centre.
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6.4 Irradiations
Irradiations were performed at the St Lukes Oncology Centre, Royal Surrey 
County Hospital (RSCH), Guilford. Investigation sought to obtain doses along the R 
and Z axes, with seven optical fibres placed in each location of interest (from I mm to 
50 mm) along the R and Z axes of the source. The duration of irradiations was 22 
days to obtain a dose to distal fibres o f ~ 0.11 Gy (at a separation of 55 mm) and ~ 
19.65 Gy to proximal fibres (at a separation o f 1 mm) along the R-axis (Yaakob, 
Wagiran et al. 2011).
Radiation Protection and Health and Safety measures in regard to this seed 
(model 9011) are the same as that for model 6711, as explained in section 5.5.
6.5 Monte Carlo Simulation
As before, results o f dose measurements have been compared against 
simulations for verification purposes, use being made o f the EGSnrc/DOSRZnrc 
Monte Carlo code (Rogers, Kawrakow et al. 2010). Section 2.4 explains the 
EGSnrc/DOSRZnrc Monte Carlo code in some detail.
The number of histories used in the simulation was 10^ ,^ leading to a run time 
of ~ 2.5 days and an estimated mean error o f 1.2 ± 0.25 %. The global photon cutoff 
energy (PCUT) and the global electron cutoff energy (ECUT) were 0.001 MeV and 
0.521 MeV, respectively.
6.5.1 Source and Phantom modelling
The source was modelled using table 2-1, with a similar seed structure to that 
of *^ I^ modle-6711 shown in figure 2-16; variations between the two models (6711 
and 9011) are provided in table 2-1, including details of the two model structures, 
geometry, materials and dimensions. The present ^^ I^ source was modelled by
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dividing the source into ten slabs (of various thicknesses) along the Z-axis, and as four 
cylinders (of different radii) along the R-axis, with one central axis (source axis). The 
source and phantom were modeled as concentric cylinders of differing materials, 
oriented along the R-axis. These cylinders were divided into slabs with different 
thickness and materials along the Z-axis, the original Z-axis is at the centre o f the seed 
(centre of the two middle Ag slabs): the seed was divided into 10 slabs; 0.028 cm 
titanium slab, 0.06 cm slab (mixture of titanium and argon gas), 0.0002 cm slab 
(mixture of titanium, argon gas , and AgBr:AgI), then in the middle four slabs: two of 
0.1 cm thickness and two of 0.04 cm o f (mixture o f a core of Ag, AgBr:AgI, argon 
gas, and titanium), 0.0002 cm slab (mixture o f titanium, argon gas , and AgBr:AgI), 
0.06 slab (mixture of titanium and argon gas), and 0.028 cm titanium slab. The source 
was also modeled to be centrally located within the PMMA phantom. The modeling 
construction is shown in Figure 6-1.
The 1-125 spectra shown in the table 5-1 (chapter 5) was used in the 
simulation, as recommended in report TG-43U1 (Rivard, Coursey et al. 2004). In turn, 
the phantom was divided into 36 cylinders of different radii along the R-axis. The 
phantom with seed was divided into 61 slabs of various thickness along the Z-axis.
6.6 VariSeed™ Treatment planning
A VariSeed™ 8.0.2 Treatment Planning System (TPS) was used to obtain 
doses along the R- and Z-axes of the seed. Doses were normalised to the dose 
obtained at a distance o f 10 mm from the source centre.
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figure 6-1: The illustrated sketeh demonstrates the modelling design of the seed and phantom used in Monte 
Zarlo simulation. All dimensions are in cm; (a) illustrates the cylinder dimensions along the R-axis; (b) illustrates 
he cylinder and slab divisions, slab dimensions, and modelling materials.
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6.7 Results and discussions
6.7.1 Dose along transverse axis of the seed
Figure 6-2 illustrates dose measurements in the PMMA, made using Ge-doped 
optical fibres obtained along the transverse axis o f another seed (15.69 MBq) of 
the same model type, from 1 mm -  50 mm from the seed centre vs. dose simulations 
and TPS values. Agreement between measurements and TPS values and between 
measurements and DOSRZnrc Monte Caro simulations were found to be within 2.6 
± 0.3 % and 3.8 ±  0.8 % respectively. The results are in line with the results of 
model 6711 (discussed in chapter 5), where difference between measurements and 
DOSRZnrc Monte Caro simulations and between measurements and TPS values were 
found to be within 1.9 ±  0.4 % and 2.7 ±  0.6 % respectively. This is in good 
agreement with the results of others (Kennedy, Davis et al. 2010). To obtain relative 
dose the dose points were normalized to the dose at a distance of 10 mm in PMMA. 
The uncertainty in relative dose measurements was within ±2.1  %, being in line with 
investigations of (Nath, Meigooni et al. 1993) and our previous findings for model 
6711 (chapter 5). A log scale has been used in figure 6-2. Error bars represent the 
uncertainty in terms o f standard error o f the mean and the size of error bars are o f the 
same size as the point markers.
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Figure 6-2: Measured and calculated dose in PMMA along the transverse axis of an 
seed model 9011 (15.69 MBq and air kerma strength 0.538 gGym^/h) for a 22 day 
duration iiTadiation. The error bars represent the standard error of the mean.
6.7.2 Dose along central axis of the seed:
Comparison has been made between dose measurements using Ge-doped 
optical fibres in a Perspex phantom and dose calculations using DOSRZnrc and 
VariSeed 8.0.2 Treatment Planning System (TPS) along the central axis (Z-axis) of 
the 1-125 seed. The results are shown in figure 6-3 on a linear-linear and log-linear 
scale, with a power (Pow2P2) curve fitting applied to measurement points. The 
average difference between dose measurements and Monte Carlo simulation results is 
1.5 ±  0.3 %, while the average difference between dose measurements and values 
provided by the TPS was 3.0 ± 0.7 %. The results iiuprove upon the agreement 
obtained in chapter 5 for the '^ 1^ model 6711 source, the difference the te between 
measurements and DOSRZnrc Monte Caro simulations being 2.7 ± 0.6 %, being also 
markedly better than the comparison between dose measurements and TPS values, 
previously being 9 + 4 %. In addition, the agreement between measurement and
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simulation results are in agreement with Kennedy et al results (Kennedy, Davis et al. 
2010). Again, dose points were normalized to dose at 10 mm to obtain relative dose. 
Error bars represent the uncertainty in terms of standard error of the mean; the error 
bar size for Monte Carlo dose calculation are of the same size as the point markers.
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Figure 6-3: Measured and calculated dose in PMMA along the central axis of an 
seed model 9011 (15.69 MBq and air kerma strength 0.538 pGym^/h) for a 22 day 
duration irradiation. The error bars represent the standard error of the mean. The 
upper panel is in linear scale while the lower panel is in log-linear form
6.8 Conclusion
The new thinner model 9011 seed has been introduced by Oncura, and GE 
Healthcare but has yet to be used in the brachytherapy clinic as its dosimetric 
properties remain under investigation, as recommended by The American Association 
of Physicists in Medicine (AAPM) Task Group (TG-43). In the current study one of 
the prime model 9011 dosimetric properties, viz dose, was measured in PMMA 
using Ge-doped optical fibre dosimeters and simulated using a Monte Carlo 
technique. The predicted dose was also obtained by using a TPS. The uncertainty in 
relative dose measurements was within ± 2.1 %.
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Dose measurements were in good agreement with simulations to within 2.1 ± 
0.2 %, while dose measurements and values obtained through use of the Variseed TPS 
agreed well, to within 2.2 ± 0.5 %. Such dose results obtained for model 9011 
are in line with the dose results obtained for model 6711 (chapter 5), for distances 
from 1mm to 50 mm, where the agreement between dose measurements and 
calculation and between dose measurements and dose predicted by TPS were 2.3 ± 
0.3 % and 2.7 ± 0.6 %, respectively. Therefore, dose measurements for both models; 
6711 and 9011 are comparable as concluded by (Kennedy, Davis et al. 2010). This 
work has succeeded in obtaining dose measurements with Ge-doped optical fibres 
thermoluminescence dosimeters down to 1 mm from the source centre. Kennedy et al, 
managed to obtain dose measurements using LiF:Mg,Ti thermoluminescent dosimeter 
(TLD-100) to 5 mm from the source centre. This is therefore a significant advance on 
previous work. The measurements have also verified using Monte Carlo simulations.
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Chapter 7
1 High Resolution HDR Ir-192 
Brachytherapy Source Dosimetry
7.1 Introduction
sources are commonly used in afterloading systems to provide HDR (High Dose 
Rate) brachytherapy treatments. Less common currently is the use of ^^Co sources, 
although these did represent one of the first HDR sources for brachytherapy 
treatments, as in for instance in the Cathetron and Ralstron devices (Liversage et al., 
1967; Wakabayashi et al., 1971). The main desirable feature of the HDR treatment is 
the short treatment time due to the high source activity, typically a maximum of 
340.98 GBq mg'^ for ^^^ Ir and 41.91 GBq mg'^ for ^^Co. The main advantage o f the 
iridium source over that o f cobalt is that due to its intermediate energy (beta 530 keV 
and 670 keV and gamma 370 keV compared with the 1.17 MeV and 1.33 MeV 
gamma emissions for ^°Co), less shielding and radiation protection requirements are 
required (Baltas et al., 2006). Conversely, ^^^ Ir has a relatively short half-life (~ 73.81 
days), which makes it necessary to change the source three to four times per year in 
order to keep the treatment time short. The half-life o f % o  is (5.27 years), thus, it can 
be used for several years before a source change is required, and therefore, less 
concern arises regarding radioactive source transportation, with activity reduction o f ~ 
1 % per month (Baltas et al., 2006). These are significant factors that need to be taken
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account of, in particular in developing countries (with reduced costs) and also for 
centres with limited numbers o f brachytherapy patients (Baltas et ah, 2006).
Several research groups have studied the dosimetric properties of HDR ^^ I^r 
sources. For example (Kirov, Williamson et al. 1995) measured the two-dimensional 
dose rate distribution around a microSelectron HDR ^^^ Ir source and compared the 
results with Monte Carlo photon transport (MCPT) simulation results. Measurements 
were performed using phosphor-based TLDs in solid water phantoms to obtain dose 
rates along the source transverse axis at distances 0 .5 -1 0  cm and to obtain the polar 
dose rate profiles at separations o f 1.5, 3 and 5 cm from the source and polar angles 0 
= 0° - 180° with respect to the source cable. At the distances 2 - 40 cm from the HDR 
source, a Si diode was used to obtain transverse axis dose rate measurements in water; 
dose rate measurements and Monte Carlo photon transport simulations being in 
agreement to within 5 %, indicating that precision MCPT simulation can be used to 
obtain absolute dose rate distributions in water or solid water phantom , for HDR ^^^ Ir 
brachytherapy sources.
(Mishra, Waterman et al. 1997) measured the anisotropy function for a 
microSelectron HDR ^^ I^r in air and water (48 x 48 x 48 cm^ water phantom) using a 
miniature (0.147 cm^) thimble-type ionization chamber, at 5 cm from the source 
centre and at polar angles from 10°-170°. They noted that anisotropy factors in water 
and in air are different, and asymmetric about the transverse axis. The in-water 
anisotropy factors obtained by Mishra et al agreed with previous TLDs measurements 
obtained by (Muller-Runkel and Cho 1994) and (Kirov, Williamson et al. 1995) to 
within 4 %, and with ionization chambers measurements obtained by (Baltas, Kramer 
et al. 1992) (Zandona, Riccardi et al. 1995) to within 3 % over all polar angles, Baltas 
et al measuring anisotropy functions at polar angles 0 = 0° - 170° and at radial 
distances r = 3, 5, and 7 cm, while Muller-Runkel and Cho measured anisotropy in 
polystyrene and air at radial distances r = 1 -  10 cm at polar angles restricted to ± 45° 
with respect to the long axis of the source. In addition, the anisotropy function 
measurement values were compared to published Monte Carlo simulation values and 
to those values obtained from the microSelectron HDR brachytherapy planning
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system (BPS). The Monte Carlo photon transport code (Williamson and Li 1995) 
underestimated the anisotropy factors by up to 4 % in the forward direction and 
overestimated it by up to 3 % in the backward direction, while the anisotropy factor 
measured by ionization chamber agreed with the BPS values to within ± 3 % except at 
170° and 180°, where the measurements values were 6 % and 15 % lower, 
respectively; the 15 % apparent underdose was found to be close to the drive cable at 
the proximal end of the target volume and therefore does not represent clinical reality. 
The anisotropy in the forward and backward directions for the Nucletron 
microSelectron HDR ^^^ Ir source is nevertheless sufficiently large that it may be 
clinically important in some situations; therefore, it is necessary for anisotropy to be 
well accounted for in both directions. The mean anisotropy factor obtained with the 
measurements of Williamson and Li was within the random error (1% - 2%), 
improving upon previous ionization chamber and TLDs measurements errors o f 3 % - 
5 %. While the small volume ionization chamber was found to be a more efficient 
detector in measuring the anisotropy of a ^^ I^r source than TLDs, the TLDs have been 
acknowledged to offer better spatial resolution. Even so, agreement was obtained 
between ionization chamber anisotropy measured values and TLDs measured values. 
The authors noted that TLDs offer no advantage over ionization chamber at a distance 
of 5 cm from the source except at 0° and 180° where better spatial resolution is 
required.
Karaiskos et al (1998) used an analytical Monte Carlo simulation code to 
calculate dosimetry parameters of the AAPM TG-43 dose calculation formula for a 
^^^ Ir HDR brachytherapy source (microSelectron HDR afterloading source), including 
the radial dose function, dose rate constant and anisotropy function. Anisotropy was 
also measured in a polystyrene phantom using LiF TLD-100 rods at radial distances r 
= 1.5, 3.0, 5.0 and 7.0 cm and along polar angles 0 = 0°-165°. TLD response was also 
investigated over the entire range o f measured distances and angles and found to be 
less than 3 % and 1 % respectively different from Monte Carlo values, also agreeing 
with published data. This group also investigated effects o f phantom dimensions on 
calculations, claiming that the radial dose function depends on the phantom dimension 
at radial distances near phantom edges, recording variations of up to 25 % due to the
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lack of the full scatter condition. As such, treatment planning systems should include 
body dimensions when aimed at calculating the absorbed dose near body edges. 
Conversely, radial dose functions are not strongly dependent on source dimensions 
and encapsulation; the dose-rate constant was found to be independent o f phantom 
dimensions and source design. Anisotropy functions show no strong dependence on 
radial distance and polar angles in the range of 30° < 0 < 150°, but do change with the 
radial distance at angles close to the long axis of the source by up to 20 % at the same 
polar angle and at various radial distance up to 5 cm.
The current study described in this chapter seeks to obtain dose measurements 
around a ^^^ Ir HDR brachytherapy source along the central and transverse axes of the 
source, use being made o f Ge-doped optical fibres, at distances from the source down 
to 1 mm. Given previous studies in the thesis, where all measurements were compared 
with dose calculations obtained using the EGSRZnrcVDOSRZnrc Monte Carlo code, 
with Monte Carlo simulation being shown to be applicable, we conclude that Ge- 
doped optical fibres are accurate and precise dosimeters. As such, this current study 
does not include comparison of dose measurements with Monte Carlo simulations of 
dose, reporting only dose measurements obtained with Ge-doped optical fibres around 
the ^^^ Ir HDR brachytherapy source.
7.2 Source
In the present study use was made of a *^ I^r HDR remote afterloading source, 
type MicroSelectron V2, (manufactured by Mallinckrodt Medical B.V., on behalf o f 
Nucletron B.V., Veenendaal, The Netherlands). The source geometry, dimensions, 
structures and composition and decay scheme were explained in detail in chapter 2 
(section 2.2.3.1) and figure 2.12. An intraluminal catheter (6 French, Lumencath, 
Nucletron, Veenendaal, The Netherlands) of 100 cm length and 2.0 mm outer 
diameter and 1.4 mm inner diameter was used to deliver the source from its storage 
location to the point of interest. At the time o f irradiation the source had the activity of 
1.938E+05 MBq and air kerma strength of 21.325 pGymVh.
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7.3 Phantom s
The same Perspex (PMMA) material phantom used in previous studies has 
also been used in this study; very minor modification being made to the design. The 
phantom design had a central cylinder shaped channel of 13.5 cm length, 3 mm 
diameter, machined to accommodate the catheter retaining the source; this channel 
locates along the origin o f the central axis o f the source (Z-axis). Sets o f holes were 
machined to accommodate the fibres. The phantom was equipped with optical fibres 
displaced along the ±  directions o f the seed R-axis at 1 mm to 100 mm from the 
source centre and at 5 mm to 100 mm along the z-axis (5.5 mm off the origin o f the 
source Z-axis and the source centre), the last restriction being due to the presence of 
the catheter that includes the source. Optical fibre locations covered the same range 
separations along the ± R-axis and ± Z-axis, but restrictively at alternating locations 
along the ± axes.
7.4 Experim ental Setup
Irradiations were performed at the St Luke’s Oncology Centre, Royal Surrey County 
Hospital (RSCH), Guilford. The present investigation sought to obtain doses along the 
R and Z axes, with seven optical fibres placed at each location of interest (from 1 mm 
to 100 mm) along the R and Z axes o f the source. By using an Oncentra Masterplan 
V4.0 Treatment Planning System (TPS) (manufactured by Nucletron B V, 
Veenendaal, The Netherlands), an irradiation duration of 299.7 sec was calculated as 
required in order to deliver 5 Gy at 2 cm off axis, along the R-axis (transverse axis) o f 
the source. Prior to irradiation, with associated insertion of the optical fibres, a 
Gafchromic film (figure 7.1) was used to locate a reprducible reference distance. This 
is the furthest distance a source can dwell away from the source safe.This reference 
position was chosen to be the medial o f the R-axis (i.e. at the origin point of R-axis). 
The reference distance was found to be 965 mm, where the length of the 6F catheter 
used is 1000 mm length. After loading the optical fibres into the phantom, another 
Gafchromic film was affixed to the top of the phantom. The microSelectrom HDR
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machine was set deliver the source to the 965 mm reference distance, and 
irradiated for 10 sec. The position of the source was then checked using the film to 
ascertain that the source was in the medial position of the R-axis. The reference 
distance was found to be correct, and therefore the irradiation of the Ge-doped optical 
fibres was continued for a further 589.4 seconds. Thus, the total irradiation time was
599.4 seconds (9.99 min) and a dose of 10 Gy was therefore delivered to the position 
of 2 cm along the R-axis of the source (transverse axis).
«Mo
Figure 7-1: Shows Gafchromic films: used to find out the reference distance prior to 
irradiation of the Ge-doped optical fibres
microSelectrom HDR “Ir treatment unit
T he b lue 6 French, L um encath  Catheter
(b)
(a)
Figure 7-2: (a) Shows the microSelectron HDR '^^Ir unit and the lumencath Catheter (b) 
The computer control unit outside the treatment room.
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7.5 Results and Discussions
7.5.1 Dose Along Transverse Axis of The ^^^Ir Source:
Figure 7.3 illustrates dose measurements in the PMMA on a linear-linear and 
log-linear scale, using Ge-doped optical fibres to obtain dose along the transverse axis 
of a HDR '^^Ir source of 1.938E+05 MBq activity and with air kerma strength of
21.325 pGym^/h at distances from 1 mm to 70 mm from the source centre. The 
irradiation time was 9.99 min. The solid line is an eye-fit to the data. Dose points were 
normalized to the dose at point 10 mm in the PMMA to obtain relative dose. The 
uncertainty in relative dose measurements was on average 0.24 %. EiTor bars 
represent the uncertainty in ternis of standard error of the mean and the size of the 
dose point markers has been set to the minimum size of the eiTor bars. It can be seen 
the error bars are of the same size as the point markers for most dose points.
15i —■ —Ge-doped Optical fibres Measurements
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Figure 7-3: Measured dose in PMMA along the transverse axis of an ’^^Ir source 
(1.938E+05 MBq and air kerma strength of 21.325 pGym^/h)) for a 9.99 min duration 
irradiation. The error bars represent the standard error o f the mean. The upper panel is 
in linear scale while the lower panel is in log-linear form.
7.5.2 Dose Along C entral Axis of The Source:
Figure 7.4 shows dose measurements in a PMMA phantom, obtained using 
Ge-doped optical fibres located along the central axis (Z-axis) of HDR ’^ I^r source of 
1.938E+05 MBq activity and with air kerma strength of 21.325 pGym^/h, for an 
irradiation duration time of 9.99 min, at distances from 5 mm to 90 mm. The graphs 
are shown on a linear-linear and log-linear scale, a power (Allometric 1) curve fitting 
being applied to fit all measurement points. Dose measurements points, as mentioned 
previously, were set 5 mm off origin o f the Z-axis. The uncertainty in relative dose 
measurements was on average 0.11 %. Again, dose points were normalized to dose at 
10 mm to obtain relative dose. Error bars represent the uncertainty in tenns of
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Standard error of the mean, and the size of error bars are of the same size as the point 
markers in most dose points
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■  Ge-doped Optical fibres Measurements 
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Figure 7-4: Measured dose in PMMA along the central axis of an '^^Ir source, 0.5 
mm off the origin of z-axis (1.938E+05 MBq activity and with air kerma strength of
21.325 pGym^/h) for a 9.99 min duration iiTadiation. The error bars represent the 
standard error of the mean. The upper panel is in linear scale while the lower panel is 
in log-linear form.
7.6 Conclusion
Ge-doped optical fibre dosimeters have been established to be viable TL- 
dosimeters in mapping high spatial resolution dose measurements along the central 
and transverse axes of a HDR ^^ I^r source, type MicroSelectron V, measured within 
PMMA to within an average uncertainty of ± 0.24 %, and 0.11 % for relative dose 
measurements along transverse and central axes respectively. Current HDR '^^Ir 
measurement results have not been compared against Monte Carlo simulation values.
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previous Ge-doped optical fibres measurement results compared against Monte Carlo 
simulation results, presented in previous chapters, demonstrating good agreement.
Results obtained in this study confirm that Ge-doped optical fibre dosimeters 
are viable for HDR brachytherapy applications. As such, these high resolution 
dosimeters are planned to be applied in the near future in obtaining dose 
measurements around a ^^Co HDR source located at Portsmouth Hospital, in water 
and in an epoxy resin solid water equivalent phantom, where full scatter situations 
prevail.
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Chapter 8
8. Conclusions and Future Work
8.1 Conclusion
The essential aim o f this research was to establish Ge-doped optical fibres as 
thermoluminescence dosimeters for brachytherapy dosimetry and to obtain dose 
measurements at distances from very close to the brachytherapy sources, down to 
about 1 mm from the source encapsulation, to as far as several tens of mm away from 
the source. Dose measurements using conventional dosimeters at distances close to 
brachytherapy sources are difficult to obtain with any useful degree o f accuracy, due 
to the fact that close to sources (i.e. < 1 cm) a particularly high dose gradient region 
exists. Therefore, within such bounds, most dose data that is available in the literature 
is obtained either from Monte Carlo simulations or through use of dose calculation 
formulae such as that represented in AAPM TG-43. The availability o f accurate dose 
measurements at such distances are required in a number o f clinical situations, 
including episcleral eye plaque therapy, for evaluation of hotspots in all implants and 
for obtaining dose to organs at risk. This research has two subsidiary aims that are 
also required to be satisfied: investigation o f the TL-dosimetry o f Ge-doped optical 
fibres dosimeters at low photon energies and the establishment o f suitable 
methodology for dose measurements using Ge-doped optical fibre dosimeters at 
distances down to 1 mm from sources. For the latter, use has been made of two 
laboratory (low activity) sources, before applying such methodology to real clinical 
brachytherapy sources.
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In chapter 3; Dosimetric parameters for Ge-doped optical fibres including dose 
response, reproducibility and fading were investigated for x-rays generated at 90 kVp 
and 300 kVp. Relative dose measurements were performed, obtaining central axis 
percentage depth dose (FDD) values by using doped fibres irradiated in water and in a 
GAMMEX RMI 4571 solid water phantom with inclusion o f solid water/water 
correction factors for various field applicators. The percentage dose measurements 
were compared with 0 . 6  cm^ graphite-walled ionisation chamber measured data and 
British Journal of Radiology Supplement 25 tabulated values (both in water). At 90 
kVp and 300 kVp, Ge-doped optical fibres provide good reproducibility, to within ± 2 
%, and linear dose response over a useful range of therapeutic doses (0.1 to 45 Gy), 
TL fading was found to be minimal, at < 1.5% over a twelve hour period. The RMI- 
457 solid water phantom correction factor at 2.0 cm depth was found to be 1.155 ±
0.152 and 0.955 ± 0.221 at 90 kVp and 300 kVp respectively. The response o f the Ge- 
doped optical fibre at 90 kVp was found to be greater by a factor o f four compared to 
that obtained at 300 kVp, as might be expected based upon the associated energy 
absorption coefficients, dominated by the photoelectric effect at lower photon 
energies. At 90 kVp, central axis percentage depth dose (FDD) data has been obtained 
for applicators of 8 , 6  and 4 cm diameter field size using Ge-doped optical fibres, with 
comparison being made against the closest available BJR supplement 25 tabulated 
data, namely for 2.3 mm A1 (HVL), 2 mm A1 (external filter) 80 kVp beam data, and 
also against measurements made using a 0 . 6  cc graphite-walled ionisation chamber 
provided by the RSCH. The uncertainty in dose measurements with Ge-doped optical 
fibres was within 2 %. FDD measurements made with Ge-optical fibres in water were 
in good agreement with the same measurements made in the RMI 457 solid water 
phantom, the maximum difference recorded being 3.1% for the 6  cm diameter 
applicator. FDD measurements obtained with Ge-optical fibres in water were in good 
agreement with FDDs tabulated data and with FDDs from 0.6 cc graphite-walled ion 
chamber measurements, the maximum discrepancies being 2.3 % (observed for the 8  
cm circular applicator) and 2 .1 % (for the 6  cm diameter applicator).
At 300 kVp central axis FDD data were measured using Ge-doped optical 
fibres in water and RMI 457 solid water phantom for a 10 x 10 cm^ square field size
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and 6 , 4 cm diameter field size applicators. The circular fields were obtained by 
making use o f 6  and 4 cm lead cut-outs for the 10 x 10 cm applicator. Ge-doped 
optical fibre measurement results were compared with 300 kVp, 4.0 mm Cu (HVL), 
BJR supplement 25 FDD tabulated data in water and also with measurements using
0.6 cc graphite-walled ionisation chamber ionisation chamber measured FDD data in 
water. An uncertainty o f 2 % in dose measurement was recorded. Good agreement 
was obtained between FDD measurements in water by using Ge-doped optical fibres 
within 1.5% and 1.1% with ionization chamber measurements and BJR tabulated data 
respectively. In addition, agreement between FDD measurements by optical fibres in 
water and the RMI 457 solid water phantom was within 2.5% for the 10 x 10 cm^ 
field size applicator, while the maximum deviation between the optical fibre 
measurements for FDD in water and in RMI 457 was 3.7%, observed for the square 
applicator with a 6  cm diameter lead insert, the variation reducing to 2.5% for the 
square applicator with a 4 cm diameter lead insert. No significant difference was 
observed between optical fibre measurements for FDD in water and RMI 457 solid 
water phantom for the 6  and 4 cm circular field size. This is o f interest given the 
concern mentioned by Lee and Chan (2000) that use o f a lead cut-out with the square 
applicator might be expected to lead to scatter production for small field sizes with 
consequent effect upon depth doses. While no such effect was observed, nevertheless 
the present study does indicate that the small size and high sensitivity o f Ge-doped 
optical fibres dosimeters allows for the mapping of doses at small field sizes, also 
addressing the alignment problems stated in the addendum to the IFEMB code 
(Aukett et ah, 2005).
In chapter 4 the aim was to establish the methodology o f dose measurements 
using Ge-doped optical fibres dosimeters to distances down to 1 mm and to 
investigate the sensitivity of the dosimeters for detection both for the possibility of 
short range dose deposition from beta components as well as gamma/x-mediated dose. 
Ge-doped optical fibres dosimeters have been employed in obtaining doses at 
distances very close to the source (for the particular exercise, down to separations o f 1 
mm). Use was made o f two lab sources; ^^^Ba and ^"Co, the sources being chosen due 
to their low activity of 0.41 MBq and 0.434 MBq at time o f use, respectively, and in
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part because of the associated beta emissions, allowing investigation o f beta dose 
close to the encapsulation surface. Here the concern was that a fraction o f beta 
particles might not have been stopped by the encapsulation as a result o f possible 
imperfections in the source encapsulation. In air measurements were obtained along 
the transverses axes of the ^^^Ba and ^^Co sources at distances from 2  mm to 2 0  mm 
from the source centre using the Ge-doped optical fibres and an irradiation duration of 
3 weeks and 3 days for the two sources respectively. Simulation of the setup was 
made using the EGS/DOSRZnrc Monte Carlo code. Dose measurements were 
compared with Monte Carlo simulated doses when only photon-mediated dose was 
included, and when electron and photon-mediated doses were included. Good 
agreement was obtained between dose fall off measured for separations from 2  mm up 
to 20 mm with simulations of photon-mediated dose obtained using the DOSRZnrc 
Monte Carlo code, to within 2.6 % and 1.6 % for the ^^^Ba and ^^Co sources, 
respectively. Comparing dose measurements and simulation results for the ^C o 
source when beta emission was excluded and when both beta and photons emissions 
were included in the simulation, the results were found to be the same, confirming 
that, within measurement uncertainties, beta particle dose contributions were absent, 
the encapsulation acting in accordance with design, being effective in filtering out 
beta dose. The results of chapter 4 demonstrate Ge-doped fibre dosimeter offer 
considerable advantages over conventional dosimeters, for instance in mapping dose 
distribution measurements applicable at distances that range from very close to 
sources though to more distal evaluations. Chapter 4 results therefore encouraged 
utilization o f the Ge-doped fibre dosimeter dose measurement methodology to obtain 
dose distributions around some LDR (Low Dose Rate) sources and a ^^ I^r HDR 
(High Dose Rate) source down to 1 mm from the sources encapsulation.
In chapter 5, Ge-doped optical fibre dosimeters were utilized to obtain high 
spatial resolution dose measurements along the central and transverse axes at 
distances from 1 mm to 60 mm from the centre o f LDR '^^I seed model 6711 (14.8 
MBq and air kerma strength 0.508 pGym^/h at time of use) in PMMA. An 18 day 
irradiation period was used. Anisotropy in dose was also measured in PMMA at 
distances of 1 0  mm to 1 0 0  mm from the seed centre, in 1 0  mm increments and polar
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angles 10° to 90° in 10° increments from the central axis o f the seed (14.76 MBq and 
air kerma strength 0.507 pGym^/h at time o f use) for an 19 day irradiation duration. 
Dose measurements were compared with simulations of dose, obtained using the 
EGSRZnrc\DOSRZnrc Monte Carlo code, and with predicted doses obtained from the 
Variseed™ Treatment Planning System. Regarding transverse axis doses, good 
agreement was observed between measurements and TPS values and between 
measurements and DOSRZnrc Monte Caro simulations to within 2.7 ± 0.6 % and 1.9 
±  0.4 % respectively. However, larger absolute difference between the measured 
dose and that obtained through use o f the TPS along the transverse axis was recorded, 
at 16.9 % at 1 mm, the discrepancy reducing to 2.4 % by 2 mm. Regarding central 
axis doses; good agreement was obtained, again between dose measurements and 
calculations; the average difference between dose measurements and Monte Carlo 
simulation dose being 2.7 ± 0.6 %, while the average difference between dose 
measurements and values provided by the TPS was 9 ±  4 %. Good agreement was 
obtained between anisotropy dose measurements and calculations, the discrepancy 
between measured and simulated angular anisotropy of dose ranging between 1.9 ±  
1.3 % and 3.4 ±  1.0 %, corresponding to distances of 60 mm and 90 mm from the 
seed centre respectively. However, difficulties were faced in obtaining calculated 
angular dose at particular integer values o f angle due to practical restriction on 
accurate definition of r,z values, as implicit in the general formula. The results o f this 
chapter also demonstrated that the seed was symmetric in its encapsulation, 
confirming such assumption as used in modeling the seed during Monte Carlo 
simulation.
The ^^ 1^ model 9011 seed is a new thinner seed that has been introduced by 
Oncura, and GE Healthcare, the seed dosimetric properties remaining under 
investigation internationally, to the extent that the seed has not yet been used in the 
brachytherapy clinic, in line with American Association o f Physicists in Medicine 
(AAPM) Task Group (TG-43) recommendations. Chapter 6  includes study o f the 
main *^ 1^ model 9011 dosimetric properties (dose), use being made o f Ge-doped 
optical fibres dosimeters to obtain dose in PMMA along the central and transverse 
axes at distances from 60 mm down to 1 mm from the source centre for 2 2  days
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irradiation duration. The seed was o f 15.69 MBq activity and air kerma strength 0.538 
jiGym^/h at the time o f use. The EGS/DOSRZnrc Monte Carlo simulation code was 
utilized to calculate dose for the same measurement points and setup, while predicted 
doses were also obtained using a VariSeed™ 8.0.2 TPS. Dose measurements 
compared with dose calculations and predictions along the transverse axis yielded 
agreement between measurements and TPS values and between measurements and 
DOSRZnrc Monte Caro simulations, to within 2.6 ±  0.3 % and 3.8 ±  0.8 % 
respectively, in line with dose measurements and calculated dose results obtained 
along the transverse axis of the model 6711. Along the central axis, the agreement 
between dose measurements and calculations was better than that obtained along the 
same axis in the case of the model 6711, the average difference between dose 
measurements and Monte Carlo simulation results being 1.5 ±  0.3 %, while the 
average difference between dose measurements and values provided by the TPS was 
3.0 ± 0.7 %. In regard to dose measurements and calculations for the models 
6711 and 9011, it has been found that dose around both sources are comparable.
In chapter 7, Ge-doped optical fibres dosimeters were used to perform dose 
measurements around a ^^ I^r HDR brachytherapy source (MicroSelectron V2) o f 
activity 1.938E+05 MBq activity and air kerma strength 21.325 pGym^/h at time of 
use. Source central and transverse axes distances from 1 mm to 90 mm for 9.99 min 
irradiation duration in PMMA medium were investigated. On this occasion, 
comparison of dose measurements with Monte Carlo simulations of dose and with 
TPS predicted doses were not done, our previous studies o f chapters 4, 5 and 6  
indicating that Monte Carlo simulation results were in each case in accord with Ge- 
doped optical fibre measurements. Ge-doped optical fibres have been shown herein to 
be successful in mapping dose along the transverse and central axes o f a HDR *^ I^r 
source at distances from 90 mm down to 1 mm from the sources centre, with 
uncertainty in relative dose measurements producing an average of 0.24 %, and 0.11 
% respectively. Again it is shown that Ge-doped optical fibre dosimeters offer 
considerable utility as TL- dosimeters in mapping high spatial resolution dose 
measurements along the central and transverse axes of a HDR ^^^ Ir source.
FATMAISSA2012 Page 161
Chapter 8: Conclusion and Future Work
Doped Optical Fibres Thermoluminescence Dosimetry fo r Brachytherapy
8.2 Suggestions for future work
Current dose evaluations within the study are relative dose measurements, it is 
suggested that time could be devoted to calibrating Ge-doped optical fibres against 
suitable caibrated ionization chambers, with traceable calibration to a primary 
standard. In this way, conversion could be made from TL-yield to absolute dose and 
allow energy dependency correction factors, dose non-linearity correction factors, 
dose rate dependence correction factors, etc to be obtained.
The results of chapter 3 indicate that due to their small size, high sensitivity 
and high spatial resolution, Ge-doped optical fibres dosimeters provide FDD 
measurements for small field sized applicators to high accuracy. This points to an 
ability to assess and avoid problems related to alignment. It also points to the ability 
to map small radiation field dose uniformity, a matter o f considerable current interest.
The response of Si0 2  is likely to be different in water and PMMA. While 
results for ^^ I^ (chapter 5) suggest this to be a rather small problem, nevertheless 
change in the photon spectrum with distance would lead to a changing response. It is 
possible that this could be investigated by using the EGSnrc/FLURZnrc code to run 
Monte Carlo simulation, and to calculate the spectrum as a function of depth. This 
would in turn, allow the folding of the photon spectrum with the relative mass- 
absorption coefficients of SiO: to water. Otherwise, by considering the attenuation of 
each photon component (and their respective contributions to the mass-absorption 
coefficient) as a function of distance, this would not take scattering into account, 
although as suggested, this process is fairly limited for ^^ I^. Also, investigating the 
differences between PMMA and water at these at low energies would also be useful 
using Monte Carlo simulation
Dose measurements and simulations around ^^ I^ (LDR) and ^^^ Ir (LDR) 
sources, as discussed in detail in chapters 5 and 7, could also be repeated in water and 
epoxy resin solid water, in a full scatter situation. This would allow comparison with 
the results of present research, looking for differences. In addition, work could now be 
undertaken using two or more LDR ^^ I^ sources in PMMA, water and epoxy epoxy
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resin solid water, mapping more realistic brachytherapy situations and associated 
complex dose distributions.
Results of HDR *^ I^r (LDR) obtained in chapter 7 confirm that Ge-doped 
optical fibre dosimeters are of considerable utility for HDR brachytherapy 
applications. Therefore, these high resolution dosimeters can be expected to be 
applied in the near future in obtaining dose measurements around a ^C o HDR source 
(model C0 O.A8 6 , manufactured by EZAG BEBIG) as for instance located at Queen 
Alexandra Hospital Portsmouth. Again measurements should be carried out in water 
and in an epoxy resin solid water equivalent phantom, allowing full scatter situations 
to be accommodated, using titanium and plastic applicators to deliver the source from 
its storage location to the point o f interest. Measurements could then be compared 
with Monte Carlo and TPS doses.
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Appendix j i .
125I Source Decay Details
Qpc=0.1858 MeV
T,„=59.49 d
EC : 100%
;Te‘
Y= 0.3549 MeV (6 .6 8 % )
Figure A-1. Schematic representation of EC decay of 2^ 5 -^  to the first excited state of ^ 25^^ •
The disintegration energy for the decay is Q ec = 0.1858 MeV. There is a single y-ray of 0.035 
MeV with an intensity of 6 . 6 8  % emitted, whereas there are several characteristic x-ray 
emitted in the range 0.027 to 0.032 MeV as a result of IC processes (see table 5.10b). The 
average number of photons emitted per designation with energy above 10 KeV is 1.4. The
half-life for decay is 59.49 days.
A 2 5 r
Table A-1
Energies and Intensities of Electrons Emitted by EC Decay of as CEs and 
Auger Electrons
Electrons
Mean Energy 
(MeV)
Absolute 
Intensity (%)
Auger L 0.0032 158.4
CEK 0.0037 80.2
Auger K 0.0227 20.0
CEL 0.0306 10.75
GEM 0.0345 2.15
Source: From National Nuclear Data Center (NNDC), Brookhaven National Laboratory NUDAT 
2.0. Electronic Version available online at NNDC: www.nndc.bnl.gov/nudat2/, July 2005.
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Table A-2
Energies and Intensities o f  y-rays as Results o f  y-Decay and Characteristic X-Rays 
by EC Decay o f  as shown in Figure A .l
A bsolute F sfp G y h " ' M B q -' m^
Energy Intensity (A*-eVp)« - U M B q - ' )
Photons (MeV) (%) (cm^ g"^) (Equation 2.63)
X L 0.0038 14.9 8.978 X 10+^ 2.315 X 10"'
X Ka2 0.0272 40.1 2.067X 10"' 1.035 X 10"^
X K al 0.0275 74.0 2.005 X 10"' 1.871 X 10"^
X KP3 0.0305 6.83 1.464 X 10"' 1.399 X 10"^
X Kpi 0.0310 13.2 1.395 X 10"' 2.619 X 10“^
X Kp2 0.0317 3.8 1.305 X 10"' 7.214 X 10"^
7 0.0355 6.68 9.429 X 10"^ 1.026 X 10“^
Mean energy Emean • 0.0283 MeV
(Equation 5.1)
Effective energy 0.0281 MeV
(Equation 5.2)
Effective mass energy 1.851 X 10"" cm^ g""
absorption coefficient.
iF^n/p)a,cil
(Equation 5.3)
Air kerma-rate 0.0348 pGyh"■' MBq"' m^
constant
(Equation 2.64)
Mean number of 1.5 (1.446)
photons emitted
per decay
The mean energy Emean» the effective energy E^ ff, the air kerma-rate constant as well as the 
number of photons emitted per decay considers only rays above lOkeV (cut-off value 
5 =  10 keV). Mass energy absorption coefficients for dry air are according to Hubbell and 
Seltzer/^ where a log-log interpolation has been applied to these tables.
Source: From National Nuclear Data Center (NNDC), Brookhaven National Laboratory NUDAT
2.0. Electronic Version available online at NNDC: www.nndc.bnl.gov/nudat2/, July 2005.
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192Ir Source Decay Details Appendix B
'“ irQ. =1.4597 MeV E^,max=0082 MeV (0.t03%)0
—   -----------------E ^_^=  0.259 MeV (5.6%p
b-E^-m«= 0.539 MeV (41.43%) 
0.675 MeV (48.0%)
Pt*
T,„=73.81 d
B : 95.13%
Ÿ-Ô.177MeV(4.3DloV.)
= 0.280 MeV (9.0Ol0‘^%)
jf=0.594 MeV (D.C42%)^7=0.417 MeV (0.669%) yaQ.ias MeV (0.2%)
7=0.766 MeV (1.3
7=1.061 MeV (0.053%)
(a)
w -4 —
P10‘^4)7=O.I
^=0.604 MeV (8.2%)— 
7=0^885 MeV (0,291%)
)^7= 0.589 MeV.(4.5214)|Y=0-309 MeV (29.68%)
7= 0.296 MeV 
7=0.(468 MeV
7=1.378M eV (ia iO '^ 4 ) 7=0.317MeV(82.71%) 7=0.613 MeV(5.34%)
Qec=1.0462 MeV 
( Ti,,=73.81 d 
-Os* EC: 4.87%
7=0.110MeV(0.012%) 7=0.329MeV(0.01714) — 0.681%
___________ 1- I . ..t___________ I ( ♦ »
0.096%
3.99%
7- 0.201 MeV (0.473%)^ 7=0.421 MeV (0.069%)
7=0.283 MeV (0.266%)
7=0.375MeVj0.726%)
7=0.489 MeV (0.438%)
7= 0.485 MeV (3.187%) 
7=0.704 MeV (5.3x10"^)
7=0.206 MeV (3.34%)
(b «Os
Figure B-1: Schematic representations of the two different decay schemes of . (a) p' 
decay I r . This is the main disintegration process for this nuclide occurring in almost
95% of decays. decays mainly to the third and fourth excited states of ^qlPt. The
disintegration energy for that decay is Qb. = 1.4597 MeV. On average, 2.2 photons are 
emitted with energy above 10 KeV mainly with enrgies 0.296, 0.309, and 0.317 (1.4 photons
out of 2.2, see also table B-3). (b) EC decays of^^Tr. decays mainly to the fourth
excited state of ^^iQs. The disintegration energy for the decay is Q ec = 1.0462 MeV. On
average, 0.1 photons are emitted with energy above 10 KeV mainly with energies 0.206 and 
0.485 MeV (see also Table B-3). In both decay schemes, several characteristics x-rays are
emitted (see also table B-3 and table B-5). The half life for ^^ I^r decay is 73.81 days.
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Table B-1
Energies and Intensities of P Particles Emitted by p Decay of 
'^ I^r as Shown in Figure 5.6a
Mean Energy 
(MeV)
Maximum Energy 
(MeV)
Absolute 
Intensity (%)
0.0136 0.0535 0.0035
0.0195 0.0757 0.0039
0.0211 0.0817 0.103
0.0716 0.2587 5.6
0.1621 0.5388 41.43
0.2099 0.6751 48.0
Mean P“ energy 0.1807 95.13
Source: From  N ational N uclear D ata C enter (NNDC), Brookhaven N ational 
Laboratory NUDAT 2.0. Electronic Version available online a t NNDC: 
w w w .nndc.bn l.gov /nudat2 /, July 2005.
Table B-2
Energies and Intensities of Electrons Emitted by p Decay of '^^ Ir as CEs 
and Auger Electrons
Electrons Mean Energy (MeV) Absolute Intensity (%)
Auger L 0.0072 8.0
Auger K 0.0510 0.39
CEK 0.0579 0.113
CEK 0.0986 0.00034
CEL 0.1225 0.149
CEM 0.1330 0.038
CENP 0.1356 0.0112
CEL 0.1631 5.9 X 10~®
CEM 0.1737 9.0 X 10"^
CENP 0.1763 1.2 X 10-5
CEK 0.2019 0.001
CEK 0.2176 1.878
CEK 0.2301 1.805
CEK 0.2381 4.442
CEL 0.2664 0.00035
CEM 0.2770 9.0 X 10"5
CENP 0.2796 2.6 X 10"5
CEL 0.2821 0.876
CEM 0.2927 0.2203
CEL 0.2946 0.778
CENP 0.2952 0.0652
CEL 0.3026 1.952
CEM 0.3052 0.195
CENP 0.3077 0.0579
(continued)
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Table B-2: Continued
Electrons Mean Energy (MeV) Absolute Intensity (%)
CEM 0.3132 0.4888
CENP 0.3158 0.1447
CEK 0.3381 0.025
CEK 0.3897 1.018
CEL 0.4026 0.0066
GEM 0.4132 0.00162
Œ N P 0.4157 0.00049
CEL 0.4542 0.295
CEM 0.4648 0.0722
CE NP 0.4673 0.02161
CEK 0.5102 0.0583
CEK 0.5151 0.000232
CEK 0.5210 1.9 X 10"^
CEK 0.5260 0.1747
CEK 0.5341 0.0635
CEL 0.5747 0.01405
CEL 0.5796 3.7 X 10"^
CEM 0.5853 0.003392
CEL 0.5855 2.9 X 10"^
CE NP 0.5879 0.001021
CEM 0.5902 1.38 X 10"^
CEL 0.5905 0.03305
CENP 0.5928 2.48 X 10"^
CEM 0.5961 1.1 X 10“ ®
CEL 0.5986 0.01485
CE NP 0.5987 2.0 X 10“^
CEM 0.6011 0.00777
CENP 0.6037 0.00237
CEM 0.6092 0.00357
CE NP 0.6117 0.001079
CEK 0.6874 6.0 X 10“®
CEL 0.7519 9.0 X 10“^
CEM 0.7625 1.8 X 10“^
CE NP 0.7651 6.0 X 10“®
CEK 0.8061 0.00165
CEL 0.8707 0.000314
CEM 0.8812 7.39X10“®
CENP 0.8838 2.25 X 10"®
CEK 0.9831 8.8 X 10"®
CEK 1.0115 6 .2 X 1 0 “®
CEL 1.0476 1.29 X 10“®
CEM 1.0582 3.07X10“®
CENP 1.0608 8.9 X 10“^
CEL 1.0760 1.04 X 10"®
CEM 1.0866 2.4 X 10“^
CENP 1.0892 7.4 X 10"®
(continued)
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Table B-2: Continued
Electrons Mean Energy (MeV) Absolute Intensity (%)
CEK 1.2998 5.9 X 10"®
CEL 1.3643 1.2X10"®
CEM 1.3749 2.8 X 10"^
CE NP 1.3775 8.5 X 10"®
Source: F rom  N a tio n a l N u c lea r  D ata C en te r (N N D C ), B rookhaven  N atio n a l 
Laboratory  NUDAT 2.0. Electronic Version available online a t N N D C : w w w .nndc. 
bn l.gov/nudat2/, July 2005.
Table B-3
Energies and Intensities of y-Rays as Result of y-Decay and Characteristic X-Rays 
as Result of IC, by P" Decay of '^ I^r as Shown in Figure 5.6a
Absolute F s (fiGy h“" MBq“"
Energy Intensity (rtenfp)a = U MBq"')
Photons (MeV) (%) (cm^g ') (Equation 2.63)
XL 0.0094 3.96 5.669 9.728 X 10"®
XKo2 0.0651 2.63 2.768 X 10"^ 2.176 X 10"^
XKal 0.0668 4.46 2.700 X 10"2 3.694 X 10"^
XKp3 0.0754 0.533 2.475 X 10"^ 4.563 X 10"®
XKpi 0.0757 1.025 2.468 X 10"^ 8.795 X 10"®
XKP2 0.0778 0.365 2.435 X 10"2 3.175 X 10"®
y 0.1363 0.2 2.438 X 10"^ 3.052 X 10"®
y 0.1770 0.0043 2.598 X 10"^ 9.076 X 10"^
y 0.2803 0.009 2.845 X 10"^ 3.294.x 10"®
7 0.2960 28.72 2.867 X 10"^ 1.118 X 10"^
7 0.3085 29.68 2.882 X 10"2 1.211 X 10"2
7 0.3165 82.71 2.891 X 10"^ 3.474 X 10"^
7 0.4165 0.669 2.955 X 10"^ 3.779 X 10"^
7 0.4681 47.81 2.965 X 10"^ 3.045 X 10"^
7 0.4853 0.0023 2.966 X 10"2 1.519X10"®
7 0.5886 4.517 2.956X10"^ 3.607 X 10"®
7 0.5935 0.0421 2.954 X 10"^ 3.388 X 10"®
7 0.5994 0.0039 2.953 X 10"^ 3.169 X 10"®
7 0.6044 8.2 2.952 X 10"^ 6.715 X 10"®
7 • 0.6125 5.34 2.950 X 10"^ 4.428 X 10"®
7 0.7658 0.0013 2.897 X 10"2 1.324 X 10"®
7 0.8845 0.291 2.844 X 10"^ 3.360 X lO"'"
7 1.0615 0.053 2.759 X 10"^ 7.125 X 10"®
7 1.0899 0.0012 2.745 X 10"^ 1.648 X 10"®
7 1.3782 0.0012 2.602 X 10"^ 1.976 X 10"®
Mean energy 0.3607 MeV
(Equation 5.1)
Effective energy Ees 0.3987 MeV
(E q u a tio n  5.2)
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Table B-3 Continued
Absolute Fg(^iGyh-' MBq-'m^
Energy Intensity (P e J p )a  = U MBq"')
Photons (MeV) (%) (cm  ^g"') (Equation 2.63)
Effective mass energy 2.915 XlQ-^cm^g"'
absorption coefficient.
(Men/p)a,eff (Equation 5.3)
Air kerma-rate constant Fs 0.1049 ixGyh"'MBq"'m^
(Equation 2.64)
Mean number of photons 2.2 (2.1727)
emitted per decay
The mean energy Emean/ the effective energy Eeff, the air kerma-rate constant Fs as well 
as the number of photons emitted per decay considers only rays above 10 keV (cut-off value 
5 =  10 keV). Mass energy absorption coefficients for dry air are according to Hubbell and 
Seltzer,"^  where a log-log interpolation has been applied to these tables.
Source: From National Nuclear Data Center (NNDC), Brookhaven National Laboratory 
NUDAT 2.0. Electronic Version available online at NNDC: www.nndc.bnl.gov/nudat2/, 
July 2005.
Table B-4
Energies and Intensities of Electrons Emitted by EC Decay of '^ I^r as CEs 
and Auger Electrons
Electrons Mean Energy (MeV) Absolute Intensity (%)
Auger L 0.0069 3.43
CEK 0.0365 0.035
Auger K 0.0483 0.189
CEL 0.0974 0.0107
CEM 0.1074 0.0026
CENP 0.1097 0.00078
CEK 0.1274 0.108
CEK 0.1319 0.524
CEL 0.1883 0.0568
CEL 0.1928 0.371
CEM 0.1983 0.0142
CENP 0.2007 0.00412
CEM 0.2027 0.0939
CE NP 0.2051 0.0271
CEK 0.2094 0.0215
CEK 0.2553 0.0015
(continued)
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Table B-4: Continued
Electrons Mean Energy (MeV) Absolute Intensity (%)
CEL 0.2703 0.00846
CEM 0.2802 0.00209
CE NP 0.2826 0.000606
CEK 0.3006 0.02476
CEL 0.3162 0.00036
CEM 0.3261 8.7 X 10“®
CENP 0.3285 2.6 X 10“®
CEK 0.3467 0.00178
CEL 0.3615 0.0082
CEM 0.3714 0.002004
CENP 0.3738 0.000586
CEL 0.4076 0.00053
CEK 0.4107 0.0631
CEK 0.4152 0.008
CEM 0.4175 0.000128
CENP 0.4199 3.8 X 10"®
CEL 0.4716 0.0159
CEL 0.4761 0.00206
CEM 0.4815 0.00382
CENP 0.4839 0.001128
CEM 0.4860 0.000499
CE NP 0.4884 0.000147
CEK 0.6300 4.4 X 10"®
CEL 0.6909 8.9 X 10"®
CEM 0.7008 2.1 X 10"®
CENP 0.7032 6.3 X 10"^
Source: F rom  N a tio n a l N u c lea r  D ata C e n te r (N N D C ), B rookhaven  N a tio n a l 
Laboratory  NUDAT 2.0. E lectronic Version available online a t N N D C : w w w .nndc. 
bn l.gov /nudat2 /, July 2005.
Table B-5
Energies and Intensities of y-Rays as Result of y-Decay and Characteristic X-Rays 
by EC Decay of '^ I^r as Shown in Figure 5.6b
Photons Energy (MeV)
Absolute 
Intensity (%) (cm^g"')
F sffiG yh -' MBq-' m® 
= U MBq-') 
(Equation 2.63)
XL 0.0089 1.53 6.778 4.241 X 10"®
XKa2 0.0615 1.2 2.949 X 10"^ 9.988 X 10"®
XKal 0.0630 2.05 2.867 X 10"^ 1.699 X 10"'
XKp3 0.0711 0.241 2.568 X 10"® 2.019 X 10"®
XKpi 0.0714 0.466 2.559 X 10"® 3.909 X 10"®
XKP2 0.0734 0.163 2.514 X 10"® 1.380x10"®
(continued)
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Table B-5: Continued
Photons Energy (MeV)
Absolute 
Intensity (%)
(/*en/p)a
(cm® g ')
FgltiGyh-'M Bq-'m ®  
= UMBq“') 
(Equation 2.63)
7 0.1104 0.0122 2.342 X 10“® 1.448 X 10“®
7 0.2013 0.473 2.676 X 10“® 1.169X10“'
7 0.2058 3.34 2.689 X 10“® 8.482 X 10“'
7 0.2833 0.266 2.849 X 10“® 9.855 X 10“®
7 0.3292 0.0174 2.904 X 10“® 7.633 X 10“®
7 0.3745 0.726 2.937 X 10“® 3.665 X 10“'
7 0.4205 0.069 2.956 X 10“® 3.937 X 10“®
7 0.4846 3.187 2.966 X 10“® 2.102 X 10“®
7 0.4891 0.438 2.966 X 10“® 2.916 X 10“'
7 0.7039 0.0053 2.921 X 10“® 5.002X10“®
Mean energy Emean 0.2524 MeV
(Equation 5.1)
Effective energy Egg 0.3719 MeV
(Equation 5.2)
Effective mass energy 2.879 X 10“® cm® g“"
absorption coefficient.
(Pen/p)a,eff (Equation 5.3)
Air kerma-rate 0.0042 pGyh"■' MBq“" m®
constant Fg (Equation 2.64)
Mean number of photons 0.1 (0.1265)
emitted per decay
The mean energy Emean, the effective energy Egg, the air kerma-rate constant Fs as well as the 
number of photons emitted per decay considers only rays above lOkeV (cut-off value 
5=  10 keV). Mass energy absorption coefficients for dry air are according to Hubbell and 
Seltzer,"® where a log-log interpolation has been applied to these tables.
Source: From National Nuclear Data Center (NNDC), Brookhaven National Laboratory NUDAT
2.0. Electronic Version available online at NNDC: www.nndc.bnl.gov/nudat2/, July 2005.
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